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CHAPTER I 
 
INTRODUCTION 
 
Motivation 
 The American Cancer Society estimates that 18,820 new cases of and 12,820 deaths from 
malignant brain tumors will be reported in the United States in 2006 with a five-year survival 
rate of 33% [1]. The average survival time for adults with infiltrating glioblastoma multiforme is 
only 12-18 months with a 5.1% three-year survival rate [2]. The current three-prong attack for 
brain tumor treatment is surgical resection of maximum tumor volume followed by radiation and 
chemotherapy. However, the blood-brain barrier often prevents cancer-targeting drugs from 
reaching the tumor, rendering chemotherapy ineffective; and while surgery and radiation therapy 
can effectively treat the tumor core, the fingerlike protrusions at the margins of infiltrating 
tumors make treating the entire tumor near impossible. The extent of surgical margin resection 
for both low-grade and high-grade tumors has been repeatedly correlated to patient quality of life 
and mortality [3-7], but is currently limited by the surgeon’s ability to discriminate between 
normal tissue and tumor margins during surgery. To this end, tools and techniques are constantly 
being developed to help locate the tumor and identify its margins during a resection procedure, to 
maximize tumor mass resection without sacrificing neurologic function. 
 Current methods for intra-operative tumor localization are limited in their ability to 
differentiate normal brain from tumor margins. Visual inspection can be highly subjective and 
inconclusive, especially when dealing with low-grade tumors or diffuse tumor margins which 
often resemble normal neural tissue. On-site pathology is more histologically reliable but is 
expensive, is far from real-time, and does not spatially demarcate margin extent. Three-
dimensional surgical navigation with x-ray computed tomography (CT) or magnetic resonance 
imaging (MRI) is extremely useful in tumor localization and debulking [8, 9] but limited in its 
margin sensitivity, as tumor cells have been found outside of delineated image margins in many 
documented cases [10]. Furthermore, deformation of brain tissue subsequent to craniotomy, 
retraction, and debulking by as much as a centimeter degrades the accuracy of surgical 
navigation based upon pre-operative images [11, 12]. Real-time intra-operative ultrasound 
overcomes limitations from brain deformation and can detect tumor margins because brain 
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tumors are usually hyperechoic relative to normal tissue, but it is less likely to be able to 
differentiate tumor from peritumoral edema, which is also hyperechoic [13, 14] and poor image 
resolution hinders correlation between image features and surgical position. Due to the inherent 
limitations of these adopted tumor visualization techniques, significant residual tumor cells 
frequently remain after resection [3, 5], emphasizing the need to develop an objective, on-site, 
real-time imaging system that is capable of detecting the margins of brain tumors with high 
sensitivity. It should be noted that such a system is not a replacement of current existing 
techniques; it will fill a significant need existing in current practice of brain tumor resection. 
 
Statement of Problem 
 Optical spectroscopy has the capability to provide real-time, on-site detection of tissue 
changes associated with the progression of disease. Over the past 20 years, the investigation of 
optical spectroscopy to differentiate between normal and diseased tissues has grown 
tremendously and been extended to a host of bodily tissues [15-17], with our research group at 
the forefront of applying autofluorescence and diffuse reflectance spectroscopy for tissue 
discrimination in the brain [18-20]. However, the majority of these investigations employ fiber-
optic probe-based spectroscopy systems designed for retrospective, proof-of-principle studies 
aimed to correlate spectral features to histopathological diagnoses of sample biopsies at single-
point interrogation sites. While these clinical trials are sufficient to demonstrate the capability of 
optical biopsy to detect tissue changes with disease, similar to on-site pathology, probe-based 
spectroscopy provides no information as to the spatial extent of disease and therefore is of 
limited clinical use for therapy guidance.  
 The extension of probe-based spectroscopy to spectral imaging seeks to overcome this 
limitation by acquiring spectral information at every point within a two-dimensional field of 
view on the tissue surface, thereby giving an objective, comprehensive snapshot of tissue 
pathology in real time. To realize significant utility as a therapy guidance tool, spectral imaging 
must be capable of rapid image acquisition with a convenient interface for seamless integration 
into the clinical environment. The effects of the transition to imaging on measured spectral 
lineshape must be investigated to determine if spectral differences between tissue types observed 
with probe-based spectroscopy are conserved. Finally, the accuracy with which spectral imaging 
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is capable of differentiating between normal and tumor tissues in the brain must be assessed, 
most notably at the tumor margins. 
 
Overview 
The objectives of the original research proposal were designed to translate existing fiber-
optic probe-based spectroscopy to spectral imaging capable of spatially resolved, macroscopic 
tissue interrogation in vivo. While the development of spectral imaging technology is not novel 
in its own right, its clinical application using combined tissue autofluorescence and diffuse 
reflectance for intra-operative brain tumor core and margin detection and surgical resection 
guidance remains unaccomplished. The primary goal of my research project was to assess the 
efficacy of using spectral imaging to rapidly and accurately demarcate tumor margins during 
surgery. As outlined above, successful translation from spectroscopy to imaging requires 
seamless integration of spectral imaging into the clinical environment, thorough investigation 
into the effects of such a translation on fluorescence and diffuse reflectance lineshape, and 
demonstration of high diagnostic accuracy of tumor margins from spectral imaging data.  
Chapter 2 provides background information to understand the biology and pathology of 
brain tumors, their growth and development, and the current techniques in their diagnosis and 
treatment. With emphasis on how optical biopsy methods overcome limitations in current tumor 
localization techniques, the principles behind optical spectroscopy and its application to brain 
tissue discrimination are summarized. The chapter concludes with a description of the impetus to 
extend optical spectroscopy to spectral imaging, the challenges inherent to such a translation, and 
the selection of and principles behind liquid-crystal tunable filter spectral imaging which is used 
throughout my research project.  
Chapter 3 describes the in vitro measurement of absorption and reduced scattering 
spectra for white matter, gray matter, and glioma samples. The mean optical property spectra are 
correlated to diffuse reflectance spectral features from probe-based spectroscopy and are used to 
develop gelatin-based phantoms which mimic human brain tissues in chapter 4 and to provide 
practical soft-tissue optical property limits for the investigations in chapters 5 and 6. 
Building upon the preliminary results of our research group in brain tissue diagnosis 
using probe-based spectroscopy, chapter 4 describes the design, construction, and testing of a 
liquid-crystal tunable filter spectral imaging system for clinical use in the operating room. The 
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system is thoroughly characterized in terms of linearity, field of view, resolution, and sensitivity 
and functionally tested in terms of image acquisition time and its capability to spectrally 
discriminate between phantom and brain tissues in vitro and in vivo. 
Chapters 5 and 6 investigate the potential effects of the translation from fiber-optic 
probe-based spectroscopy to non-contact spectral imaging on measured spectral lineshape. Upon 
the discovery of a significant disparity between probe-based and imaging lineshapes in 
fluorescence and diffuse reflectance spectra, the disparity is definitively attributed to inherent 
differences in the excitation-collection geometry of the two systems. The behavior of the 
lineshape disparity is subsequently investigated in terms of sample optical properties, incident 
excitation angle, and emission collection angles in chapter 5 and in terms of sample optical 
properties and the distribution of source-detector separation distances in chapter 6. 
Ultimately, the capability of the spectral imaging system to intra-operatively differentiate 
glioma tissues from normal cortex was assessed clinically in a retrospective study in Chapter 7. 
Spectral features in imaging fluorescence and diffuse reflectance spectra are correlated to 
histopathological diagnoses of human brain tissue biopsies to determine discrimination 
sensitivity and specificity for brain tumor demarcation and utility for surgical resection guidance. 
A summary of and conclusions from the dissertation as well as future directions for the 
research are outlined in chapter 8. 
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CHAPTER II 
 
OVERCOMING CURRENT LIMITATIONS IN BRAIN TUMOR  
MARGIN LOCALIZATION WITH OPTICAL BIOPSY 
 
Neurobiology of Brain Tumors 
 
Basic Neuroanatomy and Physiology 
 The central nervous system consists of the brain and spinal cord. Since the major goal of 
this dissertation is improved surgical guidance of tumor resection within the brain, this 
background will not involve information regarding the spinal cord and its associated tumors. The 
main parts of the brain which can be affected by tumors include the cerebrum, cerebellum, brain 
stem, and basal ganglia (Figure 1). The cerebrum is responsible for higher cognition, initiation of 
gross bodily movement, and interpretation of sensory information. The cerebrum primarily 
consists of white matter surrounded by an outer layer of gray matter, known as the cortex (Figure 
1a). Gray matter consists of neuronal cell bodies which perform the information processing in 
the brain while the white matter consists of neuronal axons which transmit the information from 
the cortex to other areas of the brain or to the rest of the body. The thickness of the cortex 
generally varies between one and four millimeters. The cerebrum is divided laterally into two 
hemispheres which contain frontal (cognition, olfactory, speech, and gross bodily movement), 
parietal (somatosensory interpretation, written language), occipital (vision), and temporal 
    
(a)                                                        (b)                                                         (c) 
Figure 1. Gross neuroanatomy of the brain depicting the (a) cerebral lobes, cerebellum, and brain stem, (b) gray 
matter cortex and underlying white matter, and (c) basal ganglia.  
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(hearing, interpretation of verbal language) lobes (Figure 1b). The cerebellum (Figure 1b), 
located below the occipital lobes, between the temporal lobes, and behind the brainstem, controls 
somatic motor function such as muscle tone, coordination of movements, and maintenance of 
balance. The brain stem (Figure 1b) is located at the base of the brain where it connects to the 
spinal cord. It controls involuntary movements such as breathing and heartbeat and provides 
motor and sensory information for the head and neck via the cranial nerves. The basal ganglia 
(Figure 1c) are comprised of three regions of subcortical gray matter – the putamen, caudate, and 
globus pallidus – which serve to inhibit muscles during movement, carry out subconscious motor 
programs, and are affected in diseases such as Parkinson’s disease and Hodgkin’s chorea. 
 Other anatomical landmarks of the brain which can be afflicted with brain tumors or 
serve as topographical landmarks for their classification are the meninges, the tentorium 
cerebelli, and the cranial nerves (Figure 2). The meninges consist of three membranes – the dura 
mater (outermost), arachnoid (middle), and pia (innermost) – which surround the brain to serve 
as a capsule against infection (Figure 2a). While any of the three membranes can be the source of 
tumor development, tumors of the meninges (meningiomas) most frequently derive from the 
arachnoid membrane. The tentorium cerebelli is a fold of the dura mater which separates the 
cerebellum from the cerebral occipital and temporal lobes. Tumors located above the tentorium 
cerebelli which afflict the cerebral hemispheres are denoted supratentorial, whereas tumors 
              
(a)                                                                                              (b) 
Figure 2. Gross neuroanatomy of the brain depicting the (a) meninges and (b) cranial nerves.  
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below it which afflict the brainstem are denoted infratentorial. The cranial nerves (Figure 2b) 
transmit sensory information and signals to control motor movement for structures of the head 
and neck and can be the source of brain tumors which develop from the Schwann cells 
(schwannomas) that myelinate them. 
 Physiologically, different types of brain tumors are categorized by the cells from which 
they develop [1]. As will be discussed in detail in the next section, a large proportion of primary 
and primary malignant brain tumors develop from glial cells [3], of which there are three types: 
• Astrocytes support and nourish neurons and supply phagocytic behavior to repair 
brain injury. Astrocytic proliferation following brain injury, known as gliosis, can be 
histologically confused with neoplastic transformation in a brain tumor. 
• Oligodendrocytes produce myelin to sheath neuronal axons of the central nervous 
system and increase transduction velocities of neuronal signals. 
• Ependymal cells line the ventricles of the brain and serve to circulate cerebrospinal 
fluid through the cerebrospinal fluid pathway. 
While not an exhaustive list, other types of cells found within the central nervous system which 
can lead to brain tumor development are: 
• Neurons receive and transmit electrical signals for communication between various 
areas of the brain and between the brain and the rest of the body. 
• Schwann cells are similar to oligodendrocytes in that they myelinate neuronal axons 
but are limited to the cranial nerves. 
• Lymphocytes serve to fight infection and while very few are found in the central 
nervous system, they can be the source of primary brain tumor development. 
 One of the most important physiologic structures of the central nervous system in terms 
of its impact on brain tumor diagnosis and treatment is the blood-brain barrier. The gaps between 
endothelial cells within the brain vasculature are smaller than elsewhere in the body, allowing 
free diffusion of gases such as oxygen and carbon dioxide and lipid soluble substances such as 
alcohol and nicotine, but preventing passage of most foreign molecules not essential for normal 
brain function. While blood-brain barrier minimizes the risk for brain injury due to foreign 
agents, it makes treating brain injury or disease more difficult since it blocks antibiotics such as 
penicillin used to fight infection. The blood-brain barrier can also negatively impact brain tumor 
diagnosis and treatment since exogenous contrast agents for various imaging modalities and 
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chemotherapy agents for tumor therapy are rendered ineffective. While high-grade brain tumors 
often compromise the blood-brain barrier, the breakdown is rarely complete, requiring higher 
doses of contrast or chemotherapeutic agents than necessary in other organs of the body, and the 
blood-brain barrier is usually intact in low-grade tumors and at the tumor margins. 
 
Anatomy, Physiology, and Pathology of Brain Tumors 
 Brain tumors can develop from a single abnormal cell with the ability to reproduce 
rapidly and proliferate. While different brain tumor types display different characteristics, there 
are many common properties between them. As the tumor begins to develop and grow outward 
from the parent cell, the daughter cells closely resemble the size and shape of the original parent 
cell. But as more mutations are randomly incorporated in the cells’ DNA, the cells begin to adopt 
various shapes and sizes which are often indicative of the type of tumor and the grade of the 
tumor can often be estimated by the resemblance to (or lack thereof) the derivative cell type. 
Despite irregular shapes and sizes, tumors often exhibit higher cell densities than normal tissue 
due to rapid cell replication. The final tumor stage often comes when additional genetic 
mutations turn the tumor malignant, which is followed by even more rapid proliferation and 
quick fatality of the host.  
 One of the most universal characteristics of cancer is its high metabolism for rapid 
cellular proliferation. To accommodate increased metabolism, tumors develop 
nucleocytoplasmic abnormalities such as mitotic figures (spindle fibres) on the cellular level and 
neovascularization on the gross level, evident by small, highly convoluted capillaries at the 
periphery of the tumor. However, when the tumor becomes too large for the small vessels to 
maintain, necrotic zones will develop at the tumor core while the outer edges of the tumor 
continue to feed and proliferate. 
 The architecture of brain tumors can vary from being well encapsulated, facilitating 
complete resection, to extending finger-like columns of tumor cells into the surrounding white 
and gray matter several centimeters from the tumor core, creating what are known as infiltrating 
tumor margins. While treatment of well-encapsulated benign tumors can be relatively straight-
forward through surgical resection or radiation therapy, treating infiltrating malignant tumors is 
limited by the tradeoff between aggressive removal of the tumor core and margins and 
conservative resection to ensure minimal removal of normal brain tissue and prevent 
10 
neurological deficit for the patient. As will be discussed in greater detail in the next section, 
limitations in the ability to differentiate between normal and tumor margin tissue for margin 
localization during resection surgery often prompt neurosurgeons to adopt a more conservative 
resection strategy by removing the tumor core but leaving the margins intact, especially in 
regions of eloquent brain tissue (parenchyma). 
 Given the large number of central nervous system tumors, a complete description of 
every tumor type is impossible here. Tumors of the central nervous system can be separated into 
intracranial and intraspinal tumors. Since the targeted disease of this dissertation is brain cancer, 
this section will be limited to intracranial tumors, with a brief description of the most frequent 
types in adults. As mentioned previously, intracranial tumors can be topographically separated 
into supratentorial or infratentorial depending upon their location relative to the tentorium 
cerebelli and can be histologically separated as primary or secondary. Primary intracranial 
tumors derive from cells native to the central nervous system and are classified according to their 
derivative cell (Table 1). Secondary tumors develop due to metastases from cancers elsewhere in 
the body, accounting for 20-25% of intracranial tumors and most commonly deriving from 
cancers of the lung (44%), breast (10%), kidneys (7%), and alimentary tract (6%). For prognostic 
purposes, intracranial tumors are also classified according to their malignancy on a scale (grade 
Table 1. Simplified histological classification of primary intracranial tumors. Reproduced from [1]. 
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I-IV) developed by the World Health Organization and as to whether they are parenchymatous, 
afflicting eloquent areas of the brain. 
 The most common intracranial tumors found in adults are: 
• Astrocytomas are histologically benign tumors deriving from astrocytes which are 
susceptible to malignant change (anaplastic astrocytoma, glioblastoma). They 
comprise 9.8% of all primary intracranial tumors and 25% of gliomas [3].  
• Glioblastomas are malignant, rapidly fatal, astrocytic tumors which arise from 
astrocytomas or de novo. They comprise 20.3% of primary intracranial tumors and 
50.7% of gliomas [3]. The cerebral hemispheres, basal ganglia, and commissural 
pathways are sites of predilection. The tumors lack a capsule, resulting in rapid 
infiltration with possible meningeal invasion and high incidence of recurrence even 
after apparent total resection. 
• Oligodendrogliomas are benign tumors arising from oligodendrocytes and are 
usually found in the cerebral hemispheres. They comprise 3.7% of primary 
intracranial tumors and 9.2% of gliomas [3]. The prognosis is regarded as relatively 
favorable but they can undergo malignant change. 
• Ependymomas are benign tumors arising from ependymal cells and occur at any 
level of the ventricular system. They comprise 2.3% of primary intracranial tumors 
and 5.6% of gliomas [3]. They are well circumscribed but can easily metastasize 
within the central nervous system via the cerebrospinal fluid pathway and can 
undergo malignant change. 
(a)                                                                                            (b) 
Figure 3. Distribution of all primary brain and CNS (a) tumors by histology and (b) gliomas by histology subtype. 
Reproduced from [3]. 
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• Meningiomas are benign tumors originating from the meninges surrounding the 
brain, most often from arachnoidal cells. They comprise 30.1% of primary 
intracranial tumors and afflict females 2-fold more often than males [3]. 
Meningiomas can recur even after apparent total resection but remain histologically 
benign. 
• Schwannomas are benign tumors arising from Schwann cells and are usually found 
on the cranial nerves, especially the vestibulocochlear (acoustic schwannoma) and 
facial nerves. Schwannomas comprise 8.0% of primary intracranial tumors [3] and 
may recur but remain histologically benign. 
• Pituitary tumors arise in the pituitary gland and comprise 6.3% of primary 
intracranial tumors [3]. They are generally classified as functionally inactive 
(chromophobe) or hormone secreting, with several varieties depending upon the 
derivative cell type (somatotropic, corticotropic, melanotropic, thyrotropic, prolactin-
secreting).  
As will be described in greater detail in the next section, treatment of infiltrating gliomas is often 
ineffective due to limitations in the real-time differentiation between normal and tumor margin 
tissue during surgery to achieve complete tumor removal without sacrificing patient neurologic 
function. Given that gliomas represent 40% of primary intracranial tumors and 78% of those 
tumors which are malignant [3], improved glioma resection is a significant area of study in the 
field of neurosurgery. The research in this dissertation focuses on developing a real-time, 
objective imaging system to demarcate glioma margins and overcome the limitations in current 
margin localization techniques, which are outlined in the following section. 
 
Current Methods in Brain Tumor Diagnosis and Treatment 
 
Brain Tumor Diagnosis 
 Currently, routine tests for the sake of screening for central nervous system tumors do 
not exist. The majority of central nervous system tumors are diagnosed during doctor visits for 
tumor-related symptoms usually resulting from increased intracranial pressure subsequent to 
tumor growth. Increased pressure commonly causes headaches and seizures, but can also lead to 
nausea and vomiting. The types of symptoms rarely identify the type of tumor but can often 
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reflect its location. For example, tumors which afflict the basal ganglia may affect fine muscle 
movement while those of the brain stem may affect the cranial nerves and sensory or motor 
information in the head and neck. A positive side effect of symptomatic diagnosis is that tumors 
in more eloquent areas of the brain which must be treated early before malignant transformation 
are the first to present with visible signs and symptoms. 
 The standard procedure to determine tumor topography and histology is tomographic 
imaging followed by either stereotactic biopsy or biopsy during surgical resection. Tomographic 
imaging provides the location and extent of the tumor for radiation, surgical, and possible 
stereotactic biopsy guidance. Stereotactic biopsy and subsequent confirmed histology of the 
tumor can be incorporated into the treatment plan and contribute to patient prognosis. 
 The three most widely used modalities for brain tumor imaging are x-ray computed 
tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography (PET) 
(Figure 4). X-ray CT and MRI give three-dimensional soft tissue information, x-ray CT in terms 
of relative absorption of x-rays and MRI in terms of the relative concentrations of protons, most 
often in the form of water. Magnetic resonance imaging is often preferred to x-ray CT for 
surgical planning because exogenous contrast agents such as gadolinium collect in brain tumors 
with a compromised blood-brain barrier and T2-weighted MR images highlight edematous zones 
which are often correlated with infiltrating tumor margins [4]. Neurosurgeons use the core and 
margin information and their proximity to eloquent brain tissue to determine the extent to which 
they plan to resect the tumor during surgery. 
 While x-ray CT and MRI provide tomographic images of brain anatomy, PET provides 
              
(a)                                                        (b)                                                         (c) 
Figure 4. Example (a) x-ray CT, (b) MR, and (c) PET images of brain tumors. X-ray CT and MR images copied 
from http://ampat.amu.edu.pl/przyp/case1/CASE1.HTM. 
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three-dimensional information on tissue metabolism. PET measures the concentration of 
exogenously administered radioactive glucose, which unlike many radionucleide tracers used in 
nuclear medicine is capable of crossing the blood-brain barrier via transport by specialized 
proteins. Since most tumors are aggressive and highly metabolic, they appear as hotspots on the 
PET images and their intensity can indicate the grade of the tumor; however, the inherent poor 
resolution of PET imaging limits their clinical applicability for surgical planning or margin 
identification. 
 Neurosurgical biopsies are administered stereotactically or during surgery to help guide 
surgical decisions to formulate the subsequent treatment plan. In stereotactic biopsy, a biopsy 
needle is guided to the tumor using tumor location from CT or MR images and trajectory 
information from a stereotactic frame rigidly attached to the patient’s skull or frameless 
stereotaxy with a surgical navigation system. In either case, a small sample of tumor tissue is 
extracted from the tumor core, withdrawn with the biopsy needle, and sent to pathology for 
histopathological diagnosis. Intra-operative biopsies can be repeatedly acquired to determine the 
extent of tumor margin resection, but biopsy diagnosis from pathology can take on the order of 
15-20 minutes, making the process relatively inefficient. 
 
Brain Tumor Treatment 
 Depending on tumor location and histology, the current three-prong attack for brain 
tumor treatment is surgical resection of maximum tumor volume followed by radiation and/or 
chemotherapy. Resection surgery alone has a mortality rate of 1% to 2% and morbidity rate of 
only 25% for neurological deficit [5]; therefore, the relief of tumor-related symptoms is often 
enough to warrant resection surgery. Surgical resection combined with radiation therapy is often 
sufficient to cure many benign tumors such as meningiomas, some ependymomas, 
gangliogliomas, and cerebellar astrocytomas, especially if the tumors are well encapsulated. 
However, for malignant tumors such as anaplastic astrocytomas and glioblastomas with 
infiltrating margins, the current treatment methods are rarely curative, tumor recurrence is 
common, and the doctor’s goals are predominantly palliative, to reduce the patient’s tumor-
related symptoms and extend his/her life as long as possible.  
 The crux of surgical resection is the amount of tumor which should be removed. For 
benign, well-encapsulated tumors, complete tumor removal only comes into question in areas of 
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eloquent cortex. For malignant tumors with infiltrating margins, the extents of tumor core and 
margin resection have been repeatedly correlated to patient quality of life and mortality [4-8]. 
Several studies indicate that complete tumor core resection significantly improves 2-year 
survival rate, median survival time, and mean functional ability (as measured by the Karnofsky 
Performance Scale) relative to subtotal resection [5, 6]. While complete resection of the tumor 
core is feasible, complete tumor margin resection as indicated by gadolinium contrast 
enhancement in post-operative MRI is achieved in less than 20% of infiltrating tumor surgeries 
[7, 9], generally due to limitations in the ability to differentiate between normal and margin 
tissue during surgery. Visual inspection can be highly subjective and inconclusive, especially 
when dealing with low-grade tumors or diffuse tumor margins which often resemble normal 
neural tissue. On-site pathology is more histologically reliable but is expensive, is far from real-
time, and does not spatially demarcate margin extent. Three-dimensional surgical navigation 
with x-ray CT or MRI is extremely useful in tumor localization and debulking [10, 11] but 
limited in its margin sensitivity, as tumor cells have been found outside of delineated image 
margins in many documented cases [12]. Furthermore, deformation of brain tissue subsequent to 
craniotomy, retraction, and debulking by as much as a centimeter degrades the accuracy of 
surgical navigation based upon pre-operative images [13, 14]. Real-time intra-operative 
ultrasound overcomes limitations from brain deformation and can detect tumor margins because 
brain tumors are usually hyperechoic relative to normal tissue, but it is less likely to be able to 
differentiate tumor from peritumoral edema, which is also hyperechoic [15, 16] and poor image 
resolution hinders correlation between image features and surgical position. Due to the inherent 
limitations of these adopted tumor visualization techniques, significant residual tumor cells 
frequently remain after resection [6, 7]. This limited success rate of complete margin resection 
prompts surgeons to adopt a conservative approach to margin removal [4] since the costs of 
speech, motor, or other functions which significantly affect patient quality of life far outweigh 
removal of a small percentage of tumor margin which most likely fails to lead to complete 
margin resection.  
 As mentioned above, radiation therapy and chemotherapy are often used to kill residual 
tumor and tumor margins after surgical resection. The two main types of radiation therapy are 
external beam radiation focuses an outside beam of radiation on the targeted tumor tissue and 
interstitial radiotherapy, or brachytherapy, which places radioactive seeds directly within the 
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tumor to impose a higher radiation dose on the tumor cells without damage to intervening normal 
tissue. Some studies have found that radiation therapy is more effective on rapidly growing cells 
[8], so doctors often reserve radiation therapy for high-grade tumors. While some brain tumors 
can be treated completely with radiation therapy (medulloblastomas), complete treatment of the 
fingerlike protrusions at the margins of infiltrating gliomas is nearly impossible; however, 
radiation therapy is always used for glioma treatment, with doses between 5,000 and 6,000 cGy 
[5, 7, 8] administered for a 3-cm radius around the tumor core [5].  
 Chemotherapy is predominantly reserved for treatment of high-grade tumors and 
lymphomas and many times combined with radiation therapy to increase survival rates [5]. 
Chemotherapeutic agents target and kill rapidly dividing cells such as high-grade tumor cells, but 
which can lead to severe side effects by targeting bone marrow, endothelial cells in the mouth 
and intestines, and hair follicles or damaging the heart, kidneys, and peripheral nerves. For 
treatment of malignant gliomas, carmustine and lomustine nitrosoureas and oral procarbazine are 
generally regarded as the most chemotherapeutic agents; however, as any foreign agent 
attempting to enter brain tissue, an intact blood-brain barrier blocks these cancer-targeting drugs 
from reaching the tissue, rendering chemotherapy ineffective for treatment of low-grade gliomas 
or infiltrating tumor margins.  
 Due to the inability of radiation therapy to target diffuse tumor margins and of 
chemotherapy to penetrate the blood-brain barrier intact in these tissue regions, treatment of 
infiltrating tumor margins for malignant gliomas is limited to surgical resection. The extent of 
surgical margin resection is dependent upon the surgeon’s ability to discriminate between normal 
tissue and tumor margins during surgery. Current methods of intra-operative tumor margin 
localization are severely limited either in their sensitivity (visual inspection, MRI), efficiency 
and spatial demarcation (on-site pathology), or accuracy (ultrasound), leading to complete tumor 
resection in less than 20% of glioma patients and emphasizing the need for a real-time, objective, 
non-invasive technique to map out brain tumor margins with high sensitivity and specificity. 
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Optical Spectroscopy for Intra-operative Brain Tumor Detection 
 
Principles of Fluorescence and Diffuse Reflectance Spectroscopy  
 A potential candidate for objective brain tumor margin visualization is an imaging 
system with contrast based on optical spectroscopy which can quickly and non-intrusively detect 
tissue changes associated with the progression of disease. Fluorescence spectroscopy and diffuse 
reflectance spectroscopy have been investigated in recent years for the development of new 
clinical diagnostic tools. Intrinsic fluorescence or autofluorescence spectra have been shown to 
differ between normal and neoplastic tissues in various organ systems possibly due to changes in 
fluorophore concentration or environment with the progression of disease [17]. Studies which 
exploit spectral differences for tissue discrimination have been carried out for the brain [18-21], 
bronchus [22], colon [23], cervix [24], bladder [25], esophagus [26], skin [27], breast [28], and 
arterial wall [29]. Exogenous fluorescent dyes, most notably hematoporphyrin derivatives 
(Photofrin, 5-aminoluvolinic acid), have also been shown to selectively collect in tumor tissue 
and have been used for enhancement of fluorescent contrast between normal and neoplastic 
tissue in animal models [30] as well as in the human lung [31] and colon [32]. While exogenous 
dyes have also been applied in the brain [9, 33, 34], the need for the disruption of the blood-brain 
barrier give exogenous dyes poor sensitivity for detection of low-grade tumors and tumor 
margins, a limitation which is described in greater detail below. 
 While fluorescence spectroscopy provides information about the chemical and 
morphological composition of tissue, diffuse reflectance spectroscopy yields information about 
tissue absorption and scattering [35]. During the progression from normal to neoplastic, tissue 
undergoes many structural as well as chemical changes at the cellular and subcellular level, 
altering the optical properties of the tissue and thereby enabling tissue discrimination with 
diffuse reflectance spectroscopy. The most drastic changes within a tissue diffuse reflectance 
spectrum between 400 and 600 nm frequently result from the amount of blood concentration or 
oxygenation within the tissue. Since cancers often develop neovascularization to sustain a high 
metabolism and generally shift to more anaerobic cellular respiration, diffuse reflectance 
spectroscopy has the potential to detect cancerous tissue from its blood absorption “signature.” 
Diffuse reflectance spectroscopy has been studied for tissue discrimination in the bladder [36], 
breast [37], colon [38], and skin [39, 40]. Although diffuse reflectance spectroscopy has not been 
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used for brain tissue discrimination, optical properties of normal and malignant brain tissue were 
found to be significantly different [41, 42]. Thus by combining fluorescence with diffuse 
reflectance spectroscopy, optical techniques can be used for brain tumor margin detection. 
 
Fluorescence and Diffuse Reflectance Spectroscopy in the Brain 
 The first effort to guide glioma resection in the brain with optical techniques employed 
exogenous fluorescence subsequent to systemic administration of 5-aminoluvolinic acid (5-
ALA) [9, 33], one of the precursors to hematoporphyrins along the heme biosynthesis pathway. 
Photosensitizers such as 5-ALA when administered systemically or topically, have been shown 
to selectively collect in tumor tissues. While 5-ALA itself is not fluorescent, its porphyrin 
derivatives exhibit strong red fluorescence in response to blue excitation light, making them 
useful for photodynamic therapy and potentially as a means to demarcate tumor borders. As 
mentioned previously, the clinical utility of any technique for glioma resection guidance depends 
on its ability to highlight infiltrating tumor margins from the surrounding normal brain tissue. To 
assess this capability in vivo, Stummer et al administered 5-ALA to patients before tumor 
resection surgery and acquired tissue biopsies from fluorescent and non-fluorescent regions 
along the tumor margins. The presence of fluorescence was correlated to histopathological 
diagnosis, and the presence of residual porphyrin fluorescence was correlated to residual 
gadolinium contrast enhancement in post-operative MRI as a measure of the extent of tumor 
resection. Over the course of two separate studies which involved 61 patients and acquired 353 
biopsy samples, porphyrin fluorescence possessed a sensitivity of 85%, specificity of 98%, 
positive predictive value (PPV) of 100% and negative predictive value (NPV) of 60% for the 
presence of tumor cells in the biopsy samples. High diagnostic sensitivity and specificity indicate 
sensitive detection without false prediction of the presence of tumor, leading to a high PPV 
which signifies excellent safety to avoid neurologic deficit. However, the low NVP indicates that 
biopsy samples without fluorescence often contained tumor tissue, suggesting limited efficacy 
for positive tumor margin demarcation. While the results demonstrate good correlation between 
residual fluorescence and residual MR contrast enhancement, the correlation simply follows 
from the fact that margin demarcation with porphyrin fluorescence is limited in much the same 
manner as with contrast-enhanced MRI. Since gadolinium and 5-ALA are both polar molecules 
which cannot freely cross the blood-brain barrier [43], contrast enhancement in both modalities 
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is only present in regions where the blood-brain barrier has been breached, such that neither 
modality enhances infiltrating tumor margins or low-grade gliomas.  
 While exogenous contrast methods are spatially correlated to the integrity of the blood-
brain barrier, autofluorescence and diffuse reflectance spectroscopy probe intrinsic tissue 
contrast, giving them the potential to overcome limitations of exogenous contrast by demarcating 
infiltrating tumor margins based upon the inherent changes in tissue structure and biochemistry 
subsequent to tumor invasion. The capability to optically detect intrinsic tissue changes with 
tumor progression using autofluorescence spectroscopy was first assessed by Chung et al [20]. 
Fluorescence excitation-emission matrices (EEMs) were measured ex vivo and in vitro for white 
matter, gray matter, and a variety of primary intracranial tumors, including various grades of 
gliomas. The EEMs showed three distinct groups of excitation-emission peaks in brain tissue: 1) 
360 nm excitation, 470 nm emission, attributed to NAD(P)H fluorescence; 2) 440 nm excitation, 
520 nm emission, attributed to flavin fluorescence; and 3) 490 nm excitation, 630 nm emission, 
attributed to intrinsic porphyrin fluorescence. In terms of differences in autofluorescence 
between tissue types, the measurements demonstrated greater fluorescence emission in white 
matter than gray matter, with peak intensity ratios which ranged from 1.7 to 2.7, and 
significantly greater NAD(P)H fluorescence intensity in normal brain than in glioma tissues.  
 Similar changes in fluorescence intensity were observed by Bottiroli et al during 
measurement of autofluorescence emission spectra in vivo from cortex, white matter, and tumor 
tissues in three glioblastoma patients [21]. With 366-nm excitation, peak autofluorescence 
emission occurred between 445 and 465 nm and was attributed to NAD(P)H. The measured 
spectra showed significant changes in fluorescence intensity and lineshape between normal and 
tumor tissues, with greater intensity in white matter than tumor, slightly greater intensity in 
cortex than tumor, and a red-shift in the peak fluorescence wavelength for tumor relative to 
normal tissues. Since the free form of NAD(P)H, which is associated with anaerobic metabolism, 
has a 30% lower fluorescence quantum yield and a shift in its fluorescence peak from 440 to 465 
nm relative to bound NAD(P)H [44, 45], spectral differences from tumor tissue were attributed 
to an impairment in metabolic equilibrium from damage to the aerobic machinery and a shift 
toward anaerobic respiration in tumor cells.  
 Subsequent to the findings of Chung et al and Bottiroli et al, our research group 
conducted an in vitro study to quantitatively determine how accurately combined fluorescence 
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and diffuse reflectance spectroscopy could differentiate between normal and tumor tissues in the 
brain [18] Fluorescence EEMs as well as diffuse reflectance and fluorescence spectra with 337 
nm excitation were measured from normal, glioma, and secondary tumors acquired from twenty 
patients, and spectral differences were correlated to histopathological diagnosis to develop 
empirical discrimination algorithms from the observed spectral differences between tissue 
groups. Measured diffuse reflectance spectra possessed lineshapes which were strongly 
modulated by the oxy/deoxy-hemoglobin absorption bands at 415, 542, and 577 nm and 
intensities which were significantly higher in white matter than in gray matter or tumor, which 
were similar. While fluorescence EEMs demonstrated no peaks at 440/520 or 490/630 nm 
excitation-emission as observed by Chung et al and tumor fluorescence was not red-shifted 
relative to normal tissues as observed by Bottiroli et al, fluorescence emission at 460 nm was less 
intense in tumor relative to normal tissues, consistent with previous results. Based on these 
spectral differences, primary brain tumors were accurately differentiated from white and gray 
matter using the difference in fluorescence intensity at 460 nm alone (97% sensitivity, 96% 
specificity, biased results), while the diffuse reflectance intensity at 625 nm and the ratio of 
fluorescence to diffuse reflectance at 460 nm were capable of separating secondary tumors from 
normal brain tissues (94% sensitivity, 90% specificity, biased results).  
 To determine the true clinical utility of optical spectroscopy for tumor resection 
guidance, our research group is in the middle of a multi-center clinical study to determine the 
diagnostic accuracy of combined fluorescence and diffuse reflectance spectroscopy for 
discriminating between normal and tumor margin tissues in vivo [19, 46, 47]. During craniotomy 
procedures for glioma resection or temporal lobectomy, multiple gray matter, white matter, 
tumor core, and tumor margin sites are selected for spectral measurement with a portable 
spectroscopic system [19]. Excitation light from a pulsed nitrogen laser (fluorescence) and 
halogen lamp (diffuse reflectance) are sequentially delivered to a point on the tissue surface by 
two of seven fibers within a handheld, beam-steered, fiber-optic probe. The other five fibers in 
the probe are used to collect remitted fluorescence and diffuse reflectance from the tissue surface 
and deliver it to a spectrograph for spectral measurement. Spectra are grouped as normal, tumor 
core, or tumor margin according to gold-standard histopathological diagnosis of tissue biopsies 
acquired at the interrogation site and analyzed to determine spectral differences between tissue 
groups. Despite only subtle spectroscopic differences between normal and tumor tissues, initial 
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reports using multivariate analysis of fluorescence and diffuse reflectance spectra measured from 
184 tissue sites in 35 of more than 125 patients measured to date demonstrate a diagnostic 
accuracy of 100%, 96%, and 94% for normal, tumor core, and tumor margin tissue samples, with 
only 2 out of 35 tumor margin sites misclassified as normal [46]. These results indicate not only 
the promising capability of combined autofluorescence and diffuse reflectance spectroscopy to 
provide contrast between normal and tumor tissues in the brain, but also its ability to overcome 
the limitations of current tumor margin localization techniques, accurately differentiate 
infiltrating tumor margins from surrounding normal brain tissue, and potentially affect more 
complete glioma resection. 
 
Spectral Imaging Development 
 Fiber-optic probe-based spectroscopy is useful for correlating spectral features to 
histopathological diagnosis at a specific interrogation site, to prove the principle that optical 
spectroscopy has the capability to rapidly, objectively, and non-invasively differentiate between 
tissue types. However, probe-based spectroscopy has limited clinical applicability since it 
produces single-point diagnostic measurements without providing spatial information regarding 
the extent of tumor margins, information which is necessary to efficiently guide tumor resection. 
For optical biopsy to be clinically useful, single-point spectroscopy systems must be extended to 
spectral imaging in which spectral information is acquired at every pixel within a two-
dimensional field of view, yielding spatial and spectral tissue information for a comprehensive 
snapshot of tissue pathology during surgery.  
 Successful translation from probe-based spectroscopy to macroscopic spectral imaging 
depends on three main factors: 1) reasonable image acquisition time of autofluorescence and 
diffuse reflectance despite significant decreases in excitation irradiance due to larger target areas, 
2) a convenient clinical interface for seamless integration into the surgical setting, and 3) 
maintenance of accurate spectral discrimination between tissue types. While spectral 
discrimination capability will be discussed in the last section of this background, speed of 
spectral image acquisition and creating a versatile, compact imaging system for use in the 
operating room depend to a large degree on optical design and spectral imaging implementation. 
The following section outlines the various modalities for spectral imaging and the selection 
process of liquid-crystal tunable filter spectral imaging for this research project. 
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Spectral Imaging Modalities 
 Acquiring spatially resolved spectral information via spectral imaging yields three-
dimensional data cubes with two dimensions of spatial information and one dimension which 
varies with wavelength (Figure 5). Spectral imaging methods have long been used in the fields of 
astronomy [48-50], remote sensing [51-53], and chemical compound analysis [54-56] to 
elucidate the composition and characteristics of terrestrial, atmospheric, and extra-terrestrial 
objects. Spectral imaging systems developed more recently for life science applications have 
been coupled to benchtop microscopes for fluorescence in situ hybridization [57-60], general cell 
visualization [61-63], and fluorescent-protein cell trafficking (FRET) [64, 65]. The surge of 
optical methods for tissue discrimination have led to many optical imaging systems for tissue 
contrast; however, few of the systems designed to date perform true spectral imaging, a term 
generally reserved for the acquisition of detailed spectral information at every pixel, and none 
have been quantitatively tested for guidance of disease management. Most tissue-based optical 
imaging systems acquire limited spectral information (a few emission bands), trading decreased 
spectral information for increased frame rates by employing filter-based assemblies containing 
bandpass-filter wheels, dichroic filters, and/or beamsplitters and oftentimes optically 
implementing tissue classification algorithms in hardware [66, 67]. These systems have been 
most commonly applied to exploit the preferential deposition of exogenous fluorescent dyes to 
tumor tissue [30, 68, 69] and to target the hemoglobin absorption bands of soft tissue for 
perfusion imaging [70, 71]. While the speed of these optical imaging systems is impressive, 
hardware acquisition of partial spectral information limits the complexity of viable classification 
 
Figure 5. Spectral image data cube with two dimensions (x,y) of spatial information and one dimension 
(wavelength) of spectral information. 
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algorithms, which are often unique to a given organ system, further requiring a separate imaging 
system for each tissue type.  
 Spectral imaging systems capable of good resolution across all three dimensions can be 
grouped according to the method by which they acquire three dimensions of information using a 
two-dimensional optical detector (CCD camera): line-scanning, tunable-filters, and multiplexing 
methods such as Fourier-transform interferometry. Line-scanning systems (Figure 6) utilize 
motors to scan a 1-D excitation-collection line across the tissue surface. At each scan position, 
the line of light collected from the tissue surface is aligned along one dimension of the CCD 
array while a grating disperses the spectral components along the orthogonal dimension. Thus, 
each image acquired by the CCD camera contains the complete spectra from one spatial row of 
the image, and successive CCD frames are acquired as the excitation-collection line is scanned 
across the tissue surface. Line-scanning methods are simple to implement; however, the motors 
often cause vibration artifacts within the images and the images require as many CCD frames as 
the spatial dimensionality of the image, resulting in time-consuming data readout from the 
camera. 
 Tunable-filter spectral imaging systems [72-74] continuously excite and collect emission 
from the entire tissue surface and employ an electronically tunable bandpass filter, such as a 
liquid-crystal tunable filter (LCTF) or an acousto-optic tunable filter (AOTF), to transmit or 
diffract, respectively, one band of the emission spectrum to the CCD camera at a time. In this 
way, tunable filter spectral imaging systems use the filter to directly parse the wavelength 
dimension of the spectral image. A frame of CCD data is acquired for each band of the emission 
spectrum, using the entire CCD array for spatial resolution. The spectral dimension of the image 
 
Figure 6. Schematic of line-scanning spectral imaging system [2] demonstrating single-line excitation and collection 
and dispersion of the spectral components of the collected line across the second dimension of the CCD camera. 
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is constructed by acquiring successive CCD frames as the filter tuning wavelength is swept 
across the spectral range of interest. The most recent generations of these filters possess a wide 
spectral range across the visible or infrared regions of the spectrum with excellent spectral 
resolution (±5 nm) and can be tuned on the order of microseconds (AOTF) to milliseconds 
(LCTF).  
 Liquid-crystal tunable filters are constructed from a stack of linear polarizers with 
interspersed layers of liquid crystals and birefringent crystals (Figure 7a). The retardance (R) of 
each stage, defined as the product of its thickness (d) and the difference between its ordinary (no) 
and extraordinary (ne) indices of refraction 
    ( )eo nndR −= ,      (1) 
can be modulated by applying a voltage to the liquid crystal and changing its extraordinary index 
of refraction. Altering the stage’s retardance affects the phase delay between the ordinary and 
extraordinary light rays emerging from the stage, thereby changing its transmission (T) as a 
function of wavelength (λ)  
( )xT 2cos
2
1= ,      (2) 
where 
λ
Rx = .        
The thicknesses (d) of the birefringent crystals in the filter stack and the voltages applied to the 
liquid crystals are often selected to produce a binary series of retardances – R, 2R, 4R, etc. – 
              
(a)                                                                           (b) 
Figure 7. Schematics showing (a) the construction of a liquid-crystal tunable filter (www.cri-inc.com) and (b) the 
principles of operation for an acousto-optic tunable filter (www.olympusfluoview.com/products/aotfproducts.html). 
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such that all of the stages transmit the selected passband while destructive interference at the 
other wavelengths “trims” the stopband light. The number of stages employed in the filter 
dictates the width of the passband and the degree of stopband attenuation.  
 The advantage to LCTF implementation in a spectral imaging system is the simplicity in 
the optical design. Without disturbance of the passband beam or moving parts to create vibration 
artifacts in the images, the system requires only a camera lens to focus the transmitted light onto 
the CCD focal plane. However, the peak transmission of liquid-crystal devices for co-polarized 
light ranges from 5% (at 400 nm) to 60% (at 700 nm) across the visible spectrum, and a major 
drawback to any filter-based imaging system is the inherent trade-off between the system’s 
optical throughput (3-10%) – defined as the fraction of light collected by the imaging system 
which is ultimately detected by the camera – and its spectral resolution. 
 Acousto-optic tunable filters apply radio-frequency (RF) acoustic waves to modulate the 
index of refraction of the filter crystal. If the incident wavelength satisfies a momentum-
matching condition based upon the frequency of the RF wave, the linear polarization states of the 
incoming light are diffracted to the opposite state and the light is deflected upon its exit from the 
crystal, with two symmetrically diffracted passband beams and a transmitted zero-order stopband 
beam exiting the filter (Figure 7b). Since the diffracted and zero-order beams must be separated 
for spectral imaging, optical design of AOTF systems requires either: 
1) a long object distance to allow physical separation of the diffracted and zero-order 
beams; or,  
2) orthogonally oriented polarizers on either side of the filter to polarize the input 
light and allow only orthogonally oriented output light (i.e. the passband) to reach 
the camera.  
Although AOTF diffraction efficiency is on the order of 90-95% for polarized input light (and 
70% for unpolarized light), both beam separation solutions result in a loss of at least 50% of the 
light collected from the sample. 
 Multiplexing methods for optical measurements were first developed for spectral analysis 
in the infrared region of the electromagnetic spectrum due to a dearth of low-noise infrared 
detectors. Rather than isolating and measuring individual spectral bands of a signal, multiplexing 
methods weigh the spectral components in groups using orthogonal basis functions (cosines in 
the case of Fourier spectroscopy) and measure the total intensity of each weighted group. 
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Measuring multiple spectral components simultaneously and back-calculating their intensities 
from the weighted measurements provides greater optical throughput than spectrometer and 
filter-based systems with subsequent increase in signal-to-noise for equivalent integration times.  
 Fourier-based imaging systems use Michelson or Sagnac interferometers where the 
optical path difference (OPD) between two beams created and subsequently recombined by a 
50/50 beamsplitter is varied between successive CCD frames (Figure 8a). Varying the OPD 
modulates the interference pattern seen by the CCD camera, building interferograms at each 
pixel as the OPD is shifted and the CCD frames are acquired. After complete image acquisition, 
each pixel interferogram represents the Fourier transform of the pixel spectrum and can be 
individually converted to such via the inverse Fourier transform (Figure 8b). Employing a 
beamsplitter-based interferometer for multiplexing provides a theoretical system optical 
throughput of 50% (half the light is lost back out the entrance port) over the entire spectrum and 
a multiplex advantage of 8/N  (N = number of frames) over measuring the wavelengths 
individually with a filter system. However, considerable overhead is expended in image 
acquisition time since spectral extraction must be performed for every spatial pixel within the 
image. This process requires N2 additions or multiplications at each pixel, a process that can 
become computationally intensive for a highly resolved image. Also, the relationship between 
sampling the interferogram and the spectrum is not intuitive, to the point that certain 
combinations of image acquisition parameters can lead to incomplete spectra or images with 
              
(a)                                                                           (b) 
Figure 8. (a) Michelson interferometer with laser input showing interference fringes as a result of changes in optical 
path difference with radial position. In spectral imaging, one of the mirrors is replaced with the sample of interest, 
and the other mirror is scanned along the optical axis to create multiple OPD values. (b) Example inverse Fourier 
transformation from interferogram as a function of optical path difference to spectrum as a function of wavenumber 
(inverse of wavelength). 
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spatial harmonics. Furthermore, the optical designs of multiplexing systems are somewhat 
complex and system performance is often extremely sensitive to optical alignment.  
 As part of a previous project, our research group evaluated three benchtop spectral 
imaging systems to determine which system was most amenable to rapid autofluorescence 
imaging in a clinical setting [75]. A detailed description of this evaluation can be found in 
Appendix A. The three systems employed an acousto-optic tunable filter (AOTF), a liquid-
crystal tunable filter (LCTF), and a Fourier multiplexer, respectively, for resolution of the 
spectral image dimension. Briefly, the systems were quantitatively compared in terms of optical 
throughput and imaging signal-to-noise ratio in strong reflectance and weak autofluorescence 
images. While the Fourier system enjoyed the highest optical throughput, the LCTF system 
generated the highest signal-to-noise ratio in both types of imaging and proved to be the most 
versatile with the simplest optical design. It was based upon this evaluation that our research 
group chose to develop a LCTF spectral imaging system for clinical implementation in this 
research project. 
 Precise resection of brain tumors in functionally or anatomically eloquent areas or deep-
seated regions of the brain often requires enhanced tumor visualization and access. To this end, 
the neurosurgical field has increasingly exploited adjuncts such as endoscopes, operating 
microscopes, and neuro-navigational systems to affect more complete and accurate tumor 
resection. The flexibility of endoscopes facilitates neurosurgical access to and visualization of 
lesions in hard-to-reach areas of the brain with less tissue manipulation than conventional 
retraction [76]. Neuro-endoscopes have been employed for access to intraventricular lesions 
[77], for a transnasal approach to the brainstem [78, 79], and with ultrasound guidance for a 
variety of lesion treatments [80, 81]. The magnification and illumination of operating 
microscopes make them indispensable for precise resection of brain tumors such as brainstem 
and motor strip gliomas and acoustic neuromas which abut cranial nerves. Use of operating 
microscopes has become so routine for tumor resection that several image-guided surgical 
systems have been developed for direct microscopic interface. These systems [82-85] have been 
investigated for treatment of general gliomas, cerebral arteriovenous malformations, acoustic 
neuromas, and brainstem neoplasms. While not directly interfaced, operating microscopes have 
also been used in conjunction with image-guided surgery systems for epilepsy treatment and 
resection of gliomas, pituitary tumors [86], and supratentorial cavernomas [87], and have even 
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been employed with new intra-operative MR imaging systems [88-90]. With the increased use of 
operating microscopes, endoscopes, and microscope-based navigation systems during 
neurosurgery, the ultimate objective of this research project is to develop a spectral imaging 
camera head with variable interfaces that may be selected based on tumor type, location, and 
surgical need. For my dissertation research project, as a logical first step for resection guidance 
of gliomas which predominantly present within the cerebral hemispheres, coupling the spectral 
imaging system to a standard operating microscope will help affect a seamless integration of 
efficient spectral diagnosis into the surgical setting. 
 
Effects of the Translation from Probe-Based Spectroscopy to Spectral Imaging 
 Ideally, non-contact spectral imaging would produce fluorescence and diffuse reflectance 
lineshapes equivalent to probe-based spectroscopy; otherwise, time and resources spent 
developing discrimination algorithms based upon spectral differences observed in probe-based 
data during large, multi-patient clinical studies are squandered, since new imaging-based 
algorithms must be determined. Investigators in the field of probe-based spectroscopy and 
spectral imaging have always been diligent in accounting for spectral variations in source 
illumination and detector sensitivity to remove the effects on measured lineshape of factors 
extrinsic to the sample, suggesting at first glance that producing equivalent lineshapes between 
probe-based spectroscopy and spectral imaging is as simple as applying the standard spectral 
calibration procedure outlined in every optical biopsy manuscript to our spectral imaging system. 
However, investigations over the past 20 years have repeatedly demonstrated that measured 
spectral lineshape is equally affected by the excitation-collection geometry of the measurement 
system, even for probe-based spectroscopy measurements. The results of these investigations 
indicate that spectral lineshape is modulated by two main factors. First, the sample optical 
properties dictate the impulse response of light distribution within the tissue in terms of the 
relative propagation and attenuation of different wavelengths and the subsequent intensity, 
spatial distribution, and angular profile of light emitted from the tissue surface. Second, the 
excitation-collection geometry of the measurement system dictates the convolution of that 
impulse response with the spatial dimensions of the excitation and collection regions and the 
excitation-collection angles to determine what fraction of the light emitted at each wavelength is 
ultimately measured. Therefore, an excitation-collection geometry which involves spectral 
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variations in the fraction of remitted light collected by the system impacts the measured spectral 
lineshape despite correction for excitation spectrum and detector sensitivity. 
 The transition from probe-based spectroscopy to spectral imaging often involves a drastic 
shift in excitation-collection geometry, both spatially and in terms of angular relationship to the 
tissue surface (Figure 9). Spectroscopy probes often contain multiple fibers, some of which are 
used for excitation delivery and the rest for emission collection. Direct contact of the probe tip 
with the tissue surface and the specific configuration of the probe – the relative positions of the 
excitation and collection fibers, the gap between the fiber tips and the tissue surface, and the 
fiber polish angles – produce consistent excitation and collection angles for every sample but 
                
(a)                                                                    (b) 
                  
(c)                                                                     (d) 
Figure 9. Excitation-collection geometries for example probe-based spectroscopy and non-contact spectral imaging 
systems. (a) Fiber-optic probe with a single excitation fiber, fibers polished normally, and direct contact between the 
fibers and the tissue surface. (b) Spectral imaging system with non-contact excitation and collection. (c) Cross-
section of the probe-tissue interface for a six-around-one probe configuration with a central excitation fiber and six 
surrounding collection fibers relative to the light distribution in the tissue. (d) Spectral imaging field of view and 
individual pixels relative to the excitation spotsize and subsequent light distribution.  
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create a unique set of source-detector separation distances (Figure 9a,c). Since the spatial 
distribution of light remitted from tissue varies with optical properties, its relative relationship to 
the fiber configuration will vary with wavelength, such that lineshapes measured with probe-
based spectroscopy will be influenced by spectral variations in collection efficiency.  
 While multiple modalities exist for spectral imaging implementation, most spectral 
imaging systems acquire spectral data with non-contact excitation and collection (Figure 9b). 
When the excitation spot is much larger than the system field of view, as is often the case, each 
pixel in the image can be treated as a small collection region surrounded by a semi-infinite 
excitation spot (Figure 9d), and its spatial excitation-collection geometry as a convolution of all 
possible source-detector separation distances. However, non-contact imaging produces a 
geometry whose excitation and collection angles vary not only from image to image but across 
pixels within a single image when the sample surface topography is non-uniform. Therefore, 
while the collection efficiency of spectral imaging is not sensitive to optical property variations 
in the spatial distribution of remitted light, it is sensitive to the relative relationship between the 
excitation-collection angles and the angular emission profile of remitted light. If angular profiles 
of surface emission for a given excitation angle depend upon sample optical properties, angular 
emission will vary between wavelengths and their relative measured intensities will be 
modulated by detector collection that is limited to a narrow range of emission angles. If angular 
emission profiles depend upon incident excitation angle, an undulating sample surface can 
similarly induce spectral distortions within imaging spectra and extrinsic differences between 
them.  
 While previous studies in the literature, outlined below, have investigated fluorescence 
and diffuse reflectance propagation with results which hint at some of the aforementioned effects 
of excitation-collection measurement geometry on measured spectral lineshape, no group has 
examined the effect of the shift in spatial and angular excitation-collection geometry from probe-
based spectroscopy to non-contact spectral imaging. As such, there exists a need to characterize 
fluorescence and diffuse reflectance propagation and angular emission profiles as functions of 
incident excitation angle and sample optical properties to predict the potential effects of such a 
transition on discrimination accuracy between tissue types.  
 Correlations of fluorescence and diffuse reflectance angular emission to the optical 
properties of tissue and to the incident angle of excitation light have not been thoroughly 
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explored in the literature. Using Monte Carlo simulation, Qu et al reported “nearly Lambertian” 
angular emission profiles for fluorescence and diffuse reflectance when excitation is normal to 
the tissue surface [91]. Angular emission profiles for diffuse reflectance deviated from 
Lambertian behavior when the excitation was delivered at oblique angles (30° and 75° with 
respect to the surface normal) such that the emission was biased away from the source, indicating 
that angular emission of diffuse reflectance may be dependent on sample optical properties when 
the excitation is delivered at an oblique excitation angle. Churmakov et al reported similar 
roughly Lambertian emission behavior for diffuse reflectance when excited normal to the surface 
[92]. While these results hint at angular emission profiles of diffuse reflectance which are 
dependent upon incident excitation angle, neither group examined fluorescence emission 
behavior, investigated the correlation between angular emission and sample optical properties, or 
provided a detailed explanation for the behavior of the bias. 
 Research into diffuse reflectance propagation in tissue began with one-dimensional 
depth-resolved investigations in which diffuse reflectance was modeled as a function of optical 
properties using photon migration theory [93]. Several groups have also simulated or measured 
radially resolved profiles of diffuse reflectance for wide ranges of optical properties, but the 
results were used to develop inverse models for in vivo optical property determination [41, 94]. 
The authors concentrated on producing calibrated data for specific collection geometries and did 
not extend their findings to how profile changes with optical properties might affect clinically 
measured spectra. Bargo et al [95, 96] measured the collection efficiency of a single excitation-
collection fiber and of an excitation-collection fiber pair as a function of optical properties and 
separation distance, but defined collection efficiency as the fraction of light impinging on the 
face of the collection fiber that falls within its acceptance cone, without investigating how the 
absolute emission intensity varies with optical properties (i.e. wavelength) and would thereby 
also affect diffuse reflectance lineshape.  
While several studies have demonstrated changes in diffuse reflectance lineshape 
subsequent to a shift in excitation-collection geometry, the causes for the behavior were not 
thoroughly examined. Liu et al [97] simulated and experimentally measured diffuse reflectance 
for a subset of discrete optical property values and three different probe geometries, but did not 
discuss how the collection efficiencies of the specific probe geometries varied with wavelength. 
A subsequent paper from the same research group [98] used one of the investigated probes to 
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demonstrate that fluorescence and diffuse reflectance lineshapes from breast tissue change 
between three source-detector separation distances. However, the source of the disparities is not 
discussed other than to ascribe them to probing different depths of the tissue (the spectra from 
the different separation distances are used as independent inputs to a tissue classification 
scheme). Not surprisingly, the classification results show that the three sets of spectra yield 
similar discrimination success rates since there is "no apparent structural change in breast tissue 
with increasing depth," i.e. breast tissue is not layered.  
The only studies in the literature which have examined the combined effects of optical 
properties and excitation-collection geometry on diffuse reflectance lineshape were conducted by 
Schmitt and Kumar [99, 100]. Diffuse reflectance spectra were measured in the near infrared for 
a single excitation-collection fiber pair in an effort to determine how collected emission varied 
with separation distance (d = 1-6 mm) for various optical properties (µa = 0-1.0 mm-1, µs' = 0.5-
2.0 mm-1). They demonstrated that diffuse reflectance lineshape varies with source-detector 
separation distance and explained the shifts using diffusion theory. However, diffusion-based 
predictions broke down at small source-detector separation distances and thus far, no group has 
validated their results in the visible spectrum where increased scattering and absorption and the 
shorter source-detector separation distances of most fiber-optic probes (d = 0-1 mm) render 
diffusion theory inaccurate.  
Recent investigations into fluorescence propagation can be divided into two major 
categories: those that investigate depth-resolved fluorescence [101-106] and those that seek to 
extract intrinsic fluorescence information from fluorescence measurements [107-111]. Depth-
resolved fluorescence investigations predominantly aim to identify probe geometries which will 
collect fluorescence from specific layers in epithelial tissues, but they rarely worry about how 
optical properties and probe geometry affect the lineshape. While extracting intrinsic 
fluorescence information from fluorescence measurements recognizes the effects of optical 
properties on lineshape, and actually seeks to remove those effects, most of the methods nullify 
the effects of probe geometry by using diffuse reflectance information for fluorescence 
correction. Since the fluorescence and diffuse reflectance spectra are generally collected with the 
same excitation-collection geometry, diffuse reflectance is similarly modulated, eliminating any 
wavelength-specific geometry effects.  
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While depth-resolved and intrinsic fluorescence studies provide knowledge into 
fluorescence behavior, neither of them give insight into how tissue optical properties and 
excitation-collection geometry combine to modulate fluorescence lineshape. Surprisingly, while 
the recent investigations outlined above have strayed from the issue, two of the first 
investigations into fluorescence propagation initially demonstrated a dependence of fluorescence 
lineshape on excitation-collection geometry. Richards-Kortum et al [112] compared measured 
fluorescence spectra from regions inside and outside of the excitation spot. Keijzer et al [113] 
simulated and measured fluorescence spectra as a function of radial distance from the source. 
Both studies found that fluorescence lineshape drastically changes as collection is moved out of 
and further from the excitation spot. Shifts in lineshape are attributed to increased probing depth 
as the source-detector separation distance increases, subjecting the fluorescence to greater 
modulations from absorption. Since then, other groups have observed similar results [114, 115], 
but none have investigated spectral lineshapes measured with traditional fiber-optic probe 
configurations or non-contact imaging systems.  
 
 The high mortality rate for patients with malignant infiltrating gliomas due to tumor 
recurrence demonstrates the clinical need for more complete tumor margin resection, which has 
been repeatedly correlated to patient quality of life and survival. Limitations in current 
localization methods for infiltrating tumor margins emphasize the need for an intra-operative, 
objective method to spatially demarcate glioma margins for surgical resection guidance. 
Combined fluorescence and diffuse reflectance spectroscopy has proven capable of 
differentiating normal and tumor tissues in the brain and, more importantly, of discriminating 
infiltrating tumor margins from surrounding normal tissue. However, fiber-optic probe-based 
spectroscopy does not provide spatially resolved diagnostic information necessary to intra-
operatively guide tumor resection, calling for an extension of probe-based spectroscopy to 
spectral imaging for a comprehensive snapshot of tissue pathology during surgery. The 
translation from spectroscopy to imaging involves a drastic shift in measurement excitation-
collection geometry, with subsequent effects on measured spectral lineshapes that have been 
suggested in the literature but never thoroughly examined or characterized. The effect of 
excitation-collection geometry on diagnostic accuracy must be assessed by developing 
discrimination algorithms specific to spectral imaging data for differentiation between normal 
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and neoplastic brain tissues, in order to definitively determine the clinical utility of combined 
fluorescence and diffuse reflectance spectral imaging for infiltrating tumor margin resection 
guidance. The studies outlined in the subsequent five manuscripts have been designed to address 
these needs. 
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CHAPTER III 
 
IN VITRO DETERMINATION OF NORMAL AND NEOPLASTIC HUMAN BRAIN TISSUE 
OPTICAL PROPERTIES USING INVERSE ADDING-DOUBLING 
 
Abstract 
To complement a project toward the development of real-time optical biopsy for brain 
tissue discrimination and surgical resection guidance, the optical properties of various brain 
tissues were measured in vitro and correlated to features within clinical diffuse reflectance tissue 
spectra measured in vivo. Reflectance and transmission spectra of in vitro brain tissue samples 
were measured with a single-integrating-sphere spectrometer for wavelengths 400 to 1300 nm 
and converted to absorption and reduced scattering spectra using an inverse adding-doubling 
technique. Optical property spectra were classified as deriving from white matter, gray matter, or 
glioma tissue according to histopathologic diagnosis and mean absorption and reduced scattering 
spectra were calculated for the three tissue categories. Absolute reduced scattering and 
absorption values and their relative differences between histopathological groups agreed with 
previously reported results with the exception that absorption coefficients were often 
overestimated, most likely due to biologic variability or unaccounted light loss during 
reflectance/transmission measurement. Absorption spectra for the three tissue classes were 
dominated by hemoglobin absorption below 600 nm and water absorption above 900 nm and 
generally determined the shape of corresponding clinical diffuse reflectance spectra. Reduced 
scattering spectral shapes followed the power curve predicted by the Rayleigh limit of Mie 
scattering theory. While tissue absorption governed the shape of clinical diffuse reflectance 
spectra, reduced scattering determined their relative emission intensities between the three tissue 
categories. 
 
Introduction 
Diffuse reflectance spectroscopy is directly related to tissue absorption and scattering [1]. 
Because optical property differences between tissue types directly affect tissue diffuse 
reflectance, optical property spectra have the capability to explain feature disparities in diffuse 
reflectance spectra observed between normal and neoplastic tissues. The most obvious change 
within a diffuse reflectance spectrum during the progression from normal to neoplastic 
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frequently correlates to an increase in blood absorption related to the development of neo-
vascularization inherent to tumor tissue. Our research group is focused on the development of 
using combined fluorescence and diffuse reflectance spectroscopy for brain tumor demarcation. 
We are currently in the process of acquiring spectra from a large multi-center clinical study in 
order to develop an unbiased discrimination method for differentiation between human brain 
tissue types [2-4]. It is therefore of extreme interest to us to understand the effect of optical 
properties on diffuse reflectance spectra of normal and malignant brain tissues, which in turn 
affect the performance of this method in tissue discrimination. 
Optical properties of normal and neoplastic brain tissues have been measured, reported, 
and compiled [5] within the literature multiple times, both at discrete wavelengths tailored for 
specific applications [6, 7] as well as over large spectral ranges [8-10]. However, many of these 
reports measure penetration depths and effective attenuation coefficients [5, 11, 12] which 
combine the individual contributions of absorption and scattering into a single tissue parameter, 
making it difficult to correlate their individual contributions to diffuse reflectance spectral 
features. Some reports measure optical properties or related parameters at isolated wavelengths 
which cannot be used to explain inter-tissue spectral feature disparities. Finally, some employ 
indirect methods to determine optical properties, such as Kubelka-Munk (which assumes 
isotropic scattering), that approximate the light transport equation and are subsequently limited 
in their accuracy and ability to predict soft tissue behavior.  
Inverse Monte Carlo (IMC) methods can be used to determine independent absorption, 
scattering, and anisotropy coefficients over any spectral range, without any simplifications that 
might limit their accuracy. This iterative method of light propagation repeatedly adjusts the 
sample optical properties until the Monte Carlo predictions for diffuse reflectance as well as 
diffused and collimated transmission converge to experimental values for a given wavelength. 
Due to its ability to compensate for different measurement and sample geometries and to account 
for sources of experimental error such as light lost out the sides of the sample, IMC is currently 
regarded as the most robust, versatile, and accurate optical property determination method 
available. However, large computation times are needed to acquire adequate signal-to-noise ratio 
from the Monte Carlo simulations and ensure proper convergence to the correct optical 
properties at each wavelength within the spectral range of interest. Thus, the measurement 
efficiency of IMC is poor, limiting researchers to its use at a few isolated wavelengths or across 
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spectral regions for only a handful of tissue samples. Bevilacqua et al [6] reported in vivo optical 
properties of brain tissues at four near-infrared wavelengths from a total of eight different tissue 
sites within two patients. Yaroslavsky et al [10] measured IMC absorption and scattering spectra 
(360-1100 nm) for a limited number of tumor and normal brain tissues which may not accurately 
represent true population values (biased results) and the inherent inter-patient variability that 
confounds most researchers.  
The inverse adding-doubling (IAD) method developed by Prahl et al [13] represents a 
numerical solution to the radiative transport equation which can be used to calculate the 
absorption (µa) and reduced scattering (µs’) coefficients of a sample from measurements of 
reflectance (R) and transmission (T). The program predicts R and T from the sample for a given 
albedo, optical thickness, and scattering anisotropy using the forward adding-doubling method. 
The predictions for R and T are then compared to the actual measurements, and the derived 
optical parameters are adjusted to obtain more accurate predictions. The process is repeated until 
the predicted and measured values match within a specified tolerance. These final optical 
parameters can then be used to calculate absorption and reduced scattering coefficients for the 
sample. If collimated transmission is independently measured from the sample, the IAD program 
is able to separate the contributions of scattering and anisotropy to reduced scattering, giving an 
estimate for the anisotropy factor and allowing subsequent calculation of the scattering 
coefficient. The main advantage to the IAD method is its combination of fast computation and 
validity over practically all albedo values. It has been used for optical property determination 
within a host of tissues [14], using double [15] and single integrating spheres [16] for reflectance 
and transmission measurement, and its accuracy has been validated by multiple research groups 
[13, 15, 17]. 
In this paper, we present results from a study of the optical properties from normal and 
tumor brain tissues in vitro.  Transmission and reflectance were measured from 83 samples of 
human white matter, gray matter, and glioma tissues from 400-1300 nm using a 
spectrophotometer, and the optical properties were calculated using an inverse adding-doubling 
method that has the accuracy equivalent to IMC determination and efficiency sufficient to 
interrogate a large population of tissue samples [13, 17]. Calculated brain tissue optical 
properties were compared to previously published optical property values determined by IMC [6, 
10]. The results were subsequently correlated to features observed in vivo within clinical diffuse 
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reflectance spectra from the three tissue classes in an effort to elucidate the tissue differences 
which underlie the spectral feature disparities between normal and neoplastic brain tissues. 
 
Materials and Methods 
 
Optical Property Spectral Measurement in vitro 
Eighty-three brain tissue samples were acquired during open craniotomy for tumor 
resection or temporal lobectomy. The samples were snap-frozen in liquid nitrogen after tissue 
removal and stored at –80ºC until in vitro measurement. Immediately prior to measurement, the 
samples were thawed for 10 minutes in a 25ºC, 7.4 pH phosphate buffer saline solution to 
remove residual blood. The samples were then mounted between two glass microscope slides 
and compressed in order to yield adequate surface area (greater than 80% of the port size). 
Surface tension with the microscope slides trapped the saline between the slides, keeping the 
samples well-hydrated during the measurements; and spacers were placed between the 
microscope slides to maintain a constant sample thickness throughout the measurements. The 
thickness of the samples ranged from 0.22 to 1.25 mm. Total reflectance (diffuse + specular) and 
total transmission (diffuse + collimated) spectra were measured from 400 to 1300 nm at four 
sites on each tissue sample using a Perkin-Elmer Lambda 900 Spectrophotometer with a single 
150-mm-diameter integrating sphere. The four reflectance and transmittance spectra were 
averaged and composite spectra were created for each tissue sample. The mean spectra were 
filtered with a high-order low-pass digital filter to remove system noise without losing spectral 
features. 
An inverse adding-doubling technique developed by Prahl et al [13] was used to 
determine the dimensionless albedo (α) and optical thickness (τ) spectra from the mean 
reflectance and transmission spectra for each sample. Four quadrature points were used in the 
IAD calculation and the indices of refraction of tissue and the glass slides were estimated to be 
1.40 and 1.54, respectively. Since collimated transmission spectra were not obtained in these 
measurements, a fixed anisotropy coefficient (g = 0.85) [10] was assumed for every wavelength 
and for every sample. The absorption and reduced scattering spectra were calculated from the 
albedo, optical thickness, and assumed anisotropy coefficient using 
( )g
ds
−=′ 1ατµ  
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where d is the sample thickness. The measurement protocol was independently validated by 
comparing measured transmission and reflectance measurements and subsequent IAD-calculated 
reduced scattering and absorption spectra to predictions from Beer’s Law and Mie scattering 
theory for solutions of polystyrene microspheres and various chromophores. The assumption that 
the anisotropy value has negligible effect on IAD-predicted reduced scattering coefficients was 
also verified for a range of measured reflectance and transmission values.  
Optical property spectra were calculated for 83 brain tissue samples acquired from 12 
patients. After measurement, each sample was fixed in formalin and sent to histology for tissue 
classification. Samples were classified as white matter, gray matter, or glioma. Mean and 
standard error of the absorption and reduced scattering spectra were calculated for each tissue 
category. 
 
Diffuse Reflectance Spectral Measurement in vivo 
The optical properties calculated in this work were compared to in vivo diffuse 
reflectance spectra measured as part of an on-going clinical study [2-4] at Vanderbilt University 
Medical Center. All patients undergoing open craniotomy for primary tumor resection or 
temporal lobectomy were recruited equally without age, race, and gender preference and written 
consent was obtained from each patient under a protocol approved by the Vanderbilt Institutional 
Review Board. Patients with recurrent brain tumor were not particularly selected. Fluorescence 
and diffuse reflectance spectra (400-800 nm) were measured using a portable spectroscopic 
system consisting of a nitrogen laser for fluorescence excitation, a white light source for diffuse 
reflectance, and a spectrometer all controlled by a computer. A detailed description of the 
instrument can be found elsewhere [2]. Light delivery and collection was measured using an 
optical probe consisting of seven, 300-micron (core) optical fibers in a six-around-one 
configuration with the fluorescence and diffuse reflectance excitation fibers located on opposite 
sides of the outer ring of fibers. 
Six to ten sites were investigated for each patient by the participating neurosurgeons. 
These sites usually included cortical tissues, brain tumor core, tumor margins, and normal brain 
tissues distal to the tumor bed as defined by intraoperative ultrasound and a surgical navigation 
system. The fiber-optic probe was placed lightly in contact with the surface of the investigated 
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site and three optical spectra (baseline, fluorescence, and diffuse reflectance) were sequentially 
acquired. Upon completion of spectral acquisition, a punch biopsy was taken from each 
investigated site and placed in formalin. The tip of the fiber-optic probe was maintained clean 
using saline-moisturized gauze throughout the study to avoid blood clot formation, which would 
induce artifacts within the measured spectra. Reference measurements were performed at the end 
of each study to monitor and account for any variations in system performance between 
experiments. This allowed spectral calibration and therefore direct spectral comparison between 
different patients. Biopsy samples were sent for histopathological processing and read by a 
consulting neuro-pathologist. 
All spectra were processed to eliminate inherent artifacts. The baseline spectrum was first 
subtracted from each emission spectrum. Calibration factors, derived from a standard calibration 
procedure, were then multiplied to the baseline-corrected spectra to remove wavelength-
dependent characteristics of the spectroscopic system. Processed spectra were then correlated to 
their corresponding histological identities and mean diffuse reflectance spectra were calculated 
for the three tissue classes: white matter (n = 55), gray matter (n = 58), and core glioma tissues (n 
= 82). 
Correlating spectral features between in vitro optical property measurements and in vivo 
diffuse reflectance spectra relies upon the assumption that in vitro optical properties are a 
reasonable approximation of the in vivo optical properties which yield the measured diffuse 
reflectance spectra. To validate this assumption, Monte Carlo simulation was used to estimate 
diffuse reflectance emission spectra from bulk white matter, gray matter, and tumor tissues with 
optical properties equivalent to our mean measured absorption and reduced scattering spectra. 
Briefly, diffuse reflectance emission was simulated using a grid of optical property pairs (µa, µs’) 
that spanned the mean optical property spectra from the three tissue classes. Each simulation in 
the grid generated a single diffuse reflectance intensity, ultimately creating a diffuse reflectance 
emission surface as a function of absorption and reduced scattering. This surface was 
interpolated using the measured absorption and reduced scattering spectra from the three tissue 
groups to produce simulated diffuse reflectance spectra. The three simulated diffuse reflectance 
spectra were uniformly scaled by the factor necessary to give the measured and simulated spectra 
from white matter equivalent average emission intensities between 600 and 800 nm. The scaling 
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was performed for comparison purposes while maintaining spectral lineshape as well as relative 
emission intensities between the three tissue categories. 
 
Statistical Spectral Comparison 
Student’s t-tests (two-tailed, unequal variance) were applied to the diffuse reflectance and 
optical property spectra to determine regions of significant spectral differences between tissue 
categories. Each tissue category was individually compared to the other two (i.e. white matter vs. 
gray matter; white matter vs. tumor; gray matter vs. tumor), and the calibrated diffuse reflectance 
intensities and optical property values at each investigated wavelength were treated as 
independent measurements. The null hypotheses were tested using a Student’s t-test at each 
wavelength and p-value spectra were compiled for the mean diffuse reflectance, absorption, and 
reduced scattering spectra between the tissue categories.  
 
Results 
 Based on histology, which served as the gold standard for all comparisons, the 83 tissue 
samples were identified to 19 white matter samples, 25 gray matter samples, and 39 gliomas. 
 
Optical Property Spectral Measurement in vitro 
Figure 1a shows the absorption coefficient spectra for the three tissue categories. The 
absorption bands of hemoglobin below 600 nm and water above 900 nm dominate the spectra, 
with consistently low absorption over the spectral range known as the “therapeutic window” 
(600 < λ < 1000 nm). All three spectra demonstrate peak absorption bands around 425 nm and 
550 nm characteristic of oxy- and deoxy-hemoglobin. From visual inspection, these findings are 
similar to results reported by Eggert and Blazek [8] using Kubelka-Munk theory and by 
Yaroslavsky et al [10] using an IMC technique, but contain more pronounced hemoglobin 
absorption features.  
The reduced scattering coefficient spectra (figure 1b) generally decrease with increasing 
wavelength, consistent with Rayleigh scattering theory and previously published results [10]. 
The gray-matter and tumor spectra contain a scattering peak at a wavelength (420 nm) coincident 
with peak hemoglobin absorption, behavior which contrasts previous reports which showed no 
deviation from the monotonic decrease predicted by Rayleigh scattering theory. The relative 
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levels of reduced scattering are highest for white matter and lowest for gray matter for all 
investigated wavelengths, consistent with Yaroslavsky et al. 
 
Diffuse Reflectance Spectral Measurement in vivo 
The mean in vivo diffuse reflectance spectra between 400 and 800 nm measured from white 
matter, gray matter, and tumor tissues in the multi-patient clinical study (figure 1c) possess 
similar spectral shapes but different relative intensities, with white matter boasting the highest 
diffuse reflectance, gray matter the lowest, and tumor tissue between the two. This trend 
 
Figure 1. Mean experimental (a) absorption coefficient, (b) reduced scattering coefficient, and (c) diffuse reflectance
spectra for white matter, gray matter, and glioma tissues. (d) Mean predicted diffuse reflectance spectra using Monte 
Carlo simulation based upon the mean experimental absorption and reduced scattering coefficient spectra in (a) and 
(b). Simulated diffuse reflectance spectra have been normalized for comparison purposes while maintaining the 
relative intensities between tissue classes.  
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coincides with that observed in the reduced scattering properties measured in vitro, suggesting 
that relative diffuse reflectance magnitude is dictated by the degree of tissue scattering. The 
diffuse reflectance spectra contain three pronounced valleys near 420 nm, 540 nm, and 580 nm, 
corresponding to strong oxy- and deoxy-hemoglobin absorption, hence high blood content in the 
in vivo interrogated tissue volumes. The maximum diffuse reflectance consistently occurs 
between 600 and 800 nm, coincident with the low-absorption therapeutic window. These 
observations suggest that the spectral shape of diffuse reflectance is affected by tissue 
absorption. 
 
Figure 2. Mean (± one standard error) absorption coefficient spectra comparing (a) white and gray matter, (b) white 
matter and tumor, and (c) gray matter and tumor. P-values derive from two-tailed t-tests comparing the mean 
spectra. 
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This research relies upon the assumption that in vitro brain tissue samples are a 
reasonable approximation of the in vivo environment, and as such, that the in vitro optical 
property measurements in Figure 1a and b correlate to in vivo optical properties which yield the 
diffuse reflectance spectra shown in Figure 1c. To validate this assumption, Monte Carlo 
simulation was used to estimate diffuse reflectance emission spectra (Figure 1d) from bulk white 
matter, gray matter, and tumor tissues with optical properties equivalent to our mean absorption 
and reduced scattering spectra. Comparing figures 1c and 1d, several differences are observed 
between the measured and simulated diffuse reflectance spectra from white and gray matter and 
 
Figure 3. Mean (± one standard error) reduced scattering coefficient spectra comparing (a) white and gray matter, 
(b) white matter and tumor, and (c) gray matter and tumor. P-values derive from two-tailed t-tests comparing the 
mean spectra. 
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tumor. Besides the obvious disparity in oxy- and deoxy-hemoglobin absorption behavior in the 
white and gray matter spectra, another significant contributor may be assumptions made in 
specifying the excitation-collection geometry of the diffuse reflectance measurements in the 
Monte Carlo simulations. Despite these minor differences, the similarity in general lineshape and 
relative emission intensities between tissue categories indicates that the optical property spectra 
measured in vitro correlate to brain tissue optical properties in vivo. 
 
 
Figure 4. Mean (± one standard error) diffuse reflectance spectra comparing (a) white and gray matter, (b) white 
matter and tumor, and (c) gray matter and tumor. P-values derive from two-tailed t-tests comparing the mean 
spectra. 
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Statistical Spectral Comparison 
Student’s t-tests were applied to the diffuse reflectance and optical property coefficient 
spectra to highlight the statistically significant differences between the tissue categories. Large 
regions of overlap between the mean (± one standard error) absorption spectra of the three tissue 
classes (figure 2) result in only discrete ranges where the differences are statistically significant 
(p < .01). White and gray matter absorption spectra are significantly different above 936 nm; 
white matter and tumor differences are not significant for any wavelength range; and gray matter 
and tumor are significantly different at all wavelengths above 882 nm. These results indicate that 
blood absorption is similar in all three tissue classes while water absorption is significantly lower 
in gray matter relative to white matter and tumor tissue. 
The mean white matter reduced scattering spectrum is significantly higher than gray 
matter and tumor tissue reduced scattering (figures 3a,b) for all wavelengths. Differences 
between gray matter and tumor tissue scattering (figure 3c) are less appreciable with statistical 
significance only found above 438 nm (p < .01). It is important to note that while the standard 
errors appear largest for white matter, its coefficients of variance (COVs) are the smallest, while 
tumor tissue boasts the largest COVs. 
The mean (± one standard error) white and gray matter diffuse reflectance spectra (figure 
4a) do not intersect at any wavelengths, yielding significance values below 10-9 over the entire 
spectral range. While the mean tumor tissue spectrum falls between the mean gray and white 
matter spectra (figure 4b,c), the mean spectral differences were still significant (p < .001) for all 
wavelengths. For the three inter-class comparisons, the p-value spectra appeared inversely 
related to the diffuse reflectance intensities, suggesting that diffuse reflectance dispersion results 
from variable blood content (and therefore absorption) between samples and/or from the 
increased impact of system noise where measured diffuse reflectance intensities are reduced. 
This behavior is consistent with the absorption coefficient measurements where the largest p-
values were found at the hemoglobin absorption peaks.  
 
Discussion 
In this study, we report optical properties of normal and tumor brain tissues obtained 
using an inverse adding-doubling model, a method that has never been used to study brain 
tissues. This method has been proven more accurate and versatile than Kubelka-Munk theory and 
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more efficient than inverse Monte Carlo techniques [13]. While efficiency lends little weight to 
scientific significance, it allowed measurement from over 80 tissue samples and thus provided 
mean optical property spectra which complements those reported by Yaroslavsky et al [10]. 
Further, IAD yields absolute optical property coefficients which can be used to simulate photon 
migration within brain tissue. Such simulations can be exploited to extract intrinsic fluorescence 
information from tissue fluorescence spectra [18], for optical tomography image reconstruction, 
and to design fiber-optic arrangements for spectroscopy probes [19] seeking to selectively 
amplify spectral differences between normal and neoplastic tissues. Since the purpose of our 
study here is to aid in the understanding and development of optical methods for brain tumor 
demarcation, the previous demonstration of the utility of IAD for enhancing optical biopsy 
methods validate the use of this method in this study.  
Previous reports on brain tissue optical properties found in the literature can be classified 
into two categories: (1) those that report optical properties at isolated wavelengths and (2) those 
that report full optical property spectra over a wide wavelength range. Unfortunately, dispersion 
within both groups can complicate validating new study results relative to published ones. 
Optical property coefficients for human brain tissue reported in literature vary between 94% 
(white matter reduced scattering at 630 nm) and 171% (gray matter absorption at 630 nm) in 
measurements of equivalent tissue types at similar wavelengths [7, 10]. These disparities can 
typically be traced back to experimental details or to limitations in the method of optical property 
determination from experimental measurements. For example, Kubelka-Munk theory [8, 9] 
assumes isotropic scattering even though tissue scattering is forward biased. Thus, in the 
current study, any comparisons to previously published reports will emphasize relative 
optical property trends between tissue categories, as opposed to magnitudes of the 
coefficients. For simplicity, any comparisons will be limited to optical properties published 
using IMC [6, 10].  
In terms of relative differences in optical properties between tissue classes, the results 
presented here agree with the spectra reported by Yaroslavsky et al [10]. Both methods report the 
presence of equivalent hemoglobin absorption between white and gray matter, with significantly 
higher reduced scattering and water absorption in white matter. Bevilacqua et al [6] reported the 
optical properties of human gray matter in vivo at four near-infrared wavelengths using IMC 
simulation of diffuse reflectance data for multiple source-detector separations. As demonstrated 
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in table 1a, the absolute magnitude of reduced scattering reported here agree with previously 
published values, generally staying within 20%. However, as shown in table 1b, our 
measurements for the absolute magnitude of absorption generally overestimate previous results, 
most significantly at the hemoglobin absorption bands for white and gray matter and within the 
therapeutic window (600 < λ < 1000 nm) for gray matter. 
While differences between published reports can be due to simple biologic variability in 
the measured samples, potential sources of error in optical property measurement include 
artifacts induced by sample preparation, limitations in measurement technique, and assumptions 
in the inversion technique (e.g. IAD, IMC, Kubelka-Munk). The findings of Roggan et al [20] 
Table 1. Comparison of (a) mean reduced scattering coefficients and (b) mean absorption coefficients of white and 
gray matter measured by inverse adding-doubling (IAD) and inverse Monte Carlo (IMC). Percent differences are 
calculated as the ratio of the difference to the mean of the two measurements. 
 
(a) White Matter  Gray Matter 
Wavelength (nm) IAD IMC % Difference  IAD IMC % Difference 
450a 7.71 9.24 -18.1%  1.94 1.40 32.0% 
510a 6.72 8.09 -18.6%  1.48 1.27 15.2% 
630a 5.34 6.54 -20.3%  1.04 0.99 5.2% 
670a 5.01 6.02 -18.3%  0.95 0.84 12.1% 
674b     0.94 1.00 -6.2% 
811b     0.78 0.87 -10.5% 
849b     0.76 0.87 -13.9% 
850a 3.97 4.10 -3.3%     
956b     0.69 0.86 -22.7% 
1064a 3.02 3.26 -7.7%  0.53 0.57 -6.7% 
a IMC values acquired from Yaroslavsky et al (2002) 
b IMC values acquired from Bevilacqua et al (1999) 
 
(b) White Matter  Gray Matter 
Wavelength (nm) IAD IMC % Difference  IAD IMC % Difference 
450a 0.396 0.14 95.5%  0.516 0.07 152.2% 
510a 0.187 0.10 60.6%  0.227 0.04 140.1% 
630a 0.081 0.08 1.2%  0.093 0.02 129.2% 
670a 0.071 0.07 1.5%  0.081 0.02 120.7% 
674b     0.080 0.02 120.0% 
811b     0.050 0.02 85.7% 
849b     0.047 < 0.01 129.8% 
850a 0.064 0.10 -43.5%     
956b     0.052 0.02 88.9% 
1064a 0.075 0.10 -28.6%  0.050 0.05 0.3% 
a IMC values acquired from Yaroslavsky et al (2002) 
b IMC values acquired from Bevilacqua et al (1999) 
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are often cited when discussing the effects of sample preparation on tissue optical properties; 
however, the trends in the optical properties reported here are not consistent with the effects 
observed by Roggan et al. Using a single-integrating sphere combined with IMC to measure the 
optical properties of porcine liver tissue, Roggan et al determined that snap freezing tissue 
samples in liquid nitrogen produces changes in absorption and reduced scattering coefficients 
which are statistically insignificant, although it produces significant decreases in the scattering 
coefficient. Roggan et al also investigated the effect of soaking samples in saline (e.g. for 
thawing purposes) prior to measurement and observed a marked decrease in absorption due to 
washing out the chromophores. However, in a quick comparison study as part of this research, it 
was observed that snap freezing, tissue storage, and thawing in saline had minimal effect on our 
measured in vitro optical properties as compared to four tissue samples measured ex vivo 
(immediately after resection) which were subject to none of those measures. In fact, the ex vivo 
samples exhibited higher reduced scattering and lower absorption than the mean spectra reported 
here for the respective tissue categories, results counter to the findings of Roggan et al, 
suggesting the differences evident in Table 1 are not due to these sample preparation details.  
The overestimation in absorption coefficient relative to previously published reports 
(Table 1b) may be due to tissue compression or to light loss out the ports of the integrating 
sphere during reflectance and transmission measurement. According to Chan et al [21], tissue 
compression between microscope slides can lead to an increase in scattering and absorption due 
to decreased tissue volume and therefore an increase in scatterer and chromophore concentration. 
However, it should be noted that many researchers in the optical property field operate under the 
assumption that tissue is incompressible [22] and not subject to these effects. One of the most 
significant experimental errors in the determination of optical properties using integrating sphere 
reflectance and transmission measurements is light lost out the entrance and exit ports due to 
insufficient sample size [17]. If the sample diameter is not sufficient to completely cover the 
ports of the integrating sphere, significant light losses will occur, resulting in underestimation of 
transmission and reflection and overestimation of IAD-predicted absorption. Given the small size 
of human brain tissue samples that can be reasonably acquired, compression was required to 
maximally cover the entrance and exit ports (diameter = 1 inch) of the integrating sphere. Since 
complete port coverage was not always possible, our measurements may be subject to these 
artifacts and the absorption coefficients reported here may overestimate true, in vivo brain tissue 
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optical properties, consistent with the overestimation evident in Table 1b. Further, since this 
artifact is more significant in gray matter than white matter, overestimated absorption may also 
explain why the relative levels of simulated diffuse reflectance between gray matter and white 
matter are less than that measured in vivo (Figures 1c,d). 
An area of particular concern in comparing our optical property spectra with those 
published by Yaroslavsky et al is the presence of a peak at 420 nm within IAD-calculated 
scattering spectra that corresponds to peak hemoglobin absorption. This is unlike IMC scattering 
which demonstrates monotonic decreases with wavelength characteristic of the Rayleigh limit of 
Mie scattering. To investigate possible sources of this inter-parameter “crosstalk,” a problem 
which is well-known in optical tomography [23-26], IAD was used to calculate albedo and 
optical thickness for all possible combinations of measured reflectance and transmission. A 
(dimensionless) scattering coefficient surface was then created (from the product of albedo and 
optical thickness) as a function of reflectance and transmission such that measured reflectance 
and transmission spectra can be overlaid on the surface contours (Figure 5). Comparing spectra 
of samples with crosstalk to those without suggests that crosstalk occurs when hemoglobin 
absorption at 420 nm affects a larger decrease in transmission than in reflectance, causing the 
crosstalk curves to ascend the scattering contours, subsequently creating local maxima in the 
scattering spectra. Statistically, the drop in transmission relative to reflectance from the long 
wavelengths (650 to 1300 nm) to the hemoglobin peak is significantly larger in gray matter 
samples that exhibit crosstalk (p < 0.05). As such, crosstalk seen in the gray matter and tumor 
scattering spectra may be caused by inherent limitations or non-linearities in the measurement of 
low reflectance levels which result from high absorption and low scattering. This theory is 
supported by the facts that this crosstalk is most consistently present within gray matter samples 
which have the lowest scattering and is strongest within tumor samples which have the highest 
peak absorption. It should be noted that a reduced scattering surface calculated using an IMC 
technique possesses the same basic contours (results not shown) as the IAD-predicted surface in 
Figure 5, such that we would expect IMC to produce similar crosstalk when given identical 
reflectance-transmission spectra. Unfortunately, without a number of calibrated reflectance 
standards, it is difficult to experimentally validate the linearity of reflectance measurements in an 
integrating sphere setup. 
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Inspection of the mean absorption spectra suggests that tissue absorption dictates the line 
shape of diffuse reflectance spectra between the three tissue categories but has little effect on 
their relative emission magnitudes. Brain tissue absorption spectra are dominated by the 
characteristic hemoglobin and water absorption bands, with global maxima near 420 nm 
(hemoglobin) and local maxima near 550 nm (hemoglobin), 1000 nm (water), and 1200 nm 
 
Figure 5. Reflectance, transmission, and dimensionless scattering spectra for gray matter samples (a) without 
crosstalk and (b) with crosstalk. (c) Dimensionless scattering map predicted by IAD as a function of measured 
reflectance and transmission. Dimensionless scattering is the product of albedo and optical thickness. Other 
parameters (indices of refraction, scattering anisotropy) in the IAD model were kept constant with previous 
methods. Reflectance-transmission curves from the gray matter samples with and without crosstalk have been 
overlaid. Contours are spaced in one-unit increments from 1 (top left) to 50 (bottom right). 
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(water). While the diffuse reflectance spectra were not measured to encompass the water 
absorption peaks, blood absorption created emission valleys near 420 and 550 nm and relatively 
constant emission over the low-absorption therapeutic window. In terms of magnitude, the tissue 
absorption spectra depict equivalent levels of hemoglobin-related absorption (below 600 nm) 
between white and gray matter and tumor tissue, with lowest water-related absorption (above 
1000 nm) in gray matter. The diffuse reflectance spectra, on the other hand, demonstrated 
significantly higher emission for white matter and lowest emission for gray matter over the entire 
spectral range. 
It was observed that the mean white and gray matter absorption spectra exhibited a single 
absorption peak at 550 nm characteristic of deoxy-hemoglobin (Hb). In addition, normal brain 
tissues possessed absorption peaks at 420 nm which were red-shifted compared to the 
corresponding peak within the mean tumor spectrum. A closer scrutiny of the individual tissue 
sample spectra show that 3 of 19 white matter samples, 0 of 25 gray matter samples, and 22 of 
39 tumor samples show oxy-hemoglobin (HbO2) double-peak absorption at 550 nm. Thus, while 
tumor samples indeed possessed the highest percentage of samples with characteristic HbO2 
absorption, that percentage was still less than 60%. While the low proportion of HbO2 within the 
tissue samples is unexpected due to tissue exposure to room air, it is not without precedent as the 
same effect has been previously observed both in vitro and in vivo during our clinical 
spectroscopy study. Unfortunately, the cause behind whether HbO2 or Hb absorption appears 
within tissue spectra is currently unknown and appears to be random in nature. It may be 
correlated to the local environment of the sample during clinical measurement or to sample 
extraction. Often during brain tissue resection for tumor removal or temporal lobectomy, 
neurosurgeons will employ electro-cautery to stop bleeding from broken vessels. Heat diffusion 
to the blood within surrounding tissue areas during cauterization could cause hemoglobin 
denaturation and thereby affect its ability to bind oxygen. The random nature of hemoglobin 
absorption could therefore be linked to the degree of tissue heating prior to measurement. 
Regardless of its underlying mechanism, the random presentation of hemoglobin absorption 
within diffuse reflectance and absorption spectra impairs tissue discrimination based upon 
absorption profile shape. 
The majority of primary infiltrating brain tumors derive from glial cells which serve to 
support neuron cell bodies (astrocytes and microglia) and myelinate their axons 
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(oligodendrocytes) and are predominantly found within white matter, gray matter cortex, and the 
basal ganglia. As such, one might expect infiltrating glioma tumor samples (especially samples 
taken at the tumor margins) to be comprised of mixtures of tumor and white or gray matter. It 
logically follows that the mean level of tumor scattering would lie between that of the two 
normal tissue types. This observation is supported by two experimental facts: (1) the population 
of reduced scattering spectra from individual tumor samples spans the white and gray matter 
mean spectra, and (2) reduced scattering of tumor tissues shows the largest dispersion among the 
three tissue types. This observation also suggests that a discrimination algorithm to differentiate 
between tumor and normal tissues should first separate tissues by the absolute intensity of their 
diffuse reflectance emission, effectively performing an initial classification according to their 
derivative normal tissue (white or gray matter). 
Figure 1b demonstrates that gray matter exhibits lower scattering as compared to white 
matter. Gray matter and cortical tissue consist of neuron cell bodies, while white matter consists 
predominantly of myelinated axons which travel between gray matter cell bodies and their 
targets. The radii of axons are significantly smaller (10-100X) than their neuron cell bodies, with 
a higher density, which contribute to greater scattering according to Mie theory. Other reports 
postulate that the higher scattering of white over gray matter is due to myelination of the white 
matter axons (rather than their size relative to gray matter cell bodies) [8, 9]. This was based on 
an earlier report by Svaasand and Ellingsen [12] that compared scattering between adult and 
neonatal white matter and concluded that myelination increases scattering relative to 
unmyelinated axons. 
Correlation between relative levels of diffuse reflectance intensity and reduced scattering 
coefficient suggest that differences in diffuse reflectance between tissue categories result from 
variations in reduced scattering. Tissue scattering derives from microscopic refractive-index 
heterogeneities in the cells and cellular components. Theories from scattering measurements on 
other tissues have attributed differential scattering of normal and neoplastic tissues to increase in 
the number of mitochondria [27], increase in the nuclear to cytoplasm ratio [28], decondensation 
of the DNA in the nucleus [29], and fibrous tissue compositional changes [29]. However, none of 
these reports definitively correlate tissue scattering differences to one or more specific tissue 
changes which occur during the progression from normal to neoplasia. Full investigation into 
how the various cellular, sub-cellular, and extra-cellular components of brain tissue (as well as 
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their changes during tumor development and proliferation) contribute to brain tissue scattering 
and correlate to scattering differences between normal and cancerous brain tissues is beyond the 
scope of this paper. Nevertheless, known tissue changes with tumor development and their 
effects on tissue scattering as predicted by Rayleigh and Mie scattering theory can lead to 
possible explanations.  
The measured reduced scattering spectra of brain tissue presented here demonstrate the 
marked inverse relationship between scattering and wavelength predicted by the Rayleigh limit 
of Mie scattering and show significantly different (p < .01) reduced scattering coefficients 
between all three tissue classes over the spectral range of diffuse reflectance measurement (400 
nm < λ < 800 nm). Mie scattering theory predicts a general scattering decrease as wavelength 
increases relative to the scattering radius when the light is scattered by tissue components which 
are on the order of or much smaller than its wavelength (r <≈ λ). On the other hand, for particles 
with r » λ, scattering possesses no strong relationship to the wavelength of the light. For these 
scatterers, Mie theory predicts a general decrease in scattering, increase in anisotropy, and a 
subsequently large decrease in reduced scattering as the scattering radius increases. Based on the 
aspects of this theory, the difference in scattering magnitude observed in our in vitro data could 
be the result of disparities in the concentration or in the size distribution of scatterers between 
tissue categories. The concentration and/or size distribution of the large tissue scatterers such as 
cells, nuclei, mitochondria, and bilipid membranes are known to vary between tissue categories 
due to differences in general tissue composition of white and gray matter and the cellular 
transformations with tumor progression. Rapid cell proliferation during tumor growth produces 
cells of variable shapes and sizes within the tissue. This random cell morphology within tumor 
tissue allows its malignancy to be graded by the visual similarity of tumor cells to their parent 
cell; however it also prevents dense cell packing. Further, to facilitate rapid cellular replication, 
malignant tumor cell nuclei are often larger than normal [30, 31] to accommodate de-condensed 
DNA [29], effectively decreasing the scattering from cell nuclei. These decreases in scattering 
can be offset by the presence of increased numbers of mitoses and multiple nuclei in a cell [30, 
31], giving additional scattering centers. Since tumors are known to develop neo-vascularization 
in order to sustain a heightened metabolism, one might expect the number of mitochondria per 
cell to increase with tumor progression. Surprisingly, the opposite effect has been observed. 
While low-grade tumors such as oligodendrogliomas and astroctyomas will contain more 
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mitochondria [32], perhaps as a compensation mechanism since many can be atypical or 
damaged [33], the tumor cells of glioblastomas (high-grade) tend to contain fewer mitochondria. 
They transition from oxidative phosphorylation to glycolytic respiration [34], possibly in 
response to further damage to the mitochondria and its associated “respiratory machinery” of 
oxidative phosphorylation [35]. These shifts in concentration and/or radius of the various tissue 
scatterers may explain the relative levels of reduced scattering (highest in white matter, lowest in 
gray matter) that is consistent with the tenets of Mie scattering theory. Tissue and cell culture 
studies are currently in progress to thoroughly investigate the specific effects of these cellular 
changes on tissue scattering, absorption, and subsequent diffuse reflectance as a function of 
wavelength.  
 
Conclusion 
In this study we present absolute and relative reduced scattering and absorption 
coefficients of brain tissue using the inverse-adding doubling method which agree with 
previously published results using inverse Monte Carlo techniques. The major areas of 
disagreement correspond to higher absorption values and inter-parameter crosstalk in our spectra 
at the hemoglobin absorption bands. The results presented in this study demonstrate that while 
the shape of clinical diffuse reflectance spectra is mainly governed by sample absorption, the 
emission intensities of different tissue categories are determined by relative magnitudes of 
reduced scattering. Brain tissue absorption spectra are dominated by hemoglobin absorption 
bands for wavelengths below 600 nm and water absorption bands at wavelengths above 900 nm. 
Reduced scattering spectra represent a combination of Rayleigh and Mie scattering with 
significant spectral differences most likely deriving from density and size disparities in Mie 
scatterers between the tissue categories. While there are some differences observed in the 
magnitude of diffuse reflectance from measured and simulated tissue spectra, they show similar 
trends in relative emission profiles between tissue categories and general line shape, supporting 
the fundamental basis of this study which is to correlate in vivo diffuse reflectance spectra to 
inherent tissue optical properties based on in vitro measurements. Optical properties of tissue 
represent only one of the factors which govern laser-tissue interactions; other players such as 
fluorophore concentrations, fibrous tissues, perfusion, and thermodynamic properties will 
hopefully further provide spectral differences needed for a reliable, objective, real-time optical 
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diagnosis system for brain tissue using combined fluorescence and diffuse reflectance 
spectroscopy.  
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CHAPTER IV 
 
LIQUID-CRYSTAL TUNABLE FILTER SPECTRAL IMAGING FOR BRAIN TUMOR 
DEMARCATION: SYSTEM CHARACTERIZATION 
 
Abstract 
 Past studies have demonstrated that combined fluorescence and diffuse reflectance 
spectroscopy can successfully discriminate between normal, tumor core, and tumor margin 
tissues in the brain. To achieve efficient, real-time surgical resection guidance with optical 
biopsy, probe-based spectroscopy must be extended to spectral imaging to spatially demarcate 
the tumor margins. This paper describes the design and characterization of a combined 
fluorescence and diffuse reflectance imaging system which uses liquid-crystal tunable filter 
technology. Experiments were conducted to quantitatively determine the linearity, field of view, 
spatial and spectral resolution, and wavelength sensitivity of the imaging system. Spectral 
images were acquired from tissue phantoms, mouse brain in vitro, and human cortex in vivo for 
functional testing of the system. The spectral imaging system produces measured intensities that 
are linear with sample emission intensity and integration time and possesses a one-inch field of 
view for a seven-inch object distance. The spectral resolution is linear with wavelength and the 
spatial resolution is pixel-limited. Sensitivity spectra for the imaging system provide a guide for 
the distribution of total image integration time between wavelengths. Functional tests in vitro 
demonstrate the capability to spectrally discriminate between brain tissues based on exogenous 
fluorescence contrast or endogenous tissue composition. In-vivo imaging captures adequate 
fluorescence and diffuse reflectance intensities within a clinically viable two-minute imaging 
timeframe and demonstrates the importance of hemostasis to acquired signal strengths and 
imaging speed. 
 
Introduction 
 The American Cancer Society estimates that 18,820 new cases of and 12,820 deaths from 
brain tumors were reported in the United States in 2006 [1]. Gliomas comprise 40% of primary 
brain tumors and 78% of malignant tumors, with a five-year survival rate of only 33% and a 12-
18 month average survival time and 5.1% three-year survival rate for infiltrating glioblastomas 
[2]. The current three-prong attack for brain tumor treatment is surgical resection of maximum 
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tumor volume followed by radiation and chemotherapy. However, the blood-brain barrier often 
prevents cancer-targeting drugs from reaching the tumor, rendering chemotherapy ineffective; 
and while surgery and radiation therapy can effectively treat the tumor core, the fingerlike 
protrusions at the margins of infiltrating tumors make treating the entire tumor near impossible. 
The extent of surgical resection at these tumor margins for both low-grade and high-grade 
gliomas has been repeatedly correlated to patient quality of life and mortality [3-7]; but complete 
tumor resection is achieved in less than 20% of patients diagnosed with infiltrating gliomas due 
to limitation in the surgeon’s ability to discriminate between normal tissue and tumor margins 
during surgery. To this end, tools and techniques are constantly being developed to help locate 
the tumor and identify its margins during a resection procedure, to maximize tumor mass 
resection without sacrificing neurologic function. 
 Current methods for intra-operative tumor localization are limited in their ability to 
differentiate normal brain from tumor margins. Visual inspection can be highly subjective and 
inconclusive, especially when dealing with low-grade tumors or diffuse tumor margins which 
often resemble normal neural tissue. On-site pathology is more histologically reliable but is 
expensive, is far from real-time, and does not spatially demarcate margin extent. Three-
dimensional surgical navigation with x-ray computed tomography (CT) or magnetic resonance 
imaging (MRI) is extremely useful in tumor localization and debulking [8, 9] but limited in its 
margin sensitivity, as tumor cells have been found outside of delineated image margins in many 
documented cases [10]. Furthermore, deformation of brain tissue subsequent to craniotomy, 
retraction, and debulking by as much as a centimeter degrades the accuracy of surgical 
navigation based upon pre-operative images [11, 12]. Real-time intra-operative ultrasound is not 
subject to complications from brain deformation and is capable of detecting tumor margins 
because brain tumors are often hyperechoic relative to normal tissue; but ultrasound imaging is 
frequently unable to differentiate tumor from peritumoral edema, which is also hyperechoic [13, 
14], and poor image resolution hinders correlation between image features and surgical position. 
Due to the inherent limitations of these adopted tumor visualization techniques, significant 
residual tumor cells frequently remain after resection [3, 5], emphasizing the need to develop an 
objective, on-site, real-time imaging system that is capable of detecting the margins of brain 
tumors with high sensitivity.  
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 A potential candidate for objective brain tumor margin visualization is an imaging system 
with contrast based on optical spectroscopy which can quickly and non-intrusively detect tissue 
changes associated with the progression of disease. Our research group is currently in the middle 
of a multi-center, retrospective pre-clinical study to investigate the capability of combined 
autofluorescence and diffuse reflectance spectroscopy to discriminate between normal and 
malignant tissues in the human brain in vivo [15-18]. In this study, optical spectra are measured 
from multiple gray matter, white matter, tumor core, and tumor margin sites with a portable 
spectroscopic system [16] during craniotomy procedures for glioma resection or temporal 
lobectomy. Excitation light from a pulsed nitrogen laser (fluorescence) and a halogen lamp 
(diffuse reflectance) are sequentially delivered to a point on the tissue surface by two of seven 
fibers within a handheld fiber-optic probe. The remaining five fibers in the probe are used to 
collect remitted fluorescence and diffuse reflectance from the tissue surface and deliver it to a 
spectrograph for spectral measurement. Spectra are grouped as normal, tumor core, or tumor 
margin according to gold-standard histopathological diagnosis of tissue biopsies acquired at the 
interrogation site and analyzed to determine spectral differences between tissue groups. 
Preliminary analysis of the in-vivo spectroscopic differences between normal and tumor tissues 
demonstrates an unbiased diagnostic accuracy of 100%, 96%, and 94% for normal, tumor core, 
and tumor margin tissue samples using multivariate statistics, indicating the promising capability 
of optical spectroscopy to provide intrinsic contrast between normal and tumor tissues in the 
brain [15]. 
 While fiber-optic probe-based spectroscopy is useful for correlating spectral features to 
histopathological diagnosis at a specific interrogation site, it produces a single-point 
measurement on the tissue surface without providing the spatial extent of tumor margins, 
information that is necessary to efficiently guide tumor resection. Therefore, for optical biopsy to 
be clinically useful, single-point spectroscopy systems must be translated to spectral imaging in 
which spectral information is acquired at every pixel within a two-dimensional field of view, 
yielding spatial and spectral tissue information for a comprehensive snapshot of tissue pathology 
during surgery. Successful translation from probe-based spectroscopy to macroscopic spectral 
imaging depends upon maintenance of accurate spectral discrimination between tissue types with 
a reasonable image acquisition time despite significant decreases in excitation irradiance due to 
larger target areas. Ideally, spectral imaging would produce equivalent fluorescence and diffuse 
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reflectance lineshapes to probe-based spectroscopy in order to exploit discrimination algorithms 
developed from probe-based measurements. However, initial comparisons of probe-based and 
imaging spectra have shown significant disparities in fluorescence and diffuse reflectance 
lineshape due to inherent differences in excitation-collection geometry, behavior which has been 
thoroughly investigated and is described in a separate paper [19]. The ability for spectral imaging 
to discriminate between normal and tumor tissues in the brain must be independently validated 
during a separate retrospective pre-clinical study currently being conducted by our research 
group. As such, preliminary functional testing for clinical efficacy which is tested and reported in 
this paper boils down to the ability of a spectral imaging system to produce spectral contrast 
between tissue types in an image acquisition time that is clinically viable. 
 Speed of spectral image acquisition depends to a large degree on optical design and 
spectral imaging implementation. Many optical and hyper-spectral imaging systems designed to 
date for tissue interrogation acquire limited spectral information (a few emission bands), trading 
decreased spectral information for increased frame rates by employing filter-based assemblies 
containing bandpass-filter wheels, dichroic filters, and/or beamsplitters and oftentimes optically 
implementing tissue classification algorithms in hardware [20, 21]. These systems have been 
most commonly applied to exploit the preferential deposition of exogenous fluorescent dyes to 
tumor tissue [22-24] and to target the hemoglobin absorption bands of soft tissue for perfusion 
imaging [25, 26]. While the speed of these optical or hyper-spectral imaging systems is 
impressive, hardware acquisition of partial spectral information limits the complexity of viable 
classification algorithms, which are often unique to a given organ system and yet to be 
determined for imaging-based tissue discrimination in the brain. Contrary to these methods, our 
research group sought to develop a true spectral imaging system capable of acquiring full 
fluorescence and diffuse reflectance information at every pixel within a macroscopic field of 
view to clinically determine a robust diagnostic algorithm for intra-operative discrimination 
between normal and tumor tissue in the brain. 
 Imaging with full spectral information can be implemented in a variety of modalities, 
from line-scanning to tunable-filter to multiplexing methods. As part of a previous project, our 
research group evaluated three benchtop spectral imaging systems based on an acousto-optic 
tunable filter (AOTF), a liquid-crystal tunable filter (LCTF), and a Fourier multiplexer [27]. The 
three systems were quantitatively compared in terms of optical throughput and imaging signal-
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to-noise ratio for strong reflectance and weak autofluorescence images to determine the system 
that was most amenable to rapid autofluorescence and diffuse reflectance imaging in a clinical 
setting. While the Fourier system enjoyed the highest optical throughput, the LCTF system 
generated the highest signal-to-noise ratio in both types of imaging and proved to be the most 
versatile. Based on this comparison, a LCTF spectral imaging system was developed for clinical 
implementation and optimized for brain tissue autofluorescence and diffuse reflectance imaging. 
 Liquid-crystal tunable filters are constructed from a stack of linear polarizers with 
interspersed layers of liquid crystals and birefringent crystals. The retardance (R) of each stage is 
defined as the product of its thickness (d) and the difference between its ordinary (no) and 
extraordinary (ne) indices of refraction – ( )eo nndR −=  – which can be modulated by applying a 
voltage to the liquid crystal and changing its extraordinary index of refraction [28]. Altering the 
stage’s retardance affects the phase delay between the ordinary and extraordinary light rays 
emerging from the stage, thereby changing its transmission (T) as a function of wavelength (λ) as 
( )xT 2cos5.0=  where λdRx =  [28]. The thicknesses (d) of the birefringent crystals in the filter stack 
and the voltages applied to the liquid crystals are often selected to produce a binary series of 
retardances such that all of the stages transmit the selected passband while destructive 
interference at the other wavelengths “trims” the stopband light. The number of stages employed 
in the filter dictates the width of the passband and the degree of stopband attenuation. 
 Liquid-crystal tunable filter spectral imaging systems [29-32] use the filter to directly 
parse the wavelength dimension of the spectral image. A frame of CCD data is acquired while 
the LCTF passes a single band of the emission spectrum to the camera, using the entire CCD 
array for spatial resolution. The spectral dimension of the image is constructed by acquiring 
successive CCD frames as the filter tuning wavelength is swept across the spectral range of 
interest. The major advantages to LCTF-based spectral imaging systems are their simple design 
and their versatility. The entire collection leg of the imaging system can be comprised of three 
components: the filter, a collection lens, and a CCD camera. The major drawback to tunable-
filter systems is the inherent tradeoff between spectral resolution and optical throughput. Since 
only one band of the collected emission is passed to the CCD camera, the majority of collected 
emission is lost. However, the random-access tuning capability of the filter allows spectral 
interrogation at exactly and only those wavelengths that are deemed diagnostically significant.  
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 Many of the spectral imaging systems developed to date for medical applications have 
been designed for investigation of tissue sections to augment information provided by traditional 
staining methods and white-light microscopy during pathology [33-35]. Several research groups 
have also constructed tunable-filter spectral imaging systems for in-vivo tissue interrogation. 
Martin et al have developed an endoscope-based spectral imaging system which can be 
interfaced with an AOTF or LCTF for spectral resolution of fluorescence images while 
simultaneously acquiring color reflectance images with a second, color CCD camera [36, 37]. 
The researchers have correlated imaging spectra to spectrofluorimetry and probe-based 
spectroscopy data and demonstrated differences in fluorescence intensity and lineshape between 
normal and malignant tissues for mouse skin and an implanted mouse tumor model. Orfanoudaki 
et al have developed a similar LCTF-based spectral imaging colposcope to interrogate cervical 
tissue after aceto-whitening using reflectance imaging [31, 38]. While the efforts of these 
research groups lays the groundwork for spectral imaging in vivo, both imaging systems produce 
single-mode (i.e. diffuse reflectance or fluorescence) spectral images and have been coupled to 
specialty optical scopes designed for gastroenterology or cervical/lower GI applications.  
 This paper describes the first macroscopic, dual-mode, fluorescence and diffuse 
reflectance spectral imaging system, using a liquid-crystal tunable filter, designed in a simple 
lens-plus-detector configuration to image tissue in the clinical environment, and optimized for 
human brain tissue discrimination. The clinical efficacy of such a stand-alone system depends on 
its ability to rapidly and faithfully measure the fluorescence and diffuse reflectance behavior of 
human brain tissue during tumor resection surgery. While a companion paper investigates the 
effects of the transition from probe-based spectroscopy to spectral imaging on fluorescence and 
diffuse reflectance lineshapes [19], this paper presents results from a battery of tests designed to 
quantitatively characterize the system parameters important for spectral imaging performance, 
including the linearity of its measured intensities, its field of view, its spatial and spectral 
resolution, and its system sensitivity as a function of wavelength. For a more direct evaluation of 
clinical efficacy, spectral images were measured from tissue phantoms designed to optically 
mimic human brain tissue, mouse brain tissue samples in vitro, and human cortex in vivo during 
tumor resection surgery, to determine the functional capability of the imaging system to 
spectrally discriminate between tissue types based on exogenous fluorescence and endogenous 
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tissue composition and the speed with which macroscopic autofluorescence and diffuse 
reflectance images can be acquired in vivo. 
 
Materials and Methods 
 
System Description 
 The clinical imaging system was designed to perform dual-mode fluorescence and diffuse 
reflectance spectral imaging. The collection head of the imaging system is comprised of three 
components: a Varispec VIS-20 liquid-crystal tunable filter (CRI, Inc.), a variable focal length (f 
= 28-80 mm) camera lens (Nikon), and a 512 x 512 pixel PhotonMax CCD camera (Princeton 
Instruments). As shown in Figure 1a, the system is connected to a Wild Heerbrugg M690 
operating microscope (Leica), which contains a side assembly originally designed for a second 
set of oculars. The oculars were removed and the spectral imaging system was mounted in place. 
The focal length and fine focus of the imaging system collection lens are easily adjusted to align 
the focal planes of the imaging system and primary oculars. Microscope focus is adjusted via 
              
                    (a)                                                                                       (b) 
Figure 1. (a) Picture of LCTF spectral imaging system coupled to the side assembly of a Wild Heerbrugg M690 
operating microscope. (b) Schematic of excitation optics for fluorescence and diffuse reflectance imaging.  
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motorized translation of the entire microscope head (including the imaging system), rather than 
by movement of the focusing optics in the microscope, such that the distance between the 
microscope head and focal plane is maintained. This ensures that once the microscope and 
imaging focal planes are aligned, as the surgeon focuses on a tissue target with the primary 
oculars, the spectral imaging system is always focused on the same object. 
 Fluorescence and diffuse reflectance excitation (Figure 1b) are provided by a 500 W 
xenon arc lamp (Thermo-Oriel) and a 200 W halogen lamp (Luxtec), respectively. Fluorescence 
excitation light is filtered by a hot mirror and 340 nm bandpass filter (Chroma) to simulate 
nitrogen laser excitation from the probe-based spectroscopy system. A 365 nm dichroic filter 
allows light from both excitation sources to be coupled into a 10-mm core diameter liquid light 
guide (Steiner and Martins), which delivers the excitation light to the sample at the microscope 
head. Shutters (Electro-optical Products) along both beam paths allow automated switching 
between the two excitation sources for dual-mode imaging and baseline correction for ambient 
light. The entire system, including LCTF tuning, CCD camera communication, shutter control, 
and data handling, is controlled with a custom C-based computer program with graphical user 
interface controls from the Fast Light Toolkit. 
 
System Characterization 
 A battery of tests was designed to characterize the parameters of the LCTF spectral 
imaging system important for clinical spectral imaging performance. Confirming the linearity of 
measured intensities with sample emission intensity and integration time ensures that relative 
measured intensities directly correlate to relative emission levels and that image intensities can 
be normalized for changes in integration time. Measuring the field of view as a function of object 
distance provides the necessary distance between the imaging system and focal plane of the 
microscope to produce a target 25-mm field of view. Gauging the spatial resolution of the 
imaging system determines the spatial extent of visible tissue features and whether the optics of 
the LCTF pushes this extent above the pixel limits of the CCD camera. Comparing the spectral 
resolution of the imaging and probe-based spectroscopy systems predicts whether fluorescence 
and diffuse reflectance spectral features within imaging data will be broadened relative to probe-
based spectra. Finally, quantifying the wavelength sensitivity of the imaging system not only 
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allows for wavelength correction of measured imaging spectra but also predicts the relative 
signal-to-noise levels between wavelengths in the spectrum.  
 For any detection system, it is important to know whether the system output is linear with 
the system inputs. For a spectral imaging system, the output is the digital count of measured 
intensity, and two of the most significant inputs are the sample emission intensity and the 
integration time over which that intensity is allowed to impinge on the CCD array. To determine 
the linearity of measured intensity with sample emission, spectral images of a 99% diffuse 
reflectance standard (Spectralon, LabSphere) under halogen-lamp illumination were acquired 
from 400 to 720 nm in 5 nm steps with a 10 ms integration time per wavelength. The light 
intensity emitted from the sample was varied by placing neutral density filters between the liquid 
light guide and sample, effectively diminishing the excitation power. Spectral images and 
corresponding baseline images with no excitation were acquired for fourteen filter combinations 
whose optical density (OD) varied from 0 to 3.5. To determine the linearity of measured 
intensity with integration time, twelve spectral images were similarly acquired but with a 
constant excitation power and integration times which varied from 1 to 5000 ms per wavelength. 
For the two sets of variable emission and variable integration images, mean spectra were 
calculated for each spectral image and normalized relative to the maximum intensity image 
spectra (0 OD for variable emission, 5000 ms for variable integration). Regression lines were fit 
to the data in a least-squares sense and regression coefficients were calculated with each 
wavelength treated independently. 
 The field of view of the spectral imaging system was characterized as a function of 
sample distance from the distal face of the LCTF. A two-dimensional phantom was constructed 
consisting of a Cartesian grid of lines on a flat piece of plastic, spaced 1 mm apart. In these 
experiments, the phantom was placed at various distances from the distal face of the LCTF, from 
250 mm away down to the point at which the system was no longer able to focus on the 
phantom. At each position of the phantom, the system was focused on the phantom with the 
origin (0,0) positioned at the corner of the system field of view. An image of the phantom was 
subsequently acquired under ambient illumination with the filter tuned to 600 nm. For image 
acquisition at long object distances, the focal length of the camera lens was set to its maximal 
focal length (f = 80 mm). Once the object distance became too short such that the imaging 
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system could no longer focus on the phantom, the focal length was shortened until the phantom 
came into focus. 
 The spectral resolution of the imaging system was defined to be the full-width at half-
maximum (FWHM) of the mean spectrum from an image of a monochromatic input. To measure 
the spectral resolution as a function of wavelength, a pulsed nitrogen laser with tunable dye 
module (Oriel) and various fluorescent dyes were used to create multiple laser wavelengths 
across the tuning range of the LCTF (400 to 720 nm). Laser light was coupled into and delivered 
via fiber optic cable to create a roughly 10-mm-diameter excitation spot on a 99% diffuse 
reflectance standard. Baseline and spectral images were acquired of the laser spot for each of 
twenty-eight different laser wavelengths using a 1-nm increment between CCD frames. Mean 
spectra and their corresponding FWHM values were calculated for each of the images. 
 The spatial resolution of any imaging system is traditionally defined to be the separation 
distance between two objects below which the system can no longer distinguish them as 
separate. The spatial resolution of the spectral imaging system was characterized using a 
negative NBS 1963A target (Figure 2a, Edmund Industrial Optics) with rulings varying from 1.0 
to 16.0 line pairs per millimeter (lp/mm). For each image acquisition, the spatial resolution target 
was placed 180 mm from the distal face of the filter, a sample distance which yields the target 
field of view of 25 mm, according to prior measurements. For a bright background to the 
negative resolution target, the halogen lamp was used to illuminate a diffuse reflectance standard 
below the target. To quantify the capability of distinguishing adjacent lines in each ruling as 
separate, mean intensity profiles (Figure 2b) were calculated across the rows/columns along each 
                     
(a)                                                                              (b) 
Figure 2. (a) NBS 1963A spatial resolution target. (b) Example intensity profile calculated by averaging the 
measured intensity across a set of rulings for all wavelengths.  
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ruling and across all wavelengths. The five peak intensities and the four minimum intensities 
were extracted from the profile and a peak-to-valley (PVR) ratio was calculated. The spatial 
resolution of the imaging system was defined to be the separation distance between the lines in a 
ruling which produces a PVR equal to the square root of two, below which it is assumed that the 
system can no longer distinguish adjacent lines as separate objects. 
 The wavelength sensitivity of the spectral imaging system was characterized using a 
NIST calibration lamp with known spectral output. A spectral image of direct illumination from 
the lamp and a baseline image were acquired from 400 to 720 nm in 1 nm increments. 
Integration times were varied at each wavelength to acquire signal measurements at roughly half 
the dynamic range of the CCD camera for all regions of the spectrum. Measured spectra were 
subsequently corrected for differences in integration time during post-processing. The sensitivity 
of the imaging system for fluorescence was defined as the ratio of the true lamp output spectrum 
to the mean measured spectrum across the image. Calibration for diffuse reflectance imaging was 
conducted separately since diffuse reflectance spectra must also be corrected for the excitation 
spectrum of the halogen lamp. To do so, spectral and baseline images of the halogen lamp output 
were acquired similar to the NIST lamp images, from 400 to 720 nm in 1 nm increments and 
with variable integration times between wavelengths. The sensitivity of the imaging system for 
diffuse reflectance imaging was defined as the inverse of the measured spectrum averaged across 
the image. 
 
Functional System Testing 
 Functional tests for most spectral imaging systems in the literature involve demonstration 
of measured spectral contrast between normal and diseased states in the tissue of interest. Many 
such applications involve visibly observable changes which can be easily correlated to measured 
spectral features, such as selective uptake of fluorescent dyes by tumor tissue or aceto-whitening 
of abnormal tissues in the cervix. The first functional test is designed to parallel exogenous dye 
applications by establishing discrimination capability between brain tissue phantoms with stark 
optical contrast in fluorescence and diffuse reflectance. The second test demonstrates spectral 
contrast of the largest source of endogenous contrast in brain tissues, the difference in scattering 
between white and gray matter, by correlating fluorescence and diffuse reflectance features 
between white and gray matter tissues to myelin and cell-body staining in the mouse brain. 
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Based on our clinical experience with probe-based spectroscopy, subtle spectral differences 
between normal brain and tumor tissues require multivariate statistical analysis to determine 
discrimination accuracy. As such, an additional functional test demonstrates that high-quality 
autofluorescence and diffuse reflectance images can be acquired from human brain tissue in vivo 
within a clinically viable timeframe. The images validate the subtle differences in spectral 
features between normal human cortex and an infiltrating cortical glioma, solidifying the need 
for large-scale clinical testing with the imaging system to determine its ability to discriminate 
between normal and tumor tissues in the brain and improve surgical resection guidance. 
 Spectral image measurement during functional testing began with acquisition of the 
fluorescence spectral image data cube, followed by acquisition of the fluorescence baseline, 
diffuse reflectance, and diffuse reflectance baseline images. Spectral image data cubes were 
constructed from successive CCD frames acquired as the tuning wavelength of the LCTF was 
scanned across its spectral range, with one CCD frame acquisition per filter wavelength. 
Integration times were varied at each wavelength to compensate for disparities in system 
sensitivity as measured previously. Baseline images were acquired with no sample excitation 
using identical integration times as their respective fluorescence and diffuse reflectance images 
to correct for ambient illumination and CCD dark current. After measurement, imaging data was 
baseline subtracted and corrected for variations at each wavelength in system sensitivity and 
integration time. To create two-dimensional grayscale or color images from three-dimensional 
spectral image data, spectral intensities were summed on a pixel-by-pixel basis across all 
wavelengths (grayscale) or using a custom weighted integration scheme (color). Summed 
intensities were subsequently normalized to maximize the grayscale/color contrast across the 
image pixels while maintaining the relative intensities between color channels. 
 Since human brain tissue cannot be readily acquired for system testing in vitro, tissue 
phantoms were developed to optically mimic human brain tissues (white matter, gray matter, 
glioma) with regard to reduced scattering, absorption, and autofluorescence. Published mean 
reduced scattering and absorption spectra for white matter, gray matter, and glioma tissues [39] 
were used as the target values for phantom development. Within a substrate of Bloom Type A 
gelatin (Vyse Gelatin), bovine hemoglobin (Sigma-Aldrich) was employed for absorption, 
polystyrene microspheres (Polysciences) for reduced scattering, and Stilbene 420 (Exciton) for 
fluorescence. The concentrations of these components for the three tissue types are outlined in 
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Table 1. It should be noted that all concentrations were empirically determined from optical 
property measurements (using the standard integrating sphere and inverse adding-doubling 
technique as described in [40]) on the tissue phantoms and subsequent comparison to the 
previously measured spectra (Figure 3). Fluorescent dye concentrations were empirically 
determined by comparing fluorescence measurements from phantom tissues to those measured in 
vivo with a probe-based spectroscopy system as part of a separate project [18]. While the peak 
fluorescence intensity in vivo has been found to be generally constant between tissue types, the 
concentration of fluorescent dye was decreased in the tumor tissue phantom to provide 
exogenous spectral contrast between normal and tumor tissues for system testing.  
 A phantom was created using the three phantom types to simulate a frontal slice through 
the brain with a large tumor deeply seated within the white matter. Fluorescence and diffuse 
reflectance spectral images (and corresponding baseline images) were acquired from 400 to 720 
nm with the tuning wavelength incremented in 20 and 10 nm steps, respectively. Integration 
times were varied at each wavelength to acquire measured signals roughly half the dynamic 
Table 1. Phantom components for white matter, gray matter, and tumor tissues. All component concentrations are 
given per milliliter of the total phantom volume. Polystyrene microsphere concentrations represent the number of 
milliliters of 2.65% stock microsphere solution per milliliter of total phantom volume. 
 
Tissue Type Bovine Hemoglobin 
Polystyrene 
Microspheres 
(d = 0.1 µm) 
Polystyrene 
Microspheres 
(d = 0.5 µm) 
Stilbene 420 
White Matter 2.5 mg/mL 0.300 mL/mL 0.300 mL/mL 5.0 µg/mL 
Gray Matter 2.5 mg/mL 0.083 mL/mL 0.083 mL/mL 5.0 µg/mL 
Tumor 2.5 mg/mL 0.150 mL/mL 0.150 mL/mL 3.5 µg/mL 
 
                     
(a)                                                                               (b) 
Figure 3. Measured (a) reduced scattering and (b) absorption spectra from white matter, gray matter, and tumor 
tissues [39] and phantoms using a single-integrating-sphere spectrophotometer and inverse adding-doubling 
technique [40]. 
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range of the CCD camera at every wavelength. The total image integration times were 190 
seconds for fluorescence and 13.76 seconds for diffuse reflectance. To further increase the 
signal-to-noise ratio in the fluorescence images, 2 x 2 pixel binning was utilized. 
 To demonstrate the capability of the imaging system to produce spectral contrast between 
white and gray matter tissue, an intact brain from a euthanized FVB wild-type mouse was 
studied. The brain tissue was snap-frozen in liquid nitrogen immediately after removal and stored 
at -80°C until image measurement. Prior to measurement, the brain was thawed in phosphate 
buffered saline to room temperature and sliced along a frontal plane through the rostral 
diencephalon to expose the underlying white matter. Similar to the phantom measurements, 
fluorescence and diffuse reflectance (plus baseline) spectral images were acquired in vitro from 
400 to 720 nm in 20 and 10 nm steps, respectively. Fluorescence was acquired using an 
integration time of 30 seconds at each wavelength between 400-500 nm and 10 seconds between 
520-720 nm. Diffuse reflectance was measured using integration times that varied from 5 
seconds at 400 nm to 5 ms at 720 nm. The total integration time to acquire the entire spectral 
data cube was 5 minutes for fluorescence and 15 seconds for diffuse reflectance with no pixel 
binning employed in either image. It is important to note that while the mouse brain did not span 
the entire field of view of the imaging system, an 80-mm focal length and 180-mm object 
distance were maintained for a 25-mm field of view which correlates to the spatial resolution 
characterization. 
 For the ultimate functional test, fluorescence and diffuse reflectance images were 
acquired in vivo from the cortical surface of a human brain tumor patient undergoing craniotomy 
for glioma resection. The image acquisition protocol was approved by the Vanderbilt University 
Institutional Review Board. Subsequent to craniotomy and duratomy, the imaging system was 
covered in a sterile drape and positioned roughly seven inches above the patient’s brain surface 
by the attending neurosurgeon. The system field of view was focused on a cortical surface region 
near the edge of the craniotomy such that both normal cortex and glioma tissue were visible. 
Spectral and baseline images were acquired from the brain surface with integration times which 
varied inversely with system sensitivity at each wavelength. Sample integration times were 4 
seconds at 460 nm for fluorescence and 8 ms at 580 nm for diffuse reflectance. Total integration 
times for diffuse reflectance and fluorescence spectral images were 15 and 45 seconds, 
respectively, and 4 x 4 pixel binning was employed only for fluorescence imaging. Diffuse 
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reflectance images were acquired from 400 to 720 nm in 10 nm increments, while fluorescence 
images were acquired every 20 nm except between 440-480 nm where a 10-nm increment was 
used and 600-720 nm where a 40-nm increment was used. 
 
Results 
 
System Characterization 
 Measured intensity from the spectral imaging system is linear with both emission 
intensity and integration time. Sample results at 600 nm are shown in Figure 4 and the regression 
statistics averaged over all wavelengths are outlined in Table 2. Linearity was assessed before 
and after baseline subtraction, which effectively eliminated the non-zero offset from ambient 
illumination and dark current within the CCD camera observed in the measurements. 
 The field of view (FOV) for the imaging system was found to be linear with object 
distance measured from the distal face of the LCTF (Figure 5). For a collection-lens focal length 
equal to 80 mm, the system FOV varied from 20 to 36 mm over object distances which ranged 
                     
(a)                                                                             (b) 
Figure 4. Linearity measurements at 600 nm for (a) constant integration time, variable sample emission and (b) 
constant sample emission, variable integration time. Measured intensities, ideal emission intensities, and integration 
times are normalized relative to the maximum intensity images in each set of measurements (OD= 0 and 5000 ms 
integration). 
 
Table 2. Regressions statistics for linearity measurements, averaged across all wavelengths. 
 
Variable Emission Intensity  Variable Integration Time 
Baseline Subtracted  No Baseline Subtraction  Baseline Subtracted  No Baseline Subtraction 
m b R2  m b R2  m b R2  m b R2 
0.9932 0.0174 0.9990  0.6526 0.3557 0.9990  0.9919 0.0097 0.9996  0.5918 0.4087 0.9991 
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Figure 5. Imaging system field of view as a function of object distance from the distal face of the LCTF.  
from 140 to 305 mm (5.5” to 10”). For object distances shorter than 140 mm, the system FOV 
was held constant at 20 mm while the lens focal length was shortened to focus on the sample. An 
object distance of 178 mm (7.0”) allowed a system FOV of 25.4 mm (1.0”). Thus, the imaging 
system was coupled to the microscope with this target FOV and object distance, placing the 
LCTF 178 mm from the focal plane of the microscope. 
 The spectral resolution of the imaging system was determined to be linear with tuning 
wavelength of the LCTF. The mean imaging spectra acquired from the laser spots (Figure 6a) 
demonstrate increasing width as a function of peak emission wavelength, with a bandwidth that 
varies as ~λ/12, from 6.75 nm at 400 nm to 35.1 nm at 720 nm (Figure 6b). The spectral 
                     
(a)                                                                              (b) 
Figure 6.  (a) Mean imaging spectra of various laser inputs across the spectral range of the LCTF. (b) Measured 
spectral bandwidth of imaging system as function of peak emission intensity. 
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resolution at 550 nm was measured to be 20.32 nm, which agrees with the nominal hardware 
specifications of the LCTF (FWHM = 20 nm at 550 nm). 
 The spatial resolution of the imaging system proved to be pixel-limited. The measured 
peak-to-valley ratios followed a sigmoid curve as a function of the spacing between adjacent 
lines (Figure 7a). A separation distance equal to 56 µm (8.9 lp/mm) yielded a PVR equal to the 
square root of two (Figure 7b). Given the 25.4 mm field of view and 512 x 512 pixel array of the 
CCD camera, pixel-limited spatial resolution can be calculated to be 49.6 µm, roughly equivalent 
to the measured spatial resolution. 
 The wavelength sensitivity of the imaging system demonstrated large dynamic ranges for 
                     
(a)                                                                               (b) 
Figure 7. (a) Sigmoid relationship between the measured peak-to-valley ratios as a function of separation distance 
between rulings. (b) Zoomed view of sigmoid curve centered around region where separation distance yields a PVR 
equal to the square root of two. 
                     
(a)                                                                             (b) 
Figure 8. Wavelength (a) sensitivity and (b) dynamic range spectra of the spectral imaging system for fluorescence 
and diffuse reflectance. 
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both fluorescence and diffuse reflectance (Figure 8). The sensitivity of the collection leg of the 
imaging system (fluorescence) is highest at 702 nm and lowest at 400 nm, with a dynamic range 
of 177. The dynamic range for diffuse reflectance is exacerbated by the excitation spectrum of 
the halogen lamp, which peaks near 680 nm and is lowest at 400 nm, resulting in a dynamic 
range of 2650. However, since the gradient from 680 to 400 nm in the halogen excitation 
spectrum is smaller than the equivalent gradient in the fluorescence sensitivity curve, the peak 
sensitivity for diffuse reflectance is significantly blue-shifted from 702 to 584 nm. 
 
Functional system testing 
 Diffuse reflectance and fluorescence spectral images (Figure 9a,b) of the brain tissue 
       
(a)                                                       (b)                                                       (c) 
   
(d)                                                         (e) 
Figure 9. (a) Diffuse reflectance and (b) fluorescence spectral images of a brain tissue phantom in vitro. Displayed 
image intensities reflect a direct integration across all wavelengths of the diffuse reflectance and fluorescence 
spectral image intensities. (c) Diffuse reflectance spectra (averaged over the boxed 20 x 20 pixel regions) for the 
three tissue types. (d) Fluorescence spectra over the same regions. (e) Discrimination image depicting normal 
(black) and tumor (white) tissues, created from the ratio of fluorescence at 460 nm to diffuse reflectance at 700 nm 
(F460/Rd700). Pixels with F460/Rd700 < 1.15 were classified as tumor, with F460/Rd700 > 1.35 classified as normal, and 
with 1.15 < F460/Rd700 < 1.35 classified as transitional areas (gray). 
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phantom demonstrate the spatial resolution of the system and its capability to provide spectral 
contrast necessary to visualize sharp transitions and spectral differences between white matter, 
gray matter, and glioma phantom tissues. Mean imaging spectra calculated across the boxed 20 x 
20 pixel regions (Figure 9c,d) show spectral lineshapes with varying magnitudes between the 
tissues for fluorescence and diffuse reflectance. Fluorescence intensity peaked between 440 and 
460 nm for all three tissues with white matter boasting the highest fluorescence intensity. Based 
on the spectral differences between the normal and tumor tissues, an empirical algorithm was 
developed to demonstrate the capability to spectrally demarcate the tumor from the surrounding 
normal tissue using spectral imaging data. The ratio of fluorescence at 460 nm (F460) to the 
diffuse reflectance at 700 nm (Rd700) with a threshold of 1.25 effectively highlighted the tumor 
tissue (Figure 9e), showing that the LCTF spectral imaging system is capable of spectrally 
discriminating between tissues based on exogenous fluorescence. 
 Diffuse reflectance and fluorescence images from the in-vitro mouse brain illustrate sharp 
spectral contrast between gray and white matter tissues (Figure 10a,b). Spectral image features 
also show good correlation to tissue structures evident in a composite Nissl- and myelin-stained 
frontal section (Figure 10c) through the rostral diencephalon of the mouse neuroanatomy [41]. 
Raw spectra (Figure 10d) measured from white and gray matter regions without correction for 
integration time or wavelength sensitivity show measured fluorescence levels near 20,000 counts 
(of a 16-bit dynamic range). Corrected spectra (Figure 10e) demonstrate peak fluorescence 
between 460 and 480 nm, diffuse reflectance which varies inversely with hemoglobin absorption, 
and greater diffuse reflectance in white matter. 
 When comparing the spectral images to the mouse-brain atlas, the diffuse reflectance 
spectral image shows low-scattering gray matter structures that correlate to a high concentration 
of cell bodies (positive Nissl staining), such as the cortical tissue surface, basal ganglia, 
hippocampus, and diencephalon (thalamus and hypothalamus). High-scattering white matter 
fiber tracts (positive myelin staining) are also clearly visible, most notably the corpus callosum 
connecting the two cortical hemispheres and the internal capsule running between the basal 
ganglia and diencephalon. The spatial resolution and spectral contrast in the diffuse reflectance 
image are sensitive enough to visualize even subtle anatomic features such as the white matter 
striations from the corpus callosum into the cortex (e.g. into the cingulate gyrus along the 
midline) and from the internal capsule into the motor nuclei of the basal ganglia and into the 
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motor and sensory nuclei of the thalamus. The fluorescence images show increased emission 
levels with increased concentration of cell bodies and increased tissue scattering, consistent with 
the results from phantom tissues (Figure 9). The cortex (high cell body content, low scattering) 
and white matter structures (low cell body content, high scattering) show equivalent levels of 
fluorescence emission, while the hippocampus (low cell body content, low scattering) shows 
very little fluorescence and the thalamus (high cell body content, moderate scattering from white 
matter tracts) demonstrates the highest fluorescence intensity. Though not readily visible, a line 
of fluorescence contrast even exists within the low-emission hippocampus which corresponds to 
the contour of high cell concentration evident in the stained section.  
   
(a)                                                      (b)                                                       (c) 
                      
(d)                                                                              (e) 
Figure 10. (a) Diffuse reflectance and (b) fluorescence spectral images of a frontal slice of mouse brain imaged in 
vitro. Displayed color intensities reflect a weighted integration scheme, shown in (e), of the diffuse reflectance and 
fluorescence spectral image intensities. (c) Composite Nissl (pink) and myelin (black) stained frontal section 
through the rostral diencephalon of the mouse brain [19] (d) Raw fluorescence and diffuse reflectance spectra for 
white and gray matter tissues (10 x 10 pixel regions) before correction for integration time and system sensitivity as 
a function of wavelength. (e) Fluorescence and diffuse reflectance spectra after correction and the custom 
integration scheme (solid thick lines) employed to produce color images from spectral imaging data. 
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 The in vivo diffuse reflectance and fluorescence images (Figure 11a,b) provide good 
visualization of the large blood vessels and pial microcirculation along the cortical surface of the 
human brain. Based on the images and the mean spectra (Figure 11d), there appear to be only 
subtle differences (as expected) in fluorescence and diffuse reflectance between the tumor tissue 
to the left of the major blood vessel bisecting the image and the normal cortex to the right. The 
raw spectra (Figure 11c) show measured fluorescence intensities near 15,000 counts with diffuse 
reflectance intensities near 10,000 counts in the blue region of the spectrum and 40,000 counts in 
the red region. The corrected spectra (Figure 11d) demonstrate peak fluorescence between 460 
and 470 nm and greater contrast between the blue and red regions of the spectrum than the in-
vitro mouse brain measurements, both in diffuse reflectance spectra and in the peak fluorescence 
emission intensity relative to diffuse reflectance at 700 nm.  
 
                      
(a)                                                                               (b) 
                     
(c)                                                                              (d) 
Figure 11. In vivo (a) diffuse reflectance and (b) fluorescence spectral images of the cortical surface of a human 
brain tumor patient. (c) Raw fluorescence and diffuse reflectance spectra (20 x 20 pixel regions) from tumor (left of 
major blood vessel vertically bisecting the image) and normal cortex (right) before correction for integration time 
and system sensitivity as a function of wavelength. (d) Fluorescence and diffuse reflectance spectra after correction. 
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Discussion 
 While single-point spectroscopy measurements are ideal for proof-of-principle clinical 
studies in which measured spectra can be correlated to histopathologic diagnoses of punch tissue 
biopsies, they are an inefficient means to provide surgical resection guidance. This limitation 
calls for the extension of single-point spectroscopy to spectral imaging which acquires equivalent 
spectroscopic information at every pixel across a two-dimensional imaging surface, giving a 
spatial snapshot of tissue pathology during surgery. The spectral imaging system described in 
this paper is capable of combined fluorescence and diffuse reflectance spectral imaging coupled 
to an operating microscope for seamless integration into the clinical environment. The battery of 
tests designed to characterize the imaging system parameters have revealed measured intensities 
which are linear with sample emission intensity and integration time, a 25-mm field of view for a 
180-mm object distance, spectral resolution which is linear with wavelength, spatial resolution 
which is pixel-limited, and fluorescence and diffuse reflectance sensitivities with large dynamic 
ranges. Consistent with the goals of the functional tests, in-vitro images of phantom and mouse 
brain tissue showed excellent spatial resolution for visualization of fine tissue structures and 
spectral contrast based on exogenous fluorescence and endogenous tissue differences for 
successful spectral discrimination between tissue types. In-vivo imaging of the cortical surface in 
a human brain tumor patient proved that high signal-to-noise ratio images can be acquired within 
a clinically viable, two-minute imaging timeframe, resulting in minimum disruption during 
surgery for clinical data acquisition. 
 By the strictest definition of linearity, spectral imaging in the presence of dark current 
CCD noise is linear if baseline subtraction is performed. The linearity of the imaging system was 
characterized to ascertain whether increases in integration time or emission intensity increase the 
measured intensity by the same factor. For plots of normalized measured intensity versus 
normalized emission intensity or integration time, a linear system conforming to such a 
definition yields a slope of one and an intercept of zero, criteria which are satisfied when 
baseline subtraction is used to eliminate the offset due to dark current noise in the CCD camera. 
Strict linearity has two main advantages. First, wavelength ratios performed on a pixel-by-pixel 
basis directly correlate to differences in emission intensity and are immune to emission changes 
due to spatial variations in excitation light and surface topography, allowing simple correction 
for these effects. Second, and more importantly, unique integration times can be used at the 
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different wavelengths in the spectral image, and simple normalization of the measured spectra 
can be used to correct for these varied integration times during post-processing. Given the large 
dynamic range in system sensitivity for fluorescence (177) and diffuse reflectance (2650), 
variable integration times are necessary to acquire reasonable signal levels at all wavelengths in 
the images, which can subsequently be accounted for with normalization, as was performed 
during functional system testing. 
 The wavelength sensitivity of a detection system is normally reserved to correct 
measured spectra for system response. Given the linearity of the imaging system with integration 
time, the system sensitivity can also be used to guide how the total image integration time is 
distributed between wavelengths. The sensitivity measurements suggest that the majority of 
image integration time should be devoted to the blue region of the spectrum where sensitivity is 
lowest (Figure 8). Employing integration times which vary inversely with system sensitivity 
(such that the correction for wavelength sensitivity and integration time offset one another) 
ensured that measured signal levels were independent of the system response, directly correlated 
to tissue emission intensity, and created raw measured spectra (Figure 11c) that were similar in 
shape to the corrected spectra (Figure 11d).  
 Spatial and spectral resolution characterization aims to determine whether these system 
limits distort spectral imaging data from true sample behavior. Spectral resolution of the imaging 
system (10 to 35 nm) acts as a low-pass filter on the spectral lineshape, effectively widening 
spectral features with narrow bandwidths. Modeling a spectral peak and the system passband as 
Gaussian functions, the width of the peak as measured by the system can be calculated as the 
quadratic sum of the true peak width and the passband width [32]. To broaden a spectral peak by 
10%, the spectral resolution must be greater than 46% of the original peak width. Fluorescence 
and diffuse reflectance spectra are traditionally composed of broadband features (i.e. widths > 50 
nm), and those with the narrowest bandwidth, NADH fluorescence at 460 nm and the 
hemoglobin absorption bands at 420 and 540 nm (542, 578 nm for oxy-hemoglobin), occur in 
regions of the spectrum where the system spectral resolution is lowest (10-20 nm). As such, the 
distortion of fluorescence and diffuse reflectance spectral features from their true lineshapes can 
be considered negligible. 
 Given the resolution demonstrated in the mouse brain and human cortical surface images, 
pixel-limited spatial resolution of the imaging system (56 µm with no binning) will have 
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minimal effect on tissue discrimination and surgical resection guidance. While the spatial 
resolution is larger than individual neurons and glial cells in the brain and thus subject to partial 
volume effects over multiple cells, current methods of tumor resection are incapable of single-
cell removal; therefore, neurosurgeons are often interested in macroscopic more than 
microscopic discrimination. Further, it has been demonstrated that photon diffusion from areas as 
far as 10 mm from a given pixel can influence spectral imaging lineshape [19]. Therefore, partial 
volume effects in spectral imaging will be influenced less by the pixel size in the CCD camera 
and more by the scattering of light through the tissue, even when the effective pixel size is 
increased with pixel binning. 
 The question often arises regarding the effect of the polarization capability of the LCTF 
on measured spectral lineshape and the steps taken to correct for such distortions. Since 
excitation light delivered by the spectral imaging system is randomly polarized and brain tissue 
is fairly homogeneous with no known birefringence characteristics, the light remitted from the 
tissue surface is assumed to be randomly polarized across the entire tissue surface and for all 
wavelengths in the spectrum. Therefore, the polarization capability of the LCTF only serves to 
reduce the throughput of the spectral imaging system, without affecting the measured lineshapes 
of the imaging spectra, to the point that roughly 5-15% of blue light remitted from the tissue 
reaches the CCD camera for detection. It is important to note that imaging tissues with known 
birefringence (e.g. muscle) will be sensitive to the orientation of the LCTF relative to the optical 
axis of the tissue, with the potential for spectral distortion due to birefringence variations with 
wavelength. 
 Spectra from fluorescence and diffuse reflectance images of the tissue phantom (Figure 
9) and the mouse brain (Figure 10) agree with expectations based on the known optical 
properties (Figure 3), fluorophore concentrations (Table 1), and cellular composition (Figure 
10c) for the various tissue types observed in the images. The diffuse reflectance spectral 
lineshapes are inversely related to the tissue absorption spectra, while equivalent absorption 
levels between white matter, gray matter, and tumor tissues lead to a direct correlation between 
the magnitude of reduced scattering and measured diffuse reflectance intensity. Reduced 
scattering also increases fluorescence intensity, as demonstrated in the phantom images by 
higher fluorescence in the white matter than gray matter despite equivalent fluorophore 
concentrations in the two tissues. Equivalent fluorescence levels between gray matter and white 
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matter in mouse brain tissue coupled with higher reduced scatting in white matter suggests 
higher fluorescence generation in gray matter tissue, perhaps due to a higher concentration of 
cell-body content and subsequently NADH. 
 The spectral images acquired in vitro from the tissue phantom and mouse brain tissue 
demonstrate the capability of the system to spectrally discriminate between brain tissues based 
on exogenous fluorescence (Figure 9) and endogenous tissue chromophores (Figure 10). Simple 
weighted integration of spectral intensities (Figure 10e) to produce pixel-by-pixel color 
information was sufficient to create stark visible disparities between white matter and gray 
matter in the mouse brain images (Figure 10a,b) with no optimization of spectral differences. For 
the mock discrimination scenario in Figure 9e, the ratio of fluorescence at 460 nm (F460) to the 
diffuse reflectance at 700 nm (Rd700) with a threshold of 1.25 was capable of accurately 
separating normal from tumor tissue. The discrimination algorithm was based on fluorescence 
intensity while presumably correcting this intensity for spatial variations in excitation intensity 
and surface topography and for the disparate levels of scattering between the tissue types. It 
should be noted that the major sources of error in the discrimination image correspond to regions 
where specular reflectance is highlighted and where air bubbles are present on the surface of the 
phantom which reduce the fluorescence emission. Based on these results, spectral discrimination 
with our dual-mode LCTF spectral imaging system is at least on par with other imaging systems 
in the literature capable of 1) creating visible image contrast from disparities in endogenous 
tissue chromophores and 2) tissue discrimination based on spectral differences from exogenous 
tissue fluorescence. 
 The in-vitro and in-vivo brain tissue images indicate that acquiring full fluorescence and 
diffuse reflectance information with good signal intensities in vivo is feasible in a clinically 
viable timeframe, resulting in minimal disruption during surgery. The fluorescence, diffuse 
reflectance, and baseline images measured from mouse brain tissue in vitro used 10.5 minutes of 
total integration time to produce image intensities which spanned a third of the 16-bit dynamic 
range of the CCD camera (max intensity = 65535). Exploiting 4 x 4 pixel binning during in-vivo 
testing reduced the total image integration time for fluorescence from five minutes to forty-five 
seconds. Image acquisition overhead associated with data readout from the CCD (100 ms for a 
full CCD frame) and LCTF tuning (50 ms for each wavelength) diminishes the benefit of pixel 
binning for diffuse reflectance imaging, decreasing the acquisition time for a 33-wavelength 
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image from 20 s (15 s integration, 5 s overhead) to 6 seconds (1 s integration, 5 s overhead). 
With these reduced imaging times, the fluorescence, diffuse reflectance, and their associated 
baseline images can be acquired in 120 seconds, and given the pixel-limited spatial resolution of 
the imaging system, still yield a 200 µm spatial resolution sufficient for macroscopic tumor 
resection guidance. 
 In addition to the in-vitro mouse brain images demonstrating that rapid imaging is 
feasible, the in-vivo images reveal the power of superficial blood contamination and tissue 
perfusion to absorb fluorescence emission at 460 nm and affect measured signal levels, behavior 
which is consistent with our clinical experiences with probe-based spectroscopy [16, 42]. 
Fluorescence image intensity is reduced in all blood vessels regardless of size, and a thin layer of 
blood is enough to completely absorb the bright fluorescence from the cranium at the right of the 
image. Similarly, a small blood vessel traverses the internal capsule to the left of the in-vitro 
mouse brain images; despite its small size to the point of near invisibility, the vessel creates a 
distinct line of low-emission in the fluorescence image. The in-vivo fluorescence images were 
acquired with 4x4 pixel binning and a 7.5-fold decrease in integration time at 460 nm, resulting 
in a two-fold increase in collection power at 460 nm relative to the mouse brain images. The raw 
in-vivo spectra show a two-fold decrease in peak fluorescence intensity relative to the mouse 
brain spectra (Figures 10d & 11c). Hemoglobin absorbs greater in the blue-green (400 – 600 nm) 
than the red region (600 – 720 nm) of the spectrum, such that the ratio in diffuse reflectance 
intensity between these regions indicates the relative level of blood absorption in the measured 
spectrum. The increase in that ratio from 2-fold in vitro (Figure 10e) to nearly 4-fold in vivo 
(Figure 11d) indicates the increased presence of blood absorption in vivo, consistent with 
previous results [16]. Given that superficial blood is not apparent in the images, the decrease in 
measured fluorescence intensity in vivo can be attributed to increased blood perfusion in the live 
tissue, requiring increased image acquisition times in vivo relative to the in-vitro scenario to 
achieve equivalent signal levels. 
 As mentioned in the introduction, successful translation from probe-based spectroscopy 
to macroscopic spectral imaging hinges on reasonable image acquisition time and accurate 
spectral discrimination between tissues. The results in this paper demonstrate the ability of our 
dual-mode LCTF spectral imaging system to acquire fluorescence and diffuse reflectance images 
in vivo within a clinically viable, two-minute imaging timeframe with excellent spatial 
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resolution, diffuse reflectance contrast indicative of even small anatomic transitions between 
white and gray matter, and fluorescence contrast indicative of cellular composition. The imaging 
results in this paper breed confidence in our ultimate ability to delineate tumor margins in the 
brain in the face of subtle spectral differences between normal brain and tumor tissues. Success 
in such an endeavor will require careful investigation into the normal and tumor spectral 
lineshapes as measured by spectral imaging and multivariate statistical analysis of patient 
imaging data through a large, well-designed retrospective clinical study. Pre-clinical spectral 
image data acquisition for this study has already begun; the results from the investigations 
described in this paper will serve to guide us as we move further toward clinical spectral imaging 
for intra-operative brain tumor resection guidance. 
 
Conclusion 
 This paper outlines the imaging characteristics of a combined fluorescence and diffuse 
reflectance spectral imaging system designed for clinical brain tissue diagnosis and tumor 
resection guidance. Its simple design around a liquid-crystal tunable filter, its linearity of 
measured intensity with emission intensity and integration time, and its pixel-limited spatial 
resolution make it a versatile imaging system for clinical tissue diagnosis. It can acquire spectral 
information at specific wavelengths deemed diagnostically significant, employ integration times 
which vary with wavelength to acquire good signal-to-noise across the spectral range of interest, 
and utilize pixel binning to increase signal levels while maintaining sufficient spatial resolution 
for surgical guidance. Using this system, phantom tissues can be distinguished based on 
exogenous fluorescence variations and white and gray matter can be differentiated based upon 
spectral differences subsequent to disparities in scattering and cell-body concentration. In-vivo 
testing indicates that high-quality autofluorescence and diffuse reflectance images can be 
acquired from brain tissue within a clinically viable, two-minute imaging timeframe during 
surgery, and tissue perfusion and superficial blood contamination continue to play an important 
role along this front. These results will help guide data collection during a large pre-clinical 
study designed to determine the efficacy of combined fluorescence and diffuse reflectance 
spectral imaging to spectrally discriminate between normal and glioma tissues in the brain for 
tumor margin demarcation and surgical resection guidance. 
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CHAPTER V 
 
EXPERIMENTAL AND SIMULATED ANGULAR PROFILES OF FLUORESCENCE AND 
DIFFUSE REFLECTANCE EMISSION FROM TURBID MEDIA 
 
Abstract 
 Given the wavelength dependence of sample optical properties and the selective sampling 
of surface emission angles by non-contact imaging systems, differences in angular profiles due to 
excitation angle and optical properties can distort relative emission intensities acquired at 
different wavelengths. To investigate this potentiality, angular profiles of diffuse reflectance and 
fluorescence emission from turbid media were evaluated experimentally and using Monte Carlo 
simulation for a range of incident excitation angles and sample optical properties. For emission 
collected within the limits of a semi-infinite excitation region, normalized angular emission 
profiles are symmetric, roughly Lambertian, and only weakly dependent on sample optical 
properties for fluorescence at all excitation angles and for diffuse reflectance at small excitation 
angles relative to the surface normal. Fluorescence and diffuse reflectance within the emission 
plane orthogonal to the oblique component of the excitation also possesses this symmetric form. 
Diffuse reflectance within the incidence plane is biased away from the excitation source for large 
excitation angles. The degree of bias depends upon the scattering anisotropy and albedo of the 
sample and results from the correlation between photon directions upon entrance and emission. 
Given the strong dependence of the diffuse reflectance angular emission profile shape on 
incident excitation angle and sample optical properties, excitation and collection geometry has 
the potential to induce distortions within diffuse reflectance spectra unrelated to tissue 
characteristics. 
 
Introduction 
 Cancer development often leads to distinct changes in the morphology and biochemistry 
of tissue such as an increase in nuclear density. As structural and physiological characteristics of 
tissues govern its interactions with light, the concept of using light propagation characteristics to 
detect cancer (i.e. optical biopsy) has been extensively investigated over the past two decades [1-
6]. Because it can be conveniently, directly and non-invasively detected, light emission from the 
tissue surface, such as fluorescence or diffuse reflectance, is often used for optical tissue 
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interrogation. In order to truly assess tissue characteristics, it is important to acquire surface 
emission in a way that spectral distortions induced by factors other than intrinsic tissue 
characteristics are excluded. 
 The ability to discriminate between normal and diseased tissue using optical biopsy 
methods is typically investigated using fiber-optic probes which acquire emission spectra from a 
single site on the tissue surface. However, this “single-pixel” method of tissue discrimination 
limits the information transfer to the clinician. As such, the practical, long-term vision for tissue 
screening, disease diagnosis, and therapy guidance using optical methods calls for spectral 
imaging systems to implement tissue discrimination over a two-dimensional area in a single 
snapshot. Since imaging systems typically acquire emission without tissue contact, using 
detectors with limited reception angles, there is concern regarding how excitation and collection 
geometry relative to the tissue surface could induce extrinsic spectral distortions within measured 
fluorescence and diffuse reflectance data.  
 If angular profiles of surface emission depend upon sample optical properties, angular 
emission will vary between the various wavelengths within a spectrum. Consequently, their 
relative intensities will be modulated by detector collection that is limited to a narrow range of 
emission angles. Non-contact excitation and detection systems must also contend with sample-
specific surface geometry effects that modulate the incident excitation angle between 
interrogated tissue sites (i.e. between pixels within the image). If angular emission profiles 
depend upon incident excitation angle, an undulating sample surface can similarly induce 
spectral distortions within imaging spectra and extrinsic differences between them. Given these 
possible sources of spectral distortion based upon excitation and collection geometry, there exists 
a need to characterize fluorescence and diffuse reflectance angular emission as functions of 
incident excitation angle and sample optical properties to determine if constraints on imaging 
system geometry are necessary. 
 The correlations of angular emission characteristics to the optical properties of tissue and 
to the incident angle of excitation light have not been thoroughly explored in the literature. Using 
Monte Carlo simulation, Qu et al reported “nearly Lambertian” angular emission profiles for 
fluorescence and diffuse reflectance when excitation is normal to the tissue surface [7]. Angular 
emission profiles for diffuse reflectance deviated from Lambertian behavior when the excitation 
was delivered at oblique angles (30° and 75° with respect to the surface normal) such that the 
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emission was biased away from the source, indicating that angular emission of diffuse 
reflectance may be dependent on sample optical properties when the excitation is delivered at an 
oblique excitation angle. Churmakov et al reported similar roughly Lambertian emission 
behavior for diffuse reflectance when excited normal to the surface [8]. However, while these 
results hint at angular emission profiles of diffuse reflectance which are dependent upon incident 
excitation angle, neither group investigated the correlation between angular emission and sample 
optical properties or provided a detailed explanation for the behavior of the bias. 
 Our group is interested in the application of optical methods for the guidance of therapy. 
In particular, we have developed the use of combined diffuse reflectance and fluorescence 
spectroscopy for brain tumor demarcation. To transition the early single-pixel system into a 
clinically viable one, a spectral imaging system is being developed and relevant calibration 
methods evaluated for brain cancer imaging. A critical issue is one associated with non-normal 
excitation angles. While the excitation angle can be rigidly controlled in contact-based 
spectroscopy, imaging the tissue within the resection crater of a deep-seated brain tumor can 
force delivery of excitation light significantly away from the surface normal if the surgeon is 
interested in tissue diagnosis along the crater walls. The potential for spectral distortion also 
exists for a variety of other in vivo imaging applications that involve oblique excitation angles. 
Spectral endoscopy in the colon and lung excite the interior circumference of the tissue walls 
with the lumen positioned in the image center, creating excitation angles that deviate further 
from the surface normal toward the center of the images. This lack of control over excitation 
angle in many such in vivo applications drives the current investigation into the potential of 
spectral distortion induced by excitation-sample-collection geometry within diffuse reflectance 
and fluorescence spectra.  
 In this paper, angular emission characteristics of fluorescence and diffuse reflectance are 
experimentally investigated. The experimental measurements are subsequently verified with 
Monte Carlo simulations. Specifically, effects of tissue optics and incident excitation angle on 
the shape of angular emission profiles of fluorescence and diffuse reflectance are explored. 
While this investigation is not exhaustive in nature, it highlights many behaviors of fluorescence 
and diffuse reflectance emission and demonstrates a need for caution in diffuse reflectance 
system design.  
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Materials and Methods 
 
Experimental Measurement of Angular Emission Profiles 
 Effect of sample optical properties and incident angle of excitation light on the angular 
emission profiles of fluorescence and diffuse reflectance were evaluated experimentally using 
tissue phantoms and a combined fluorescence and diffuse reflectance spectroscopic system, as 
shown in Figure 1. The spectroscopic system utilizes a halogen lamp (Ocean Optics Inc, 
Dunedin, FL) and a pulsed nitrogen laser (Spectra-Physics, Mountain View, CA) for excitation 
of diffuse reflectance and fluorescence, respectively. The excitation light was coupled into a 600 
µm core optical fiber and then expanded and collimated at the distal end of the fiber, creating an 
illumination spot of ~15-mm diameter when excitation was normal to the phantom surface (at α 
= 60°, the long axis was ~30 mm in diameter). A fiber-optic probe was employed to collect the 
reemitted light from the phantom sample at various angles. To confine its collection angle and 
area, an extender 35 mm in length with a 1-mm inner diameter was attached to the collection end 
of the probe, giving the probe a collection cone half-angle equal to 0.82° and a numerical 
aperture of 0.014. The 75-mm distance between the sample and the collection probe 
subsequently yielded a collection area 2.14 mm in diameter at θ = 0°. At oblique collection 
angles, the collection area becomes elliptical with its major-axis diameter increasing by 1/cos(θ) 
as the collection angle increases relative to the surface normal. The maximum diameter of the 
collection region at θ = 80° was 12.4 mm such that it always resided within the limits of the 
excitation spot. 
 The excitation light collimator and the emission collection probe were individually 
mounted onto two mechanical arms rotating concentrically (see Figure 1), such that the 
observation area was consistently centered within the excitation spot. The optical axis of the 
excitation light and the long axis of the emission collection probe were aligned parallel to the 
axes of their corresponding mechanical arms to prevent the observation area of the probe from 
shifting laterally as the observation angle varied. Fluorescence or diffuse reflectance light 
collected by the probe was sent to a spectrometer (Ocean Optics Inc) controlled by a computer to 
effectively observe the wavelength (i.e. optical property) dependence of the angular emission 
profiles of fluorescence and diffuse reflectance. A petri dish 10 mm deep by 35 mm in diameter 
was filled to hold the tissue phantoms prepared for this study. Monte Carlo simulation was used 
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to verify that the dimensions of the phantom produced a semi-infinite medium for the angular 
profile measurements. The top of the petri dish was aligned with the x-y plane of the 
experimental setup (see Figure 1) to further prevent lateral shift of the observation spot while 
interrogating the angular emission profile from the sample.   
 Tissue phantoms utilized in this experimental study were prepared using polystyrene 
microsphere suspension (Polysciences Inc, Warrington, PA) as the base. To cover the range of 
scattering coefficients and anisotropy factors typically found in soft tissue [9], four microsphere 
suspensions were prepared for diffuse reflectance measurements as shown in Table 1a. Based 
upon Mie scattering calculations [10], these suspensions provided various scattering coefficients 
and anisotropy factors over the collected spectral range (400 – 800 nm). For fluorescence 
measurements, two phantom samples were created according to Table 1b with various 
fluorophores to provide a wide range of scattering coefficients and anisotropy factors over the 
fluorescence emission spectra. 
 For each phantom sample, fluorescence or diffuse reflectance spectra were acquired over 
an angle from θ = -80° to θ = 80° in 10º increments, at excitation angles of α = 0º and 60º, along 
the orthogonal emission planes equal to Φ = 0°/180° and 90°/270°. Some emission angles could 
not be measured due to specular reflectance from the phantom surface or obstruction between the 
excitation optics and the collection probe. Five emission spectra were collected from each 
combination of excitation and collection angles to ensure reproducibility, and the mean spectrum 
 
Figure 1. Schematic for experimental measurement of fluorescence and diffuse reflectance angular emission profiles 
as a function of emission angle θ. The diagram depicts measurement along the Φ = 0°/180° plane for a possible 
range of excitation angles (α) between 0° and 90°. The collection sub-system was rotated 90° with respect to the 
sample to measure profiles along the depicted Φ = 90°/270° plane. An extender on the end of the collection probe 
limited its numerical aperture and confined collection to a narrow range of emission angles at each angular position. 
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was calculated. The mean intensities of fluorescence or diffuse reflectance at various emission 
angles were grouped such that angular emission profiles as functions of θ could be formed for 
each combination of excitation angle, emission plane, and wavelength (optical properties). 
Measured angular profiles were multiplied by cos(θ) to correct for changes in observation area of 
the collection probe with respect to θ. Angular emission profiles were further normalized to their 
corresponding peak emission intensity to facilitate comparisons of angular emission profile 
shape among various excitation angles and sample optical properties. 
 A metric was developed to quantify the symmetry of the experimentally measured 
angular emission profiles. The metric calculates the mean percent difference (MPD) between the 
positive- and negative-angle emission intensities measured in this study:  
( ) ( ) ( )( ) ( )∑
=
= 


 ∗∗−=+∗+=
∗−=−∗+==
8
1
00
00
100
1010
10101%
N
k kIkI
kIkI
N
MPD θθ
θθ .   (2) 
A perfectly symmetric profile would have a MPD value equal to zero; a profile skewed toward 
positive angles would have a positive MPD; and a profile skewed toward negative angles would 
have a negative MPD. MPD values were calculated for all experimentally measured emission 
profiles, but the angle pairs were limited to those present in all profiles (θ = ±20°, ±30°, and 
±40°) to prevent bias between MPD measurements due to larger noise contributions at smaller 
emission intensities. MPD values were then plotted as a function of reduced scattering 
coefficient (µs’) for the various excitation-collection geometries of diffuse reflectance and 
fluorescence emission. The regression coefficient (R2) of a least-squares line fit to the MPD vs. 
µs’ data and the correlation coefficient (ρ) between the two parameters were calculated for each 
Table 1. Tissue phantoms for experimental measurement of (a) diffuse reflectance and (b) fluorescence angular 
emission profiles. The polystyrene microspheres in the fluorescence phantoms were 0.954 µm in diameter. 
Phantom Microsphere Diameter (µm)
Microsphere 
Conc. (mg/g) λ (nm) µs (cm
-1) µa (cm-1) g
1 0.954 15 400 - 800 790 - 330 0.02 - 0.18 0.938 - 0.897
2 0.954 5 400 - 800 265 - 110 0.02 - 0.18 0.938 - 0.897
3 0.535 20 400 - 800 955 - 245 0.02 - 0.18 0.906 - 0.761
4 0.535 7.5 400 - 800 360 - 90 0.02 - 0.18 0.906 - 0.761  
(a) 
Phantom Microsphere Conc. (mg/g) Fluorophore(s)
Fluorophore 
Concentration µs (cm
-1) µa (cm-1) g λ (nm) µs (cm-1) µa (cm-1) g
1 5 NADH 10 mg/mL (14.1 mM) 272 189.6 0.936 400 - 600 390 - 260 3.32 - 0.18 0.938 - 0.922
Stilbene 420   0.1 mg/mL (0.18 mM) 815 8.2 0.936 400 - 550  790 - 590 0.46 - 0.18 0.938 - 0.928
Rhodamine Chloride 610 0.1 mg/mL (0.21 mM) 815 1.9 0.936 570 - 650 560 - 465 16.8 - 0.18 0.925 - 0.918
EmissionExcitation (λ = 337 nm)
2 15
(b) 
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excitation-collection geometry to quantify the dependence of the profile MPD, and thus any bias 
in the profile, on the reduced scattering coefficient of the sample. 
 
Theoretical Validation 
 To validate the experimental measurements, a Monte Carlo simulation model for 
fluorescence and diffuse reflectance in biological media was developed based on the principles 
of Jacques and Wang [11] to be capable of: 
1) Arbitrary incident angles (α) of the excitation light, 
2) Fluorescence photon generation and propagation, 
3) Simultaneous diffuse reflectance and fluorescence monitoring as a function of 
position (x,y) and escape angles (θ, Φ). 
The excitation and collection geometry utilized in this model is defined as shown in Figure 2. 
Consistent with traditional Monte Carlo simulations for light propagation [11], the sample 
surface is defined along the x-y plane with the z-dimension indicating depth within the sample. 
Excitation light is defined by its beam radius ® and by its incident angle (α) relative to the 
surface normal (i.e. negative z-axis) within the x-z plane.  
 The photon initialization routine in the simulation model was modified to accommodate 
non-normal excitation angles, which eliminate the symmetry of emission with respect to the 
radial axis. To simulate a collimated excitation beam, the initial direction cosines of the photon 
 
Figure 2. Geometry assignments for Monte Carlo simulation of light propagation in tissue. 
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are calculated using: 
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where n0 and n1 are the refraction indices of the incident and sample media, respectively, and αR 
is the refraction angle of the incident light as determined by Snell’s Law. Each simulation 
measured the impulse response of the tissue to the angled excitation light by consistently placing 
the initial photon position at the origin. The tissue emission response to a finite-width excitation 
beam was subsequently acquired by convolving the impulse response with the spatial profile of 
the excitation beam on the tissue surface. The excitation profile was elliptical with minor- and 
major-axis radii equal to R and R/cos(α), respectively. 
 Fluorescence photon generation occurs after every absorption event of an excitation 
photon. A fluorescence photon, with an initial weight equal to the product of the user-specified 
quantum yield of the tissue layer and the excitation photon weight absorbed by the tissue, is 
generated at the location of the absorption event. If its initial weight is larger than 10-4, the 
fluorescence photon is propagated and its direction cosines can be randomly calculated using 
isotropic (g = 0) scattering equations (i.e. isotropic generation). The propagation of the 
fluorescence photon can be tracked using a stepsize and direction defined by user-specified 
emission-wavelength absorption and scattering coefficients until the photon is terminated due to 
insufficient weight or tissue escape.  
 Photon emission is described using four variables: 1,2) its position (x,y) with respect to 
the origin; 3) its angle (θ) relative to the surface normal; and 4) its angle (Φ) within the x-y plane 
relative to the negative x-axis; thus diffuse reflectance and fluorescence emission are recorded as 
four-dimensional functions. Exit position is uniformly and isotropically (with respect to x and y) 
divided into emission bins whose number and extent are specified by the user. Emission angles 
were varied from [0, π/2] for θ and [0, 2π] for Φ to cover the entire emission hemisphere. To 
normalize the surface area and solid angle of each bin and to convert emission weights to units of 
W/cm2/Sr (assuming that N photons provided 1 W of power), the intensity in each emission bin 
is scaled by (2π N r sinθ ∆r ∆θ ∆Φ)-1, where ∆r, ∆θ, and ∆Φ are the uniform bin widths (in cm, 
rad, and rad, respectively) for the (x, y), θ, and Φ dimensions. 
 Eight single-slab Monte Carlo simulations were run to determine the effects of scattering, 
incident excitation angle, and emission plane on diffuse reflectance and fluorescence angular 
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emission profiles (Table 2). The limits of the scattering coefficients employed in the simulations 
were chosen to coincide with the scattering extremes typically found within soft tissue, while the 
absorption and anisotropy coefficients were maintained at average soft-tissue values [9]. The 
ratio of optical properties at the fluorescence excitation and emission wavelengths was based on 
the general trend of Mie scattering and oxy- and deoxy-hemoglobin absorption at the 
wavelengths which correspond to NADH brain tissue autofluorescence (λem = 460 nm) under 
ultra-violet excitation (λex = 360 nm) [12].  
 A uniform collimated beam with a diameter of 1 cm was used for excitation. The slab 
thickness was set to 5 cm to prevent transmission and subsequently maximize emission of each 
photon. The slab index of refraction was set to 1.4 to mimic soft tissue [13]. Changes in quantum 
yield were assumed to modify the intensity but not the direction of fluorescence photon 
emission; therefore, the quantum yield was set to 1.0 for all simulations in which fluorescence 
was simulated. Emission position was tracked within 50 spatial bins between –2.5 mm and 2.5 
mm along the x- and y-dimensions. Emission direction was divided into 30 bins for θ є [0, π/2] 
and 48 bins for Φ є [0, 2π]. 
 Statistical independence of each excitation photon allowed the computations for each 
simulation to be expedited by distributing them among 18, 2.4 GHz processors of a 9-node 
UNIX cluster using Message Passage Interface (MPI) routines.  The number of photons for the 
various cases of incident excitation angle and sample optical properties varied from 10 billion to 
4 trillion photons for diffuse reflectance simulation and 50 million to 1.5 billion photons for 
Table 2. Monte Carlo simulations of (a) diffuse reflectance and (b) fluorescence angular emission profiles along the 
φ = 0°/180° and φ = 90°/270° emission planes for α = 0° and α = 60° excitation angles. 
0.9 10 0.909 0.500 0 6 x 1011
0.9 10 0.909 0.500 60 6 x 1011
0.9 80 0.988 0.889 0 1 x 1010
0.9 80 0.988 0.889 60 1 x 1010
A A' α (deg)g µs' (cm-1) N
 
(a) 
100 10 0.9 70 7 0.86 10 0.909 0.588 0 1.5 x 109
100 10 0.9 70 7 0.86 10 0.909 0.588 60 1.5 x 109
800 10 0.9 560 7 0.86 80 0.988 0.920 0 5 x 107
800 10 0.9 560 7 0.86 80 0.988 0.920 60 5 x 107
A α (deg) N
Excitation Wavelength
µs' (cm-1) A'µs (cm-1) µa (cm-1) g µs (cm-1) µa (cm-1) g
Emission Wavelength
 
(b)
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fluorescence. Simulation times varied (from several hours to several days) depending upon 
fluorescence generation, the number of photons simulated, the incident excitation angle, and the 
sample optical properties. Regardless of parameters, simulations required roughly two additional 
hours of computation time to compile the emission results from the various nodes of the cluster.  
         
 
Figure 3. Experimentally measured angular profiles for diffuse reflectance emission: (a) α = 0° excitation, both 
emission planes; (b) α = 60° excitation, Φ = 0°/180° plane; (c) α = 60° excitation, Φ = 90°/270° plane. Multiple 
curves in each plot represent discrete detected wavelengths and optical properties (µs, g shown in the legend) for the 
phantom samples. 
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Results 
 
Experimental Measurement of Angular Emission Profiles 
 The experimentally measured angular emission profiles of diffuse reflectance and 
fluorescence are shown in Figures 3 and 4. Figure 5 depicts the MPD values as a function of 
reduced scattering coefficient (µs’) for the various excitation-collection geometries of diffuse 
reflectance and fluorescence emission. In general, diffuse reflectance along the incidence plane 
(Φ = 0°/180°) possesses a consistent angular distribution over a broad range of sample optical 
properties for α = 0° (Figures 3a and 5a). Noticeable data spreading is found in the experimental 
                
 
Figure 4. Experimentally measured angular profiles for fluorescence emission: (a) α = 0° excitation, both emission 
planes; (b) α = 60° excitation, Φ = 0°/180° plane; (c) α = 60° excitation, Φ = 90°/270° plane. Multiple curves in each 
plot represent discrete detected wavelengths and optical properties (µs,em, g shown in the legend) for the phantom 
samples at the emission wavelength. The measurements for plot (a) were acquired from fluorescence phantom 1 
described in Table 1b. The measurements for plots (b) and (c) were acquired from fluorescence phantom 2.  
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data; however, there was no correlation between the MPD of the profile and the reduced 
scattering coefficient of the sample (R2 = 0.12, ρ = 0.34). In other words, the angular emission 
profile of diffuse reflectance seems to be optical-property independent at α = 0°.  
 For large-angle excitation of diffuse reflectance (α = 60o – Figures 3b & c), an optical-
property dependence of the angular emission is evident within the incidence plane (Figure 5a). 
The positive MPD values for the Φ = 0°/180° emission plane, observed (but not shown) for all 
sample solutions and all wavelengths, indicate a diffuse reflectance emission skewed toward 
positive emission angles, opposite the excitation source. As the reduced scattering coefficient 
increases, the asymmetry in the angular emission profile decreases, behavior that is clearly 
depicted in Figure 5a and further demonstrated by the magnitude of the regression and 
correlation coefficients (R2 = 0.85, ρ = -0.91). The α = 60°, Φ = 0°/180° excitation-collection 
geometry of diffuse reflectance is the only geometry with a regression coefficient above 0.13 and 
a correlation coefficient magnitude greater than 0.36.  
 The optical-property dependence of the angular emission profile of diffuse reflectance is 
only observed within the incidence plane (Figures 3c and 5a). While on average the MPD values 
for the Φ = 90°/270° plane are similar to those for the Φ = 0°/180° plane, the symmetry of the 
angular emission profile in the Φ = 90°/270° plane is not affected by the optical properties of the 
phantom (R2 = 0.04, ρ = 0.20). 
 
Figure 5. Mean percent difference versus reduced scattering for various excitation angles and emission planes of 
experimentally measured (a) diffuse reflectance and (b) fluorescence. Regression lines were calculated using a least-
squares fit. 
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 Fluorescence along both emission planes is consistent over a broad range of optical 
properties (Figures 4 and 5b). Since the most extreme excitation angle (α = 60° - Figures 4b & c) 
yields unbiased, symmetric fluorescence within the incidence (R2 = 0.01, ρ = 0.11) and 
orthogonal (R2 = 0.13, ρ = -0.36) emission planes, fluorescence behavior was subsequently 
characterized only for positive emission angles and only within the incidence plane for α = 0° 
 
Figure 6. Angular emission profiles produced by Monte Carlo simulation versus spatial position within the impulse 
response: (a) diffuse reflectance after 0° excitation, (b) diffuse reflectance after 60° excitation, (c) fluorescence after 
0° excitation, (d) fluorescence after 60° excitation. The header of each figure depicts the five emission regions from 
which the angular emission profiles were calculated as well as a contour of the impulse response integrated over all 
emission angles. The profiles derive from the Φ = 0/180° emission plane with simulation parameters (at the 
excitation wavelength for fluorescence): µs = 100 cm-1, µa = 10 cm-1, g = 0.9.   
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excitation (Figure 4a). Therefore, no MPD values were calculated for these profiles.  
 
Theoretical Validation 
 Figure 6 outlines the spatial dependence within representative diffuse reflectance and 
fluorescence impulse responses. Mean profiles are integrated over the five shaded areas shown in 
the header of each figure. No emission regions outside the central 1 mm by 1 mm area of the 
impulse response were used because the largest full-width at half maximum (FWHM) of the four 
impulse responses was 174 µm. The mean angular emission profiles have been normalized with 
respect to the peak of the (x = 0, y = 0) profile to maintain the relative emission levels of the five 
emission regions.  
 For α = 0° excitation, the mean diffuse reflectance and fluorescence profiles from the 
regions centered about the origin are symmetric about the surface normal. The mean profiles 
from regions centered along the y-axis are similarly symmetric. However, the regions along the 
x-axis on either side of the origin are mirror images of one another, skewed away from the 
spatial origin of the impulse response.  
 For α = 60° excitation, the diffuse reflectance and fluorescence profiles from the regions 
centered about the origin are no longer symmetric. The oblique excitation angle shifts the point 
of maximum emission intensity roughly 100 µm from the origin along the positive x-axis and 
skews the profiles from regions centered along the y-axis slightly toward negative emission 
angles. The profile from the region centered along the positive x-axis remains skewed away from 
the spatial origin.  
 Figure 7 outlines the representative spatial dependence of angular emission profiles of 
diffuse reflectance and fluorescence within the excitation area along the sample surface. Only a 
60° excitation profile is shown because the minor-axis of the profile can be used to indicate the 
response after 0° excitation. All profiles are individually normalized to a peak emission intensity 
of 1.0. Figures 7a and c indicate that the angular emission profile is consistent when the emission 
region is well within the limits of the excitation profile. This consistent profile is equivalent to 
the summation profile over the entirety of the impulse response and therefore results when the 
emission point can be described as surrounded by a semi-infinite excitation area. This description 
fails to apply near the edges of the excitation spot, as indicated in Figures 7b and d. In these 
regions, portions of the impulse response are no longer included in the integrated emission 
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response, resulting in profiles disparate from the profiles in the interior of the excitation area. 
The extent of these edge effects inside the boundaries of the excitation profile will depend upon 
the optical properties of the sample and will be related to the FWHM of the impulse response. 
Since spectral imaging systems can be designed to exclude emission collection from the outer 
regions of the excitation spot, and thus prevent these edge effects, the remainder of the 
 
Figure 7. Angular emission profiles produced by Monte Carlo simulation versus spatial position within the 
excitation spot: (a) diffuse reflectance within the spot interior, (b) diffuse reflectance along the spot edges, (c) 
fluorescence within the spot interior, (d) fluorescence along the spot edges. The profiles were integrated over 1 x 1 
mm surface areas (shown in the headers of Figures 7a and b) and derive from the Φ = 0/180° emission plane with 
simulation parameters (at the excitation wavelength for fluorescence): µs = 100 cm-1, µa = 10 cm-1, g = 0.9, α = 60°.  
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simulation results will concentrate on angular emission profiles integrated over the emission 
region depicted in Figure 7a located at the center of the excitation area.   
 Figures 8 and 9 show representative angular emission profiles of diffuse reflectance and 
fluorescence, respectively. The MPD values for these profiles are outlined in Table 3. While the 
profiles in Figures 8a, c & d are symmetric about the surface normal, the optical-property 
dependent skewing phenomenon of diffuse reflectance emission within the incidence plane of the 
excitation appears in the simulation result for a large excitation angle (α = 60°, Figure 8b). The 
 
Figure 8. Representative angular emission profiles of diffuse reflectance produced by Monte Carlo simulation: (a) α
= 0o excitation, (b) α = 60o excitation. An absorption coefficient of µa = 10 cm-1 and an anisotropy coefficient of g = 
0.9 were used for all simulations.  
 
Figure 9. Representative angular emission profiles of fluorescence produced by Monte Carlo simulation: (a) α = 0o
excitation, (b) α = 60o excitation. Scattering coefficients shown correspond to the excitation wavelength. Scattering 
at the emission wavelength was consistently equal to 70% of scattering at the excitation wavelength. Absorption 
coefficients for all simulations were set to 10 cm-1 for excitation and 7.0 cm-1 for emission. An anisotropy coefficient 
of g = 0.9 was used for all simulations for excitation and emission.  
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effect of reduced scattering on skewing implied by the simulation model, however, is less than 
that derived from the experimental results under the same conditions. The mean percent 
differences (MPDs) for simulated diffuse reflectance emission after 60° excitation decrease from 
13.4% to 5.5% when the reduced scattering increases from 10 cm-1 to 80 cm-1; whereas the 
MPDs of the experimental data decrease from 26.2% to 3.5% over a similar increase in µs’ (13 
cm-1 to 82 cm-1). The average MPD for the unskewed profiles (n = 6) is 0.01%, demonstrating a 
great degree of symmetry. This gives cause to believe that the corresponding experimentally 
measured diffuse reflectance profiles would be similarly symmetric if not for measurement noise 
and error.  
 The diffuse reflectance simulation results also show that angular emission profiles from 
samples with low scattering properties (µs’ = 10 cm-1) possess a greater profile width than 
profiles from samples with high scattering (µs’ = 80 cm-1), regardless of the emission plane or 
incident excitation angle. For the profiles in Figure 8 which demonstrate no skewing, the full-
width at half-maximum (FWHM) values are significantly larger (∆ = 6.0°, p < 0.001, paired t-
test, n = 3) for µs’ = 10 cm-1 profiles than µs’ = 80 cm-1 profiles.  For the skewed profile from the 
Φ = 0°/180° emission plane after α = 60° excitation, the FWHM of the µs’ = 10 cm-1 profile is 
0.8° narrower than the µs’ = 80 cm-1 profile, possibly due to the disparate degree of skewing 
between them. 
 As suggested by the simulation model (Figure 9) and consistent with experimental 
observations, angular profiles of fluorescence emission are not affected by tissue scattering 
properties, excitation angle, or observation plane. The average MPD value for the profiles in 
Figure 9 (n = 8) is 0.07%, again giving cause to believe that the asymmetry in the experimentally 
measured fluorescence profiles was due to measurement noise and error. Similar to diffuse 
Table 3. Mean percent difference (MPD) of diffuse reflectance (Rd) and fluorescence (F) angular emission profiles 
for two excitation angles (α), two reduced scattering coefficients (µs’), along the two emission planes (Φ). All 
simulations employed g = 0.9 for the scattering anisotropy. The µs’ values correspond to the excitation wavelength. 
Emission α Φ µs' = 10 cm-1 µs' = 80 cm-1
0/180 -0.08% 0.03%
90/270 0.04% -0.02%
0/180 13.38% 5.45%
90/270 0.03% 0.05%
0/180 0.08% 0.19%
90/270 0.02% 0.01%
0/180 0.08% 0.17%
90/270 0.04% 0.00%
F
0o
60o
Rd
0o
60o
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reflectance, unskewed angular emission profiles (n = 4 pairs) of simulated fluorescence with 
lower reduced scattering coefficients (µs,em’ = 7 cm-1) possess higher FWHM values (∆ = 6.1°, p 
< 1x10-5) than profiles with higher reduced scattering (µs,em’ = 56 cm-1), suggesting that this 
phenomenon is intrinsic to the tissue properties of the sample and not specific to diffuse 
reflectance. 
 The skewing behavior in diffuse reflectance emission profiles for oblique incident 
excitation angles was investigated relative to the sample scattering coefficient, absorption 
coefficient, and anisotropy factor. Monte Carlo simulation was employed for this investigation 
due to its capability to vary the magnitude of one optical property coefficient while holding the 
                
 
Figure 10. Simulated diffuse reflectance angular emission profiles within the incidence plane at α = 60° excitation 
and for: (a) varying scattering coefficients, (b) varying absorption coefficients, and (c) varying anisotropy 
coefficients. When not varied, the other optical property coefficients were held constant at µs = 100 cm-1, µa = 10 
cm-1, and g = 0.9. 
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other two constant. The simulations are outlined in Table 4. Figure 10 outlines the results, 
demonstrating that the “degree” of skewing increases as the scattering coefficient decreases, as 
the absorption coefficient increases, and as the anisotropy factor increases. 
 The mathematical definitions of optical parameters such as reduced scattering (µs’ = µs[1-
g]), albedo (A = µs/[µs+µa]), and reduced albedo (A’ = µs’/[µs’+µa]) play against one another the 
effects of scattering, absorption, and anisotropy on skewing behavior. For example, increasing 
the scattering coefficient lowers skewing while increasing absorption amplifies it. Since 
proportionately increasing scattering and absorption yields a consistent albedo, skewing behavior 
may be constant for a constant albedo, regardless of the scattering and absorption coefficient 
magnitudes. Similar arguments can be made for reduced scattering and reduced albedo. To 
investigate these possibilities, three additional sets of Monte Carlo simulations (Table 5) were 
Table 4. Monte Carlo simulations to investigate the effects of optical properties (µs, µa, and g) on diffuse reflectance 
angular emission profiles along the φ = 0°/180° emission plane for α = 60° excitation. 
µs (cm-1) µa (cm-1) g µs' (cm-1) A A' α (deg) N
100 10 0.9 10 0.909 0.500 60 6 x 1011
400 10 0.9 40 0.976 0.800 60 1 x 1011
800 10 0.9 80 0.988 0.889 60 1 x 1010
100 1 0.9 10 0.990 0.909 60 1 x 1011
100 10 0.9 10 0.909 0.500 60 6 x 1011
100 25 0.9 10 0.800 0.286 60 2 x 1012
100 100 0.9 10 0.500 0.091 60 4 x 1012
100 10 0.5 50 0.909 0.833 60 3 x 1011
100 10 0.8 20 0.909 0.667 60 4 x 1011
100 10 0.9 10 0.909 0.500 60 6 x 1011
100 10 0.95 5 0.909 0.333 60 6 x 1011  
Table 5. Monte Carlo simulations to investigate the effects of reduced scattering coefficient (µs’), albedo (A), and 
reduced albedo (A’) on diffuse reflectance angular emission profiles along the φ = 0°/180° emission plane for α = 
60° excitation. 
µs (cm-1) µa (cm-1) g µs' (cm-1) A A' α (deg) N
10 10 0 10 0.500 0.500 60 2.4 x 1012
20 10 0.5 10 0.667 0.500 60 2.4 x 1012
50 10 0.8 10 0.833 0.500 60 1.2 x 1012
100 10 0.9 10 0.909 0.500 60 6 x 1011
100 10 0.9 10 0.909 0.500 60 6 x 1011
800 80 0.9 80 0.909 0.500 60 1 x 1011
800 10 0.9 80 0.988 0.889 60 1 x 1010
100 1.25 0.9 10 0.988 0.889 60 1 x 1011
100 10 0.9 10 0.909 0.500 60 6 x 1011
50 25 0.5 25 0.667 0.500 60 5 x 1011
800 10 0.9 80 0.988 0.889 60 1 x 1010
400 25 0.5 200 0.941 0.889 60 5 x 1010  
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run to determine if consistent values of these optical parameters produce consistent emission 
profiles regardless of the magnitudes of the individual optical property coefficients.  
 The first set of simulations (Figure 11a) maintained constant reduced scattering 
coefficients (µs’ = 10 cm-1) by adjusting the scattering coefficient and anisotropy factor. The 
observed increase in profile skewing despite the increase in the scattering coefficient 
demonstrates that the effect of the anisotropy overpowers the effect of scattering. The second set 
of simulations measured the skewing for two scenarios each of two different albedos (A = 0.909 
and 0.988) and show that profile skewing is constant between scenarios with equivalent albedos 
and that skewing increases as the albedo decreases (Figure 11b). This suggests that profile 
skewing responds to changes in scattering and absorption via their effect on the sample albedo 
                
 
Figure 11. Simulated diffuse reflectance angular emission profiles within the incidence plane at α = 60° excitation 
and for: (a) constant reduced scattering, µs’ = 10 cm-1; (b) two cases of constant albedo, A = 0.909 and 0.988; and 
(c) two cases of constant reduced albedo, A’ = 0.5 and 0.889. 
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and that consistent profile skewing only requires consistent albedo and anisotropy factors. The 
final set of simulations measured profile skewing for two cases each of two different reduced 
albedos (A’ = 0.5 and 0.889) by manipulating the scattering coefficient, absorption coefficient, 
and anisotropy factor. The profiles (Figure 11c) demonstrate that profile skewing is not 
consistent with reduced albedo and that the skewing follows no trend with either the albedo or 
the anisotropy factor, instead most likely involving a complex interplay between the two. 
 It was previously indicated in this paper that an optical property dependence of angular 
emission profiles can lead to a change in spectral shape dependent upon the excitation-collection 
geometry of the imaging system. Since the experimental and simulation results demonstrate that 
the angular emission profiles of diffuse reflectance emission are optical property dependent 
within the incidence plane, Monte Carlo simulation was used to model imaging spectra under the 
four excitation-collection geometries emphasized in this paper. Diffuse reflectance emission was 
simulated with α = 0° and 60° excitation for wavelengths 400 nm to 700 nm in 20 nm 
increments. The sample optical properties at the simulated wavelengths (Figure 12a) were 
modeled after glioma brain tissue using in vitro spectrophotometer measurements of diffuse 
reflectance and transmission measurements from 58 glioma samples [12]. Reduced scattering 
 
 
Figure 12. Demonstration of spectral distortion due to the optical property dependence of angular emission profiles: 
(a) sample optical property spectra employed in spectral imaging simulation, (b) normalized diffuse reflectance 
spectra for four excitation-collection geometries. 
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and absorption spectra were calculated from the reflectance and transmission spectra using an 
inverse-adding doubling method [14]. Sample anisotropy values were taken from anaplastic 
astrocytoma data published by Yaroslavsky et al [15] and used to determine sample scattering 
from the reduced scattering spectra.  
 Diffuse reflectance emission was recorded as a four-dimensional function similar to the 
angular profile simulations. To simulate collection from an f/3.86 (NA = 0.26) camera lens 
positioned at θ = 45°, emission intensities for each excitation-collection geometry at each 
wavelength were calculated by integrating the respective emission profiles from θ = 30° to 60°. 
The four simulated spectra were normalized to a peak of one. The resultant spectra (Figure 12b) 
demonstrate as expected that collection within the incidence plane after α = 60° excitation 
distorts the shape of the diffuse reflectance spectrum. However, unexpectedly, the spectrum from 
the orthogonal emission plane after α = 60° excitation also deviates from the α = 0° spectra. 
 
Discussion 
 Many studies have investigated fluorescence and diffuse reflectance emission as a 
function of radial position [16-18]; however, there are only a handful of papers that have 
addressed how sample optical properties and incident excitation angle affect the angular profiles 
of fluorescence and diffuse reflectance emission [7, 8, 19, 20]. This information can be critical to 
design of spectral imaging systems for tissue diagnosis because angular profile dependence on 
incident excitation angle and/or sample optical properties can induce extrinsic distortions within 
imaging spectra. 
 For the case where emission is collected within the limits of a semi-infinite excitation 
spot, we demonstrated both experimentally and theoretically that the optical properties of a 
sample have little or no influence on the angular emission profile of diffuse reflectance when the 
incident angle of the excitation light is normal to the tissue surface (α = 0°) or when emission 
occurs within the Φ = 90°/270° plane orthogonal to the incident excitation plane. For these cases, 
angular emission profiles are symmetric about the surface normal (θ = 0°) and slightly 
underestimate a Lambertian profile at all emission angles. 
 For large excitation angles (α = 60°), the angular emission profile of diffuse reflectance 
loses its symmetry within the incident excitation plane with emission that is biased away from 
the incident light. The bias, or skewing, of the angular emission profile is found to be dependent 
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on sample optical properties. From the results in Figure 11, skewing for oblique excitation angles 
depends solely upon the albedo (A = µs/[µa + µs]) and scattering anisotropy (g) of the sample, 
with the degree of skewing inversely related to the albedo and directly related to the anisotropy 
factor. As such, the effects of variations in scattering and absorption on skewing are related to 
how they modulate the sample albedo, regardless of their absolute magnitudes. 
 Unlike diffuse reflectance, angular emission profiles of fluorescence are symmetric in 
shape and independent of sample optical properties. They show no alteration as the excitation 
angle changes. These observations have been confirmed both experimentally and theoretically. 
Since the diffuse reflectance simulations demonstrate that anisotropy is one of the major players 
in determining angular emission behavior, the isotropic local generation of fluorescence within 
the sample is most likely responsible for its symmetric emission profile. It decouples the photon 
propagation direction, and hence its emission angle, from the incident excitation angle, 
regardless of the number of scattering events before emission. 
 The skewing observed in diffuse reflectance emission was previously reported by Qu et 
al [7]. Skewing was attributed to the forward-scattering nature of tissue, which reduces the 
chance for scattering back toward the excitation source relative to scattering away from it. 
However, Qu et al simulated diffuse reflectance and fluorescence emission for a single sample 
(µa = 16.5 cm-1, µs = 184 cm-1, g = 0.9) without further investigating a possible dependence of 
diffuse reflectance skewing on optical properties. A hypothesis to explain this dependence must 
address: (1) the skewing bias of diffuse reflectance emission away from the excitation source 
within the incident excitation plane for large excitation angles; (2) the loss of bias within the 
orthogonal emission plane, at low excitation angles, and for fluorescence emission; (3) 
equivalent profile skewing degree between samples with similar albedo and anisotropy factors 
for an oblique excitation angle; (4) increased profile skewing with decreased albedo and 
increased scattering anisotropy. 
 The most obvious explanation for optical-property dependent skewing is that it depends 
upon the degree of correlation between the incident excitation angle and the photon emission 
angle for a given set of sample optical properties. Fluorescence emission is symmetric because 
the isotropic nature of its local generation within the tissue automatically decouples the two 
angles. For diffuse reflectance emission with forward-biased scattering, since each scattering 
event increases the randomness in photon direction, the correlation between incident and 
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emission angles as well as the emitted photon energy relates inversely to the mean number of 
scattering events undergone by the emitted photons. To demonstrate this relationship, the mean 
number of scattering events was calculated for emission at Φ = 0°, 90°, 180°, and 270° for the 
various Monte Carlo simulations outlined in Figures 6 through 11. Since the contribution of each 
photon to the angular emission profile is weighted by its emitted photon energy, the contribution 
(SE) of each photon to the mean number of scattering events (µSE) calculated over the number of 
emitted photons (N) was similarly weighted by the emitted energy (w):  
∑
∑
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wSE
1
1µ      (3) 
The results outlined in Table 6 demonstrate how excitation angle, emission plane, anisotropy, 
and albedo affect this metric. 
 Photons that excite normal to the tissue surface must change direction equal amounts to 
emit along each of the four emission quadrants outlined in Table 6 (Φ = 0°, 90°, 180°, 270°). As 
such, the number of scattering events before emission is equal between the quadrants and the 
photons are equally likely to emit along each of them, resulting in symmetric angular emission 
profiles within both emission planes regardless of sample optical properties. For an oblique 
excitation angle, the photon direction is biased toward the Φ = 0° quadrant and away from Φ = 
180°. Therefore, less scattering events are needed to emit along Φ = 0°, resulting in larger 
emitted photon energies and an angular emission profile within the incidence plane which is 
skewed toward positive emission angles (θ = 0-90°). For emission along the orthogonal emission 
plane (Φ = 90°/270°) with an oblique excitation angle, photons must change direction an equal 
Table 6. Weighted mean number of steps per emitted photon along the four quadrants of the principal emission 
planes for various simulation parameters. Means were calculated over the 90° range of polar emission angles (θ) 
within each quadrant. 
α (deg) µs (cm-1) µa (cm-1) g Φ = 0o Φ = 90o Φ = 180o Φ = 270o
0 100 10 0.9 13.9 13.9 13.9 13.9
60 100 10 0.9 12.4 13.1 13.9 13.3
0 100 10 0.5 9.1 9.1 9.2 9.1
60 100 10 0.5 8.3 8.7 9.0 8.8
0 800 10 0.9 52.8 52.8 52.8 52.8
60 800 10 0.9 46.1 48.9 51.9 49.6
0 800 80 0.9 13.9 13.9 13.9 13.9
60 800 80 0.9 12.4 13.1 13.9 13.3
Number of Steps - Weighted Mean Simulation Parameters
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amount to emit along the two quadrants so no relative bias exists between them. Therefore, the 
mean number of scattering events is equivalent between the two, resulting in symmetric angular 
emission profiles regardless of sample optical properties. Finally, less skewing is present for 
lower anisotropy factors because they are able to randomize the photon direction and 
subsequently decorrelate the incident and emission angles in fewer scattering events, decreasing 
the disparity in the mean number of scattering events between the Φ = 0° and 180° quadrants 
(5.7% difference for g = 0.9 to 4.0% difference for g = 0.5, µs = 100 cm-1, µa = 10 cm-1).  
 In terms of the relationship between the albedo of the sample and the angular emission 
profile, it is logical for equivalent albedo values to produce similar degrees of profile skewing. 
As demonstrated in Table 6, proportionately increasing the scattering and absorption coefficients 
only shrinks the scale of the simulation and does not change the average number of scattering 
events undergone by a photon before emission. Equivalent numbers of scattering events translate 
into equivalent correlations between the incident excitation and ultimate emission angles, 
equivalent photon emission energies, and equivalent disparities between the Φ = 0° and Φ = 
180° quadrants, given that there is no change in the anisotropy factor.  
 The increase in skewing with decreased albedo also relates to the disparity in mean 
number of photon scattering events (and hence the correlation between entrance and emitted 
direction) per emitted photon within the diffuse reflectance. Total diffuse reflectance from the 
tissue surface is composed of what Qu et al term “nearly diffuse reflectance” and “diffuse 
reflectance.” “Nearly diffuse reflectance” results from photons which are emitted after a small 
number of scattering events and whose emission directions are therefore reasonably correlated to 
the incident excitation angle within strongly forward-scattering media. “Diffuse reflectance” 
derives from those photons which are scattered many times and whose emission directions are 
completely randomized. Therefore, the degree of skewing directly depends upon the relative 
contributions of “nearly diffuse reflectance” and “diffuse reflectance” to the “total diffuse 
reflectance” emission profile; an increased “nearly diffuse reflectance” contribution will produce 
a more highly skewed angular emission profile.  
 Employing theory developed by Wu et al [21] using photon migration, decreasing the 
albedo from one to zero causes exponential decreases in the weighted mean number of scattering 
events per emitted photon, the emitted “diffuse reflectance”, and the emitted “nearly diffuse 
reflectance.” However, the exponential decay rate for “nearly diffuse reflectance” is significantly 
120 
lower than the rate for “diffuse reflectance,” such that the total diffuse reflectance is completely 
“nearly diffuse” at an albedo of zero for any anisotropy and reasonable threshold number of 
scattering events used to divide these two types of reflectance. Therefore, subsequent to a 
decrease in albedo, the contribution of the “nearly diffuse reflectance” becomes more dominant 
in the “total diffuse reflectance” profile, the intensity-weighted mean number of scattering events 
per emitted photon decreases (as supported by Table 6), and the skewing in the angular emission 
profile subsequently increases. It is important to note that while Wu’s theory was designed for 
excitation light normal to the tissue surface, non-normal excitation does not qualitatively affect 
the results in terms of the effect of albedo. 
 Thorough comparison of the experimental and simulated angular emission profiles 
uncovers four behaviors which differ between the two sets of results: 1) the degree of skewness 
in the diffuse reflectance emission profiles after 60° excitation is less pronounced experimentally 
than in the simulation results; 2) experimental measurement indicates that the emission profiles 
after low-angle excitation and/or within the Φ = 90°/270° emission plane are optical property 
independent while the simulation results suggest that profile width (FWHM) depends on sample 
scattering; 3) the experimentally measured profiles underestimate Lambertian behavior at all 
emission angles while the corresponding simulation results closely follow Lambertian emission; 
4) simulated angular emission profiles are more symmetric than the corresponding experimental 
profiles as quantified by the MPD metric. 
 The marked discrepancy in skewing between the simulation and experimental results 
most likely relates to the differences in absorption between the two sets of measurements. The 
absorption of the phantom samples varied from 0.02 to 0.18 cm-1 according to optical property 
measurements using inverse-adding doubling [14]. Therefore, the albedo of the experimental 
samples varied from 0.9986 to 0.9997 for reduced scattering extremes of 13 and 82 cm-1, while 
the simulation albedo varied from 0.9091 to 0.9877 for similar scattering extremes (µs’ = 10 to 
80 cm-1). Since skewing increases as albedo decreases, the larger range in albedo for the 
simulation results creates a more significant change in skewing between the scattering extremes.  
 According to the experimental results, the angular emission profiles of fluorescence and 
diffuse reflectance disclosed in this paper are relatively symmetric to normal (θ = 0°) and 
consistent with optical properties of the phantom samples when excitation is delivered at small 
excitation angles. However, the simulation results (Figures 8 and 9) suggest otherwise. Samples 
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with lower scattering properties produce emission profiles that are statistically wider than the 
profiles from higher-scattering samples. Because of potential experimental errors, it is possible 
that this small variation in profile width between low- and high-scattering samples was buried in 
the noise of the experimental data. Further Monte Carlo simulation studies (results not shown) 
indicate that the emission-profile FWHM is similarly dependent upon sample absorption and 
anisotropy. While exhaustive investigation of this phenomenon is beyond the scope of the 
current paper, existing results indicate that the FWHM dependence may be due to change in 
optical properties or differences in spatially sampling the impulse responses relative to their 
FWHM values. 
 Experimentally measured profiles after low-angle excitation and within the Φ = 90°/270° 
emission plane underestimate Lambertian behavior at all emission angles, while the 
corresponding simulation results closely follow Lambertian emission. Two sources of 
experimental error may be responsible for this difference since both errors cause underestimation 
at oblique observation angles. First, producing a perfectly uniform excitation spot is near 
impossible with fiber-optic delivery and spherical focusing optics. The intensity profile of the 
excitation spot used in this study was visually non-uniform, with its peak intensity positioned at 
the center of the phantom surface and collection area. Since the collection area of the detection 
probe increases with the observation angle as 1/cos(θ), it incorporates regions with lower 
excitation intensity at oblique observation angles. This reduces the mean excitation irradiance 
over the collection area and underestimates the emission intensity at larger emission angles. 
Similarly, when the sample surface is not perfectly aligned to the x-y plane, the observation spot 
will move laterally along the sample surface as the collection angle increases, subsequently 
shifting it away from the area of peak excitation and collecting from an excitation area with 
lower mean excitation irradiance.  
 Differences in the symmetry of experimental and simulated emission profiles may be due 
to errors in the measurement of the observation angle itself. Careful inspection of the 
experimentally measured profiles shows that in some cases, the profiles would be more 
symmetric about the surface normal (θ = 0°) if the observation angles were uniformly shifted by 
2-3°. This shift could be due to rotation of the protractor while positioning the collection arm, 
incorrect alignment of the collection arm with the angle indicated on the protractor, or a lack of 
correspondence between the rotation center of the collection arm and the vertex of the protractor. 
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Normalizing the measured emission intensity by the collection area – which varies as 1/cos(θ) – 
only serves to exacerbate this error. While every precaution was taken to minimize the 
experimental errors outlined above, we acknowledge that no experimental design is perfect, 
giving rise to inherent errors that may influence the shape of the measured angular emission 
profiles. Because Monte Carlo simulation is free from the types of errors that plague 
experimental measurements, we believe the simulated results are more accurate in their depiction 
of the true angular behavior of fluorescence and diffuse reflectance emission.  
 The study results indicate that angular emission profiles of diffuse reflectance within the 
incidence plane after small-angle excitation, diffuse reflectance within the orthogonal emission 
plane, and all types of fluorescence are consistently symmetric with profile widths that weakly 
depend on sample optical properties when emission is collected within the limits of a semi-
infinite excitation spot. For large excitation angles, the optical-property dependence of angular 
emission intensity of diffuse reflectance within the excitation plane becomes pronounced. From 
these results, we would not expect the line-shapes of fluorescence imaging spectra to be 
significantly affected by the excitation and collection geometry when emission is collected well 
within the boundaries of the excitation area, whereas the line-shapes of diffuse reflectance 
spectra could be drastically altered for a large-excitation-angle condition when the sample albedo 
and/or scattering anisotropy vary significantly across the spectral range. Without significant 
variation in optical properties, the angular emission profile will be identical for all emission 
wavelengths and the presence of profile skewing can be removed during routine spectral 
normalization. However, the deviation in line-shape for the orthogonal emission plane after 
large-angle excitation from the α = 0° spectra during the spectral imaging simulation (Figure 
12b) indicate that there may be other sources dependent on incident excitation angle that also 
affect the line-shape of diffuse reflectance spectra. One potential source of additional distortion 
is the magnitude of diffuse reflectance and fluorescence angular emission profiles which is also 
optical property dependent and therefore could directly affect spectral line-shapes. By 
normalizing the angular emission profiles for comparison sake, the investigation outlined in this 
paper was limited to the effects of incident excitation angle and sample optical properties on 
angular profile shape. However, preliminary results during this investigation indicate that the 
optical property dependence of profile magnitude varies with incident excitation angle and 
relates to the mean number of scattering events (Table 6), and the depth of tissue penetration by 
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the photons, in much the same manner as the extent of profile skewing. Thus, there is reason to 
believe that the optical property dependence of angular profile magnitude will similarly affect 
fluorescence line-shape after oblique-angle excitation. This effect is currently under 
investigation. 
 The results indicated in this paper and the conclusions derived therein are particularly 
relevant for the design and application of tissue spectral imaging. Spectral discrimination 
algorithms developed for individual tissue types will remain effective for spectral imaging 
systems if they are capable of faithfully reproducing the reliable and true fluorescence and 
diffuse reflectance spectra of tissue. Therefore, spectral imaging system development must take 
into account the possible influence of sample optical properties, incident excitation angle, and 
edge effects along the boundaries of the excitation area on diffuse reflectance and fluorescence 
spectral line-shape, most notably when designing angular excitation and collection system 
geometries relative to tissue surfaces and their variable surface topographies. 
 
Conclusion 
 When emission is collected from an area surrounded by a semi-infinite excitation region, 
fluorescence for all excitation angles, low-excitation-angle diffuse reflectance within the 
incidence plane, and both emission types within the Φ = 90°/270° plane possess consistent, 
symmetric angular distributions whose widths are weakly dependent on sample optical 
properties. For similar collection within a semi-infinite excitation region, diffuse reflectance 
along the incidence plane after large-angle excitation is biased away from the excitation source. 
The degree of bias is dependent only upon sample albedo and scattering anisotropy and is related 
to the correlation between the entrance and emission photon directions. Since the angular 
distribution of fluorescence is only weakly dependent on sample optical properties, constraints 
on system geometry are not required for fluorescence spectral imaging to avoid spectral 
distortions due to angular emission profile shape. Geometry-induced distortions within diffuse 
reflectance spectra can occur for high-angle excitation when the sample albedo and/or scattering 
anisotropy vary significantly across the spectral range. In this case, to avoid spectral distortions 
due to profile shape, diffuse reflectance spectral imaging systems should be designed to 
minimize incident excitation angles or collect emission from the orthogonal emission plane (Φ = 
90°/270° plane), constraints which can be difficult to control with a variable surface topography.  
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CHAPTER VI 
 
COMPARISON OF SPECTRAL VARIATION FROM SPECTROSCOPY  
TO SPECTRAL IMAGING  
 
Abstract 
 Optical biopsy has been shown to discriminate between normal and diseased tissue 
with high sensitivity and specificity. Fiber-optic probe-based spectroscopy systems do not 
provide the necessary spatial information to guide therapy effectively, ultimately requiring a 
transition from probe-based spectroscopy to spectral imaging. In this paper, the effect of such a 
transition on fluorescence and diffuse reflectance lineshape is investigated. Inherent differences 
in spectral lineshape between spectroscopy and imaging are characterized and much of these 
differences may be attributed to a shift in illumination-collection geometry between the two 
systems. Sensitivity of the lineshape disparity is characterized with respect to changes in sample 
absorption and scattering as well as to changes in various parameters of the fiber-optic probe 
design (e.g. fiber diameter, beam-steering). Differences in spectral lineshape are described in 
terms of the relative relationship between the light diffusion within the tissue and the distribution 
of source-detector separation distances for the probe-based and imaging illumination-collection 
geometries. Monte Carlo simulation is used to determine fiber configurations that minimize the 
lineshape disparity between the two systems. In conclusion, we predict that fiber-optic probe 
designs that mimic a spectral imaging geometry and spectral imaging systems designed to 
emulate a probe-based geometry will be difficult to implement, pointing toward a posteriori 
correction for illumination-collection geometry to reconcile imaging and probe-based spectral 
lineshapes or independent evaluation of tissue discrimination accuracy for probe-based and 
spectral imaging systems. 
 
Introduction 
 Optical spectroscopy has been extensively investigated for real-time, objective, non-
invasive discrimination between normal and diseased tissues [1-3]. Clinically motivated by the 
desire to improve upon tissue diagnosis, these studies seek to demonstrate that optical 
spectroscopy is capable of detecting tissue structural and biochemical changes which inherently 
occur during the progression from normalcy to a diseased state. They typically employ handheld 
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fiber-optic probes to deliver illumination light to and collect remitted light from a point of 
interest on the tissue surface, after which a punch biopsy is acquired from the interrogated tissue 
site. The measured spectra are grouped according to gold-standard histopathologic diagnoses of 
the biopsy samples and are analyzed to discern spectral differences between the tissue groups. 
The observed differences are used to develop discrimination algorithms and to determine 
unbiased estimates of discrimination accuracy between the various tissue classes. 
 Combined fluorescence and diffuse reflectance spectroscopy has been specifically 
explored by our research group for differentiation between normal brain and infiltrating tumor 
margins [4-7] towards guiding intra-operative brain tumor resection, in which extent of tumor 
margin resection has been repeatedly correlated to patient quality of life and survival rate [8-11]. 
During craniotomy procedures for glioma resection or temporal lobectomy, multiple gray matter, 
white matter, tumor core, and tumor margin sites are selected for spectral measurement with a 
portable spectroscopic system [5]. Discrimination accuracy at these sites is subsequently 
assessed in a manner similar to the protocol outlined above. Despite only subtle spectroscopic 
differences between normal and tumor tissues, initial reports using multivariate analysis of 
fluorescence and diffuse reflectance spectra measured from 184 tissue sites in 35 of more than 
125 patients measured to date demonstrate a diagnostic accuracy of 100%, 96%, and 94% for 
normal, tumor core, and tumor margin tissue samples, respectively, with only 2 out of 35 tumor 
margin sites misclassified as normal (in review). The results indicate not only the promising 
capability of combined autofluorescence and diffuse reflectance spectroscopy to provide contrast 
between normal and tumor tissues in the brain, but also its ability to accurately differentiate 
infiltrating tumor margins from surrounding normal brain tissue and potentially affect more 
complete brain tumor resection. 
 While the methodology described is fairly universal in the field of optical diagnosis and 
is tailored for retrospective studies designed to assess discrimination accuracy, the 
instrumentation is often limited in its clinical applicability. Fiber-optic probes produce single-
point diagnostic measurements without providing information regarding the spatial extent of 
disease. This is particularly relevant in the case of therapeutic guidance where spatial 
information such as the extent of tumor margins is necessary to fully target the diseased tissue. 
As such, once optical spectroscopy is proven as an effective means of disease detection, 
researchers often move from fiber-optic probe-based spectroscopy to spectral imaging, which 
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provides spectroscopic information at every pixel within a two-dimensional field of view for a 
comprehensive snapshot of tissue pathology. In order to limit complexity of instrumentation, 
researchers often use fluorescence imaging at specific emission wavelengths to provide spatial 
information. However, recent studies indicate detailed spectral information is required for true 
effective classification [12, 13], emphasizing the need for spectral imaging development with full 
lineshape information for accurate disease demarcation. 
 For a seamless transition from spectroscopy to imaging, spectral imaging systems would 
produce tissue spectra which are identical in lineshape to probe-based spectra; otherwise, time 
and resources spent developing discrimination algorithms based upon spectral differences 
observed in probe-based data are squandered, since new imaging-based algorithms must be 
determined. Once discrimination algorithms are successfully developed, spectral imaging 
instrumentation can be simplified and image acquisition can be expedited by selectively 
interrogating wavelengths which are deemed diagnostically significant.  
 Spectral lineshape is modulated by two main factors: the optical properties of the tissue 
sample and the illumination-collection geometry of the measurement system. While tissue 
optical properties dictate the light distribution within the tissue, the relative propagation and 
attenuation of different wavelengths, and the subsequent spatial distribution of remitted light 
from the tissue surface, the illumination-collection geometry dictates what fraction of the light 
remitted at each wavelength is collected by the system.  
 While tissue optical properties are independent of the spectral measurement system, the 
transition from spectroscopy to spectral imaging involves a drastic shift in the spatial geometry 
between the illumination and collection regions (Figure 1). Spectroscopy probes typically 
contain multiple fibers, some of which are used for illumination delivery and the remainder for 
collection of remitted light. The specific configuration of the probe – e.g. the relative positions of 
the illumination and collection fibers, the gap between the fiber tips and the tissue surface, and 
the fiber polish angles – create a unique set of source-detector separation distances relative to the 
light distribution within the tissue (Figure 1c). While multiple modalities exist for spectral 
imaging implementation, including line-scanning, tunable-filter, and multiplexing methods, most 
spectral imaging systems acquire spectral data with non-contact illumination and collection 
(Figure 1b). When the illumination spot is much larger than the system field of view, as is often 
the case, each pixel in the image can be treated as a small collection region surrounded by a 
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semi-infinite illumination spot (Figure 1d), and its illumination-collection geometry as a 
convolution of all possible source-detector separation distances. Therefore, the fraction of 
remitted light collected by probe-based spectroscopy varies due to changes with optical 
properties (i.e. wavelength) in the spatial distribution of remitted light relative to the fiber 
configuration, while the fraction collected by spectral imaging is generally independent of these 
changes. Thus, spectral imaging lineshape is sensitive to how tissue optical properties affect the 
total intensity of remitted light, but probe-based spectroscopy lineshape is also sensitive to how 
they affect its spatial distribution. To our knowledge, a thorough study of the effects of the 
                
(a)                                                                    (b) 
                  
(c)                                                                     (d) 
Figure 1. Illumination-collection geometries for typical probe-based spectroscopy and non-contact spectral imaging 
systems. (a) Contact-based fiber-optic probe with a single illumination fiber and fibers polished normally. (b) 
Spectral imaging system with non-contact illumination and collection. (c) Cross-section of the probe-tissue interface 
for a six-around-one probe configuration with a central illumination fiber and six surrounding collection fibers 
relative to the light distribution in the tissue. (d) Spectral imaging field of view and individual pixels relative to the 
illumination spotsize and subsequent light distribution.  
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transition from probe-based spectroscopy to non-contact spectral imaging on fluorescence and 
diffuse reflectance lineshape as a function of optical properties has never been conducted.  
Previous studies in the literature have investigated fluorescence and diffuse reflectance 
propagation in tissue, hinting at some of the effects of illumination-collection geometry on 
fluorescence and diffuse reflectance lineshape. Research into diffuse reflectance propagation in 
tissue began with one-dimensional depth-resolved investigations in which diffuse reflectance 
was modeled as a function of optical properties using photon migration theory [14]. Several 
groups have also simulated or measured radially resolved profiles of diffuse reflectance for wide 
ranges of optical properties, but the results were used to develop inverse models for in vivo 
optical property determination [15, 16]. The authors concentrated on producing calibrated data 
for specific collection geometries and did not extend their findings to how profile changes with 
optical properties might affect clinically measured spectra. Bargo et al [17, 18] measured the 
collection efficiency of a single illumination-collection fiber and of an illumination-collection 
fiber pair as a function of optical properties and separation distance, but defined collection 
efficiency as the fraction of light impinging on the face of the collection fiber that falls within its 
acceptance cone, without investigating how the absolute intensity of remitted light varies with 
optical properties (i.e. wavelength) and thereby also affects diffuse reflectance lineshape.  
While several studies have demonstrated changes in diffuse reflectance lineshape 
subsequent to a shift in illumination-collection geometry, the causes for the behavior have not 
been thoroughly examined. Liu et al [19] simulated and experimentally measured diffuse 
reflectance for a subset of discrete optical property values and three different probe geometries, 
but did not discuss how the collection efficiencies of the specific probe geometries varied with 
wavelength. A subsequent paper from the same research group [20] used one of the investigated 
probes to demonstrate that fluorescence and diffuse reflectance lineshapes from breast tissue 
change between three source-detector separation distances. However, the source of the 
disparities is not discussed other than to ascribe them to probing different depths of the tissue 
(the spectra from the different separation distances are used as independent inputs to a tissue 
classification scheme). Not surprisingly, the classification results show that the three sets of 
spectra yield similar discrimination success rates since there is "no apparent structural change in 
breast tissue with increasing depth," emphasizing the fundamental difference in terms of 
131 
diagnostic utility between changes in lineshape due to tissue morphology/architecture and 
changes due to illumination-collection geometry.  
The only studies in the literature which have examined the combined effects of optical 
properties and illumination-collection geometry on diffuse reflectance lineshape were conducted 
by Schmitt and Kumar [21, 22]. Diffuse reflectance spectra were measured in the near infrared 
for a single illumination-collection fiber pair in an effort to determine how collection of remitted 
light varied with separation distance (d = 1-6 mm) for various optical properties (µa = 0-1.0 mm-
1, µs' = 0.5-2.0 mm-1). They demonstrated that diffuse reflectance lineshape varies with source-
detector separation distance and explained the shifts using diffusion theory. However, diffusion-
based predictions broke down at small source-detector separation distances and thus far, no 
group has validated their results in the visible spectrum where increased scattering and 
absorption and shorter source-detector separation distances in most fiber-optic probes (d = 0-1 
mm) render diffusion theory inaccurate.  
Investigations into fluorescence propagation for tissue diagnosis can be divided into two 
major categories: those that investigate depth-resolved fluorescence [23-28] and those that seek 
to extract intrinsic fluorescence information from fluorescence measurements [29-33]. Depth-
resolved fluorescence investigations predominantly aim to identify probe geometries which will 
collect fluorescence from specific layers in epithelial tissues, but they rarely worry about how 
optical properties and probe geometry affect the lineshape. While extracting intrinsic 
fluorescence information from fluorescence measurements recognizes the effects of optical 
properties on lineshape and actually seeks to remove those effects, most of the methods seek to 
minimize the effects of probe geometry by using diffuse reflectance information for fluorescence 
correction. Since the fluorescence and diffuse reflectance spectra are generally collected with the 
same illumination-collection geometry, diffuse reflectance lineshape is similarly modulated and 
can be used to help correct for any wavelength-specific geometry effects.  
While depth-resolved and intrinsic fluorescence studies provide knowledge of 
fluorescence behavior, neither of them give insight into how tissue optical properties and 
excitation-collection geometry combine to modulate fluorescence lineshape. Surprisingly, while 
the recent investigations outlined above have strayed from the issue, two of the first 
investigations into fluorescence propagation demonstrated a dependence of fluorescence 
lineshape on excitation-collection geometry. Richards-Kortum et al [34] compared measured 
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fluorescence spectra from collection regions inside and outside of the excitation spot, and Keijzer 
et al [35] simulated and measured fluorescence spectra as a function of radial distance from the 
source. Both studies found that fluorescence lineshape drastically changes as collection is moved 
out of and further from the excitation spot. Shifts in lineshape are attributed to increased probing 
depth as the source-detector separation distance increases, subjecting the fluorescence to greater 
modulations from sample absorption. Since then, other groups have observed similar results [36, 
37], but none have investigated spectral lineshapes measured with traditional fiber-optic probe 
configurations or non-contact imaging systems.  
The goals of this paper are two-fold: 1) to thoroughly examine the behavior of 
fluorescence and diffuse reflectance lineshape as a function of illumination-collection geometry 
and tissue optical properties and 2) to determine the specific effects of the transition from fiber-
optic probe-based spectroscopy to non-contact spectral imaging on measured lineshapes. Here, 
we first demonstrate the differences in fluorescence and diffuse reflectance lineshape upon the 
shift from probe-based spectroscopy to spectral imaging and attribute the spectral differences to 
a fundamental change in illumination-collection geometry. The sensitivity of the disparity in 
lineshape to changes in sample absorption and reduced scattering is examined using tissue 
phantoms with known optical properties. The effects of beam-steered fibers, fiber diameter, and 
using illumination fibers for collection of remitted light are assessed via experimental 
measurement and Monte Carlo simulation and subsequently used to determine the ideal fiber-
optic probe configuration that minimizes the spectral disparity between spectroscopy and 
imaging. The results of this investigation provide insight into the behavior of fluorescence and 
diffuse reflectance lineshape with shifts in illumination-collection geometry and can be used to 
guide the design and planning of tissue diagnosis studies that rely on optical spectroscopy by 
aiding in the design of fiber probes that simplify the transition of such studies to spectral 
imaging. 
 
Materials and Methods 
 
System Descriptions 
 The probe-based spectroscopy [5] and spectral imaging [38] systems used in this study are 
employed in the brain tissue diagnosis study and have been described in detail elsewhere; only the 
133 
significant details will be repeated here. For spectroscopy measurements, a fiber-optic probe with seven 
fibers (d = 300 µm, NA = 0.22) in a six-around-one configuration delivered light from a pulsed nitrogen 
laser (337 nm, 120 µJ per pulse, 20 Hz repetition rate, Spectra-Physics) for fluorescence excitation and 
from a white-light halogen lamp (6.5 W, Ocean Optics) for diffuse reflectance illumination. Illumination 
light was delivered by two opposing fibers at the six o’clock and twelve o’clock positions along the outer 
ring, while the remaining five fibers delivered remitted light, collected from the sample surface, to a 
spectrometer (S2000-FL, Ocean Optics) for spectral measurement. All seven fibers were polished 
normally and placed in direct contact with the sample surface during each measurement. 
 Spectral imaging was performed with a liquid-crystal tunable filter spectral imaging system 
(Figure 1b) which consisted of three components: a Varispec VIS-20 LCTF (CRI, Inc.), a variable focal-
length camera lens (f/3.5, Nikon), and a thermo-electrically cooled CCD camera (PhotonMax, Princeton 
Instruments) [38]. Images were acquired in a non-contact manner with a 25 mm x 25 mm field of view 
and an object distance of roughly 180 mm. Light from a 500 W xenon arc lamp, bandpass filtered at 340 
nm, was used for fluorescence excitation, while light from a 200 W halogen lamp (Luxtec) was used for 
diffuse reflectance. A 365 nm dichroic filter coupled both illumination sources into a single, 10-mm-core 
liquid light guide which delivered the illumination light to the sample. Quartz lenses at the distal end of 
the light guide focused the illumination light to a spot roughly 50 mm in diameter. 
 
Lineshape Disparity 
 To demonstrate the lineshape disparity between spectra from probe-based spectroscopy 
and spectral imaging, fluorescence and diffuse reflectance measurements were acquired with 
both systems from gelatin-based phantoms designed to optically mimic human white and gray 
matter brain tissue. The phantoms were developed as part of a separate project (in review), with 
polystyrene microspheres used for reduced scattering, bovine hemoglobin for absorption, and 
Stilbene 420 dye for fluorescence. The concentrations of the three components were empirically 
determined to yield optical property spectra which matched mean reduced scattering, absorption, 
and fluorescence spectra experimentally measured from human white and gray matter brain 
tissues. In sum, the white matter and gray matter phantoms contained equivalent levels of 
absorption and fluorescence, with roughly 3.5-fold higher reduced scattering in the white matter 
phantom. Probe-based fluorescence and diffuse reflectance spectra were acquired from both 
tissue phantoms from 400 to 720 nm with a 200-ms integration time and spectral resolution of 10 
nm. Corresponding imaging spectra were acquired over the same spectral range with a 10-nm 
wavelength increment and total image integration times of 8 s and 165 s for diffuse reflectance 
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Figure 2. Schematic of probe-based spectroscopy measurement with an imaging excitation-collection geometry. 
and fluorescence, respectively. Mean spectra averaged across ten measurements for probe-based 
spectroscopy and across all pixels within the spectral images were corrected for system 
sensitivity and the illumination spectrum of the halogen lamp according to a standard calibration 
procedure using direct-view measurements from a NIST calibration lamp and the white-light 
halogen lamp [6, 7, 39]. Corrected fluorescence and diffuse reflectance spectra were normalized 
to a maximum or mean of one, respectively, for comparison of spectral lineshape between 
systems.  
 To identify the shift in illumination-collection geometry between the systems as the 
cause for the observed lineshape disparity, a third set of fluorescence and diffuse reflectance 
measurements were acquired from the gray matter phantom: probe-based spectra using an 
imaging illumination-collection geometry (Figure 2). The fiber-optic probe was positioned 
roughly 25 mm from the sample surface and the illumination optics from the imaging system 
were used to create an illumination spot on the phantom surface 50 mm in diameter. Given the 
collection fiber NA = 0.22, this configuration produced a collection region roughly 11 mm in 
diameter within the 50-mm illumination spot. While this collection region was significantly 
larger than the 50-µm pixel-limited spatial resolution of the imaging system, it was sufficiently 
small relative to the illumination spot when considered in terms of photon diffusion.  
 
Effect of optical properties 
 Two series of gelatin phantoms were created to determine how the disparity in 
spectroscopy and imaging lineshape is affected by sample optical properties (Table 1). The first 
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series contained five phantoms with increasing hemoglobin concentrations but equal microsphere 
concentrations, giving variable absorption but constant reduced scattering at a level between gray 
and white matter scattering [40]. The second series of five phantoms were created with 
increasing concentrations of polystyrene microspheres but equal hemoglobin concentrations, 
giving variable reduced scattering but constant absorption at a level shared by gray and white 
matter tissue [40]. For each phantom, absorption and reduced scattering spectra were measured 
at 337 nm for fluorescence excitation and from 400 to 720 nm for fluorescence and diffuse 
reflectance collection using a single-integrating-sphere spectrophotometer and inverse adding-
doubling technique [40-42]. Probe-based spectroscopy and spectral imaging measurements were 
acquired from each of the ten phantoms with parameters similar to the lineshape study described 
above. The spectra were corrected for wavelength sensitivity and the halogen illumination 
spectrum, averaged across ten measurements for spectroscopy and across pixels for imaging, and 
normalized for comparison purposes.  
 
Effects of probe configuration 
Fiber-optic probes are often designed using illumination and collection fibers whose tips 
are beveled to steer and create overlap between the illumination and collection regions, in an 
effort to increase the signal collected from the sample [43, 44]. To determine the effect of steered 
fibers on the disparity between probe-based and imaging spectra, two sets of probe-based spectra 
were measured from each of the ten phantoms in Table 1. While the first set was acquired with 
the same probe used in previous experiments, the second set was acquired with a fiber-optic 
probe (custom-designed by Visionex, Inc.) consisting of the same six-around-one fiber 
configuration (d = 300 µm, NA = 0.22), but with a central conventional fiber surrounded by six 
fibers beam-steered toward the central fiber to enhance the collection efficiency [43]. As with 
previous experiments, ten fluorescence and diffuse reflectance measurements were acquired 
from each phantom, corrected for wavelength sensitivity and the halogen illumination spectrum, 
averaged, and normalized for comparison purposes. 
The effects of other fiber-probe design parameters on the disparity between probe-based 
and imaging spectra were investigated. Since many different probe designs exist and probes with 
other fiber diameters, with other fiber configurations, and with fibers used for simultaneous 
illumination and collection were not readily available, Monte Carlo simulation was used to 
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determine their effects. Diffuse reflectance Monte Carlo simulations were performed for a series 
of homogeneous, semi-infinite samples whose optical properties formed a grid of optical 
property pairs (µa, µs’) which spanned the optical properties measured from human brain tissue 
[40]. For each simulation (i.e. set of optical properties), photons were launched at the origin with 
a random azimuthal incidence angle whose probability density function was uniformly 
distributed between zero degrees and the half-angle of the fiber divergence as dictated by its NA 
(0.22).  
Photons were propagated through the tissue, consistent with the principles of Jacques and 
Wang [45] using an anisotropy factor of 0.85, and their exit from the tissue surface was recorded 
as a two-dimensional function of radial position and azimuthal angle. Imaging and probe-based 
diffuse reflectance collection intensities were determined for each optical property pair via 
convolution of the recorded exit function with functions describing the illumination and 
collection geometries of the two systems. Piecing these calculated intensities together formed a 
collection surface as a function of absorption and reduced scattering for each system, and diffuse 
reflectance spectra were then constructed for a given sample via interpolation using its 
experimentally measured absorption and reduced scattering spectra.  
Monte Carlo diffuse reflectance spectra were constructed for each of the ten tissue 
phantoms in Table 1 for a spectral imaging geometry and for six-around-one probe 
configurations (similar to the experimental probe, without beam-steering) with three different 
Table 1. Component concentrations and experimentally measured optical properties (specified at 550 nm) for the 
variable absorption, constant scattering and variable scattering, constant absorption series of tissue phantoms. 
Hemoglobin and microsphere concentrations are given relative to total phantom volume (15 mL). Microsphere 
concentration indicates the equal concentrations of 0.1 and 0.5 µm diameter polystyrene microspheres, such that the 
total microsphere concentration in the phantom was twice the indicated value. 
 
Phantom 
Series 
Phantom 
Name 
Hemoglobin 
Concentration 
Microsphere 
Concentration 
Absorption 
Coefficient (mm-1) 
Reduced Scattering 
Coefficient (mm-1) 
12.5 mg 0.833 mg/mL 0.0663 3.3382 
25.0 mg 1.667 mg/mL 0.1482 3.9416 
37.5 mg 2.500 mg/mL 0.2277 3.8880 
50.0 mg 3.333 mg/mL 0.2903 3.2931 
Variable 
Absorption, 
Constant 
Scattering 
62.5 mg 4.167 mg/mL 
0.2 mL/mL 
0.3544 3.4767 
0.5 mL 0.033 mL/mL 0.1812 0.5041 
1.5 mL 0.100 mL/mL 0.2143 1.8291 
2.5 mL 0.167 mL/mL 0.2332 2.9371 
3.5 mL 0.233 mL/mL 0.2118 3.7553 
Variable 
Scattering, 
Constant 
Absorption 
4.5 mL 
2.5 mg/mL 
0.300 mL/mL 0.2296 4.9926 
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fiber diameters – 110, 220, and 330 µm (core + cladding). Spectra were then created for the same 
three probe geometries with the illumination fiber included in the collection region. Finally, 
based upon the experimental and Monte Carlo results, multiple fiber configurations were tested 
in an attempt to identify the ideal probe configuration that minimizes the disparity between 
imaging and probe-based spectra. 
 
Results 
 
Lineshape Disparity 
 Mean fluorescence and diffuse reflectance spectra from gray and white matter tissue 
phantoms (Figure 3) demonstrate a significant disparity between probe-based spectroscopy and 
spectral imaging. For diffuse reflectance, imaging spectra show greater intensity contrast 
                          
 (a)                                                                               (b) 
                          
(c)                                                                                (d) 
Figure 3. Demonstration of lineshape disparity between probe-based spectroscopy and spectral imaging. (a) Diffuse 
reflectance spectra from gray matter phantom. (b) Fluorescence spectra from gray matter phantom. (c) Diffuse 
reflectance spectra from white matter phantom. (d) Fluorescence spectra from white matter phantom. 
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between the blue/green (400 – 600 nm) and red spectral ranges (600 – 720 nm) than the probe-
based spectra for both tissue types. Similarly, the wavelength of peak fluorescence is red-shifted 
in imaging spectra relative to the probe-based measurements, again indicating greater preference 
for the red wavelengths relative to the blue/green. These observed differences are more 
pronounced in gray matter than white matter spectra, suggesting an optical property dependence 
in the lineshape disparity between the two systems. 
 Acquiring fluorescence and diffuse reflectance spectra with the probe-based 
spectroscopy system while using an imaging illumination-collection geometry removed the 
disparity in spectral lineshape (Figure 3a,b). The red-blue intensity contrast in diffuse reflectance 
and the peak fluorescence wavelength were shifted on par with the mean imaging spectra, 
demonstrating that the difference in illumination-collection geometry between probe-based 
spectroscopy and spectral imaging is responsible for the lineshape disparity observed in Figure 3. 
 
Effect of optical properties 
 Probe-based spectroscopy and spectral imaging measurements were acquired from all ten 
phantoms described in Table 1. In an effort to more clearly depict the trends in fluorescence and 
diffuse reflectance lineshape with optical properties, mean spectra are plotted for only three of 
the five phantoms in each series. Spectra from the other phantoms consistently follow the trends 
depicted in the figures. 
 Since hemoglobin absorption is greater in the blue/green region than the red region of the 
spectrum, increases in the modulation of spectral lineshape due to hemoglobin absorption, which 
will be henceforth referred to as absorption modulation, produce greater contrast in the measured 
intensities between these two regions and are exhibited by higher normalized diffuse reflectance 
intensities at 720 nm and increased red-shift of the fluorescence peak. Increasing concentrations 
of hemoglobin in the variable absorption phantoms produce greater absorption modulation for 
both probe-based and imaging spectra in fluorescence and diffuse reflectance spectra (Figure 4). 
The modulation of spectral lineshape is consistently larger in imaging than in probe-based 
spectra, indicating that the photons collected by the imaging system are subject to greater 
modulation from absorption. This behavior suggests that, on average, imaging photons have 
increased path lengths before exit from the tissue (i.e. increased tissue interaction) and are more 
diffuse. While not readily apparent from visual inspection of Figure 4, ratios of probe-based to 
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imaging spectra (results not shown) demonstrate that the disparity in lineshape between the 
probe-based and imaging systems decreases with increased absorption. 
 Increases in reduced scattering affect opposing changes in imaging and probe-based 
spectra for fluorescence and diffuse reflectance (Figure 5). Imaging spectra show decreased 
absorption modulation with increased scattering, while probe-based spectra show increased 
absorption effects. This behavior suggests that while the photons collected by the imaging 
system have shorter path lengths and interact less with the tissue with increased scattering, 
probe-based photons have increased path lengths and interact more with the tissue. The disparity 
in lineshape between the probe-based and imaging systems decreases with increased scattering, 
consistent with results observed in gray and white matter tissue phantoms (Figure 3). 
 
                          
(a)                                                                               (b) 
                          
(c)                                                                                (d) 
Figure 4. Effect of sample absorption on lineshape disparity between probe-based spectroscopy and spectral 
imaging. (a) Probe-based diffuse reflectance spectra. (b) Probe-based fluorescence spectra. (c) Imaging diffuse 
reflectance spectra. (d) Imaging fluorescence spectra. 
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Effect of probe configuration 
 While beam-steered fibers have been shown to increase the collection efficiency of fiber-
optic probes [43, 44], the comparison between identical probes with and without beam-steering 
demonstrates that beam-steered fibers increase the disparity between imaging and probe-based 
spectra (Figure 6). Beam-steered fibers consistently create diffuse reflectance and fluorescence 
(results not shown) spectra that exhibit less modulation from sample absorption than 
conventional fibers for variable absorption and scattering. This behavior is consistent with the 
theory behind the probe design, which aims to create overlapping illumination and collection 
regions and minimize absorption by shortening photon path lengths through the tissue. Since 
imaging spectra demonstrate greater absorption modulation than conventional probe-based 
spectra, reducing photon path lengths and subsequent photon interaction with the tissue using 
beam-steered fibers only exacerbates the disparity. 
                          
(a)                                                                               (b) 
                          
(c)                                                                                (d) 
Figure 5. Effect of sample reduced scattering on lineshape disparity between probe-based spectroscopy and spectral 
imaging. (a) Probe-based diffuse reflectance spectra. (b) Probe-based fluorescence spectra. (c) Imaging diffuse 
reflectance spectra. (d) Imaging fluorescence spectra. 
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 For fiber-optic probes with conventional fibers (i.e. no beam-steering), decreasing the 
diameter of the illumination and collection fibers reduces the absorption modulation of diffuse 
reflectance spectra (Figure 7a-c). Decreasing fiber diameter reduces the collection area of the 
fiber-optic probe, eliminating photon collection from regions distant from the illumination fiber. 
Since photon path length, subsequent interaction with the tissue, and absorption increase with 
source-detector separation distance, shrinking the source-detector separation distances across the 
probe illumination-collection geometry decreases the lineshape modulation due to absorption 
within measured spectra. Given that the disparity between imaging and probe-based spectra is 
characterized by greater modulation of imaging photons, decreased fiber diameter increases the 
disparity. 
Similarly, fiber-optic probes which use illumination fibers for collection of remitted light 
produce fluorescence and diffuse reflectance spectra with less absorption modulation than probes 
where the illumination and collection fibers are mutually exclusive (Figure 7c-d). Including the 
illumination fiber in the collection region biases the population of collected photons towards 
singly scattered photons which are less diffuse and interact less with the tissue, thereby 
increasing the disparity between imaging and probe-based spectra. While Monte Carlo 
fluorescence spectra were not simulated, the changes in fluorescence spectra relative to the 
changes in diffuse reflectance spectra in Figure 7 are assumed to be consistent with the changes 
depicted in Figures 4 and 5.  
                          
(a)                                                                                (b) 
Figure 6. Effect of beam-steered fibers on lineshape of probe-based diffuse reflectance spectra from variable 
absorption phantoms: (a) without beam-steering (b) with beam-steering. 
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To minimize the disparity between imaging and probe-based spectra, the ideal fiber-optic 
probe configuration must come as close as possible to re-creating an imaging illumination-
collection geometry, in which a small collection region falls within a large illumination spot. 
While this would imply a single collection fiber surrounded by concentric rings of illumination 
fibers, such a design is impractical since distributing the illumination light across multiple fibers 
would significantly reduce the illumination irradiance. If viewed in terms of source-detector 
separation distances, an imaging geometry collects photons across all separation distances 
ranging from zero to the maximum distance between the pixel location and the edge of the 
illumination spot, which can often be considered infinite relative to the photon diffusion 
distance. To mimic this scenario, the collection fibers should extend as far as possible, with 
uniform coverage as a function of distance from the illumination fiber. For a conventional fiber 
configuration with a single illumination fiber surrounded by concentric rings of collection fibers 
                          
(a)                                                                                (b)                                                  
                          
(c)                                                                                 (d) 
Figure 7. Effect of fiber diameter and using the illumination fiber for collection on Monte Carlo predicted lineshape 
of probe-based diffuse reflectance spectra from variable absorption phantoms: (a) 110 µm diameter fibers (core + 
cladding) (b) 220 µm diameter fibers (c) 330 µm diameter fibers (d) 330 µm diameter fibers with illumination fiber 
used for collection. 
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(Figure 8a), each ring of fibers sits within an annulus of width equal to the fiber diameter (2R). 
Since the area of an annulus of constant width (∆r) increases with radius (r) as 2πr∆r, to provide 
uniform coverage at each source-detector separation distance, the number of fibers within each 
ring must increase linearly with this distance. Therefore, if the first ring has N fibers, the second 
ring should have 2N fibers, the third ring 3N fibers, and so on. While ideally this pattern would 
extend ad infinitum, practically it would extend to a point which could be deemed semi-infinite 
relative to photon diffusion for the given sample optical properties. 
Using Monte Carlo simulation to determine the most practical fiber-optic probe design in 
terms of fiber diameter (R) and extent of coverage (rMAX), the results demonstrate that the fiber 
geometry must extend out to a point roughly 15 mm from the illumination fiber to minimize the 
disparity between probe-based and imaging diffuse reflectance lineshape for the lowest 
                          
(a)                                                                                  (b) 
                          
(c)                                                                                  (d) 
Figure 8. Ideal fiber configuration to minimize the disparity between imaging and probe-based diffuse reflectance 
lineshapes from variable scattering phantoms: (a) ideal fiber configuration (b) Monte Carlo imaging spectra and 
probe-based spectra for R = 165 µm, N = 1, and various rMAX values for 0.5 mL phantom (c) Monte Carlo imaging 
and probe-based spectra for R = 165 µm, N = 1, and rMAX = 5 mm for variable scattering phantoms (d) Monte Carlo 
imaging spectra and probe-based spectra for R = 165 µm, N = 1, and various rMAX values for 0.5 mL phantom with 
absorption equal to 133% of µa value in (b). 
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scattering phantom in the variable scattering series (Figure 8b). Since Figure 5 shows opposing 
trends with increased reduced scattering for probe-based and imaging spectra, the trend for 
probe-based spectra must reverse itself to emulate imaging lineshape behavior, a transition which 
occurs at roughly rMAX = 5 mm (Figure 8c). The radial extent of the fiber probe to emulate 
imaging behavior (Figure 8d) and the transition point (results not shown) are both dependent on 
the level of sample absorption, decreasing with increasing absorption. 
 
Discussion 
 The results outlined in this paper demonstrate an inherent disparity between probe-based 
spectroscopy and spectral imaging in fluorescence and diffuse reflectance lineshape (Figure 3). 
The results show that the lineshape disparity is due to differences in the illumination-collection 
geometry of the two systems (Figure 3a,b) and is dependent on the optical properties of the 
sample. Increased sample absorption leads to greater lineshape modulation due to hemoglobin 
absorption (“absorption modulation”) for both systems with consistently greater modulation in 
imaging than in probe-based spectra (Figure 4). Increased sample scattering reduces the 
absorption modulation in imaging spectra while simultaneously increasing absorption effects in 
probe-based spectra (Figure 5). While more readily apparent with changes in sample scattering, 
both increased absorption and increased scattering decrease the lineshape disparity between the 
two systems. Beam-steered fibers (Figure 6), decreasing the fiber diameter (Figure 7a-c), and 
using the illumination fiber for collection (Figure 7c,d) decrease the absorption modulation in 
probe-based spectroscopy, thereby increasing the disparity to imaging lineshape. 
 The first inclination upon comparing the probe-based and imaging spectra shown in 
Figure 3 is to attribute the lineshape disparity to changes in instrumentation (spectral resolution, 
illumination sources) and/or errors in wavelength calibration between the probe-based 
spectroscopy and spectral imaging systems. Before positively identifying the shift in 
illumination-collection geometry as the true root, each of these causes was investigated to 
determine its effect on the measured lineshapes. The probe-based spectroscopy system possesses 
a spectral resolution of roughly 10 nm across its spectral range; the spectral resolution of the 
spectral imaging system varies from 10 nm at 400 nm to 35 nm at 720 nm. While the disparity in 
spectral resolution will widen spectral features and increase the contrast between the red and blue 
wavelengths in imaging measurements, the spectral resolution of the two systems are roughly 
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equivalent (10-15 nm) at the point of peak fluorescence observed in this study (460 nm), 
fluorescence peaks are sufficiently wide as to be negligibly affected by spectral resolution, and 
such an increase in contrast does not explain the complete reversal in the trend of that contrast 
with changes in scattering between spectroscopy and imaging. Further, shifting from a nitrogen 
laser to a bandpass-filtered xenon lamp and between halogen lamps were determined to have no 
effect on measured fluorescence and diffuse reflectance lineshapes, respectively (results not 
shown), based upon probe-based spectroscopy measurements acquired from a gray matter 
phantom using the probe-based and imaging illumination sources with a non-contact 
illumination-collection geometry (Figure 2). Inaccuracies in wavelength calibration were 
eliminated as the cause for the lineshape disparity using a similar comparison between non-
contact imaging and probe-based spectra from a 99% diffuse reflectance standard (Spectralon, 
LabSphere) illuminated by the halogen lamp from the spectral imaging system.  
 Once the shift in illumination-collection geometry was identified as the cause for the 
lineshape disparity, the differences in geometry were theoretically contrasted to those 
investigated by Richards-Kortum et al [34]. Richards-Kortum et al originally compared spectral 
lineshapes from a geometry with perfect overlap of the excitation-collection regions to one with 
adjacent but non-overlapping regions. By concluding that emission should only be collected 
within the limits of the excitation spot in order to produce spectral lineshapes independent of 
excitation-collection geometry effects, Richards-Kortum et al suggest that the degree with which 
the collection region overlaps the excitation spot is paramount in predicting the effects of 
absorption on spectral lineshape. Since the probe-based geometry in this study produces adjacent 
but non-overlapping illumination-collection regions and the collection region in the imaging 
geometry falls completely within the illumination spot, the lineshape investigation in this paper 
resembles the comparison by Richards-Kortum et al in terms of illumination-collection overlap. 
However, while the spectra measured by Richards-Kortum et al with perfect overlap show less 
absorption modulation than the non-overlapping case, the imaging spectra in this study 
consistently show more absorption effects than the probe-based spectra.  
 Figure 9 frames the comparison in another way. Rather than concentrate on overlap 
between illumination and collection, it depicts the relative relationship between impulse response 
curves and the relative distributions of source-detector separation distances (SDSD) for the 
experimental illumination-collection geometries of the imaging and spectroscopy measurements 
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in Figures 4 and 5. To highlight the effects of changes with sample optical properties, the 
impulse response curves were predicted by Monte Carlo simulation for diffuse reflectance 
emission from four combinations of high and low absorption and scattering. Consistently greater 
absorption modulation in imaging than probe-based spectra suggests longer photon path lengths 
before exit from the tissue and subsequently greater interaction of imaging photons with the 
tissue. As seen in Figure 9, increased tissue scattering effectively shrinks the radial scale of 
photon diffusion, shortening overall photon path lengths and decreasing photon-tissue 
interaction. Since the SDSD distribution for imaging extends well beyond the extent of the 
impulse responses, the imaging system effectively collects the same population of photons 
regardless of spatial changes in photon diffusion with scattering, and the decrease in photon path 
lengths produces imaging spectra with decreased absorption modulation consistent with reduced 
tissue interaction. On the other hand, by shrinking the scale of photon diffusion, increased 
scattering leads to collection of additional diffuse photons which originally emitted outside the 
finite extent of the SDSD distribution in probe-based spectroscopy, resulting in increased 
absorption modulation and a shift toward imaging lineshape.  
 As such, as the scale of photon diffusion decreases relative to the fixed geometry of the 
fiber-optic probe, probe-based spectroscopy approaches the imaging scenario in which more 
diffuse photons are collected. Beam-steered fibers, decreasing the fiber diameter, and using the 
 
Figure 9. Normalized impulse response and source-detector separation distance (SDSD) distributions for diffuse 
reflectance. Impulse responses are plotted for four combinations of high and low scattering and absorption (µs’ = 20 
and 1100 cm-1, µa = 0.1 and 50 cm-1). Each impulse response was normalized to a peak of one. The imaging and 
spectroscopy SDSD distributions were calculated for the illumination-collection geometries for the experimental 
measurements in Figures 4 and 5, with the imaging distribution for a 50 µm pixel at the center of a 25-mm-diameter 
excitation spot. 
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illumination fiber for collection, all of which bias probe-based photon collection toward photons 
with shortened path lengths, decrease the effects of absorption modulation and produce spectra 
with increased disparity to imaging lineshape. These results indicate that rather than on the strict 
overlap between the illumination and collection regions as proffered by Richards-Kortum et al 
[34], the lineshape effects from illumination-collection geometry depend on the distribution of 
source-detector separations relative to the scale of photon diffusion within the tissue. Therefore, 
the capability for two spectral measurement systems to produce spectral lineshapes equivalent to 
one another depends on the equality of their illumination-collection geometries, not in terms of 
illumination-collection overlap but in terms of the overall distribution of source-detector 
separation distances. 
An interesting hypothetical result regarding the lineshape comparison presented by 
Richards-Kortum et al [34] accurately illustrates the point above. In their paper, fluorescence 
spectra are initially compared between fiber-based spectroscopy and an in vitro non-contact 
measurement system. The fiber geometry was designed to create 1-mm diameter excitation and 
collection regions with significant overlap to perfectly mimic the excitation-collection geometry 
of the non-contact system. It is interesting to note that had the fiber-based system maintained 
perfect overlap but used 2-mm excitation-collection diameters, the distribution of source-detector 
separation distances would diverge from the non-contact system since source-detector separation 
distances for a pair of overlapping excitation-collection regions extend up to the diameter of 
those regions. Based on the results in this paper, spectra deriving from illumination-collection 
regions with different diameters would be subject to different levels of absorption modulation 
and possess different lineshapes, despite perfect illumination-collection overlap.  
 The effects of absorption and scattering changes on lineshape disparity depend on the 
relative contributions of the absorption and scattering coefficients to the scale of photon 
diffusion within the tissue. According to Jacques and Wang, the absorption and scattering 
coefficients carry equal weight in determining the probability density function for photon 
stepsize – ( ) ( )ssp tt µµ −= exp  where ( )sat µµµ +=  – and the subsequent photon diffusion scale 
within the tissue. However, because the scattering coefficient magnitude is significantly larger in 
most soft tissues (Table 1) [46], changes in absorption affect proportionately smaller changes in 
the total attenuation coefficient µt. Using the optical properties in Table 1, a five-fold change in 
µa across the variable absorption phantoms produces only a 4% increase in µt, while a ten-fold 
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change in µs’ (and therefore µs) produces a 946% increase in µt. The unequal effects of changes 
in absorption and scattering to changes in µt and the subsequent scale of photon diffusion 
demonstrate why large changes in lineshape disparity are apparent across the variable scattering 
phantoms while the changes with absorption are barely visible.  
Despite the fact that the disparate lineshapes of diffuse reflectance and fluorescence make 
direct comparison difficult, Figures 3 through 5 appear to indicate that the lineshape disparity is 
less significant in fluorescence than in diffuse reflectance. For equivalent sample optical 
properties, the fluorescence spectra demonstrate only subtle shifts in the location and width of 
the emission peak at the same time that diffuse reflectance spectra show large changes in spectral 
lineshape. While quantitative data is currently unavailable to corroborate this assertion, the 
differences in lineshape disparity between the two types of spectroscopy most likely trace back 
to the isotropic nature of fluorescence generation in tissue. Diffuse reflectance photon 
propagation is entirely subject to forward-biased scattering events, resulting in radially disperse 
distributions of photon emission. Replacing one of those scattering events with absorption and 
isotropic photon generation logically results in fluorescence photon emission after fewer 
scattering events and spatial distributions which are less disperse. As such, the narrow 
fluorescence distributions relative to diffuse reflectance allows the collection geometry of probe-
based spectroscopy to mimic the semi-infinite imaging geometry, with less fluorescence 
lineshape sensitivity to changes in optical properties. 
As outlined in the Results section, the ideal fiber-optic probe configuration that 
minimizes the disparity between probe-based and imaging spectral lineshape must simulate an 
imaging illumination-collection geometry. Therefore, given a central illumination fiber 
surrounded by concentric rings of collection fibers (Figure 8a), the number of collection fibers 
must increase linearly with the distance from the central illumination fiber. Based on the results 
in Figure 8b for reduced scattering and absorption spectra which are indicative of human brain 
tissue, probe-based collection fibers must extend roughly 15 mm to produce diffuse reflectance 
lineshapes equivalent to spectral imaging (though a less extensive probe could arguably achieve 
equivalent fluorescence lineshapes). While these numbers provide a blueprint for a fiber-optic 
probe design that minimizes the lineshape disparity from non-contact spectral imaging, it also 
indicates how far from a given spectral imaging pixel heterogeneities in the tissue will affect 
measured imaging lineshape. While this paper focuses on spectral lineshape from homogeneous 
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samples, since photons collected by the imaging system traverse source-detector separation 
distances up to 10-20 mm, heterogeneous tissue structures in the intervening regions will 
contribute to the overall imaging lineshape. 
The probe-based spectra for rMAX = 10 mm in Figures 8b,d show greater absorption 
modulation than imaging spectra which involve maximum imaging source-detector separation 
distances greater than 10-20 mm. Greater absorption modulation in spectroscopy despite shorter 
maximum source-detector separation distances results from a lack of photon collection within the 
illumination fiber where source-detector separation distances are short and absorption 
modulation is minimal. This overshoot in probe-based absorption modulation for probe designs 
with large rMAX values can be minimized by decreasing the illumination fiber diameter, using the 
illumination fiber for collection, or decreasing the diameter of the collection fibers (results not 
shown). However, reducing the illumination fiber diameter reduces the delivered illumination 
irradiance due to imperfect fiber coupling at the illumination source; using the illumination fiber 
for collection over-corrects the disparity by over-sampling the source-detector separation 
distances within the illumination fiber; and reducing the collection-fiber diameter presents a 
tradeoff between minimizing the lineshape disparity and minimizing the number of collection 
fibers in the probe. The number of collection fibers for a given fiber diameter (2R), radial extent 
(rMAX), and number of fibers in the first ring of collection fibers (N) is equal to 
Number of Collection Fibers 

 +



= 1
222 R
rFLOOR
R
rFLOORN MAXMAX , 
where FLOOR() indicates rounding down to the nearest integer. For the scenario in Figure 8b 
with a 330 µm diameter fiber (plus cladding), N = 1, and rMAX = 10 mm, the total number of 
collection fibers is 465 fibers. If the fiber diameter is decreased to 110 µm, the number of fibers 
increases to 4095 fibers, creating probe designs which are non-trivial to construct. 
 Figure 8c demonstrates that as the radial extent (rMAX) of the fiber-optic probe increases, 
the trend in absorption modulation changes from increased modulation with increased scattering 
to decreased modulation with increased scattering, similar to the trend in imaging spectra. This 
behavior indicates that a radial extent exists for which spectral lineshape is independent of 
changes in sample scattering. These findings are consistent with the results of Schmitt and 
Kumar [22] who sought to determine a source-detector separation distance for an illumination-
collection fiber pair which minimized the measurement sensitivity to background scattering for 
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NIR absorption spectroscopy. Consistent with the results in this paper (Figures 8b,d), they found 
that this transition point increases with decreased absorption, so to obtain scattering-independent 
measurements, the probe configuration must be adaptive for changes in sample absorption. 
 While much of this paper focuses on how changes in fiber design affect probe-based 
spectra, several of the issues raised above (large number of collection fibers required, spectral 
imaging sensitivity to tissue heterogeneities) suggest that changes to the spectral imaging 
method, rather than to the fiber probe, should be investigated to minimize the lineshape disparity 
between probe-based and imaging spectra. Since the lineshape disparity is characterized by 
increased collection of diffuse photons by the imaging system, it can be minimized by limiting 
the viable source-detector separation distances in the spectral imaging geometry. Three such 
methods include probe-based spectral imaging, polarization spectral imaging, and a flying-spot 
scanner. 
 Geometrically speaking, the most straight-forward solution is a fiber-optic probe 
designed for spectral imaging. The probe would contain a spatial grid of illumination-collection 
bundles that serve as image pixels with a fiber configuration for each bundle which mirrors the 
fiber configuration from probe-based spectroscopy. Such a solution would be an adaptation of 
the fiber bundle image compression (FBIC) technique developed by McClain et al [47] in which 
the sample image from a microscope is focused onto one end of a fiber bundle, while the 
opposite ends of the fibers are aligned parallel to the entrance slit of a CCD-based spectrograph. 
Each row of the CCD array measures the entire spectrum for a single fiber within the bundle and 
unique spatial position within the image, yielding an entire spectral image within a single CCD 
frame. However, implementing the FBIC technique for in vivo spectral imaging introduces 
several complicating factors. Extending FBIC for fiber-based illumination and multi-fiber 
collection at each pixel requires large fiber bundles coupled to illumination sources and 
collection fibers precisely aligned at the spectrograph. While the spatial resolution of a FBIC 
microscope is limited by the fiber diameter and image magnification at the fiber bundle, the 
spatial resolution of a probe-based imaging system is limited to the width of the existing fiber 
configuration (660 µm). Since photons have been demonstrated to travel as far as 10-20 mm 
radially from tissue entry to exit, spectra from the pixel-bundles in the probe must be 
sequentially acquired to avoid crosstalk between pixels, a process which could prove to be very 
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time-consuming. Despite these limitations, such a spectral imaging design would ensure perfect 
replication of the illumination-collection geometry from probe-based spectroscopy. 
 An alternative imaging solution is co-polarization of the illumination and collected light 
during spectral image acquisition. It has become common knowledge that polarized photons 
progressively lose polarization state as they travel through and scatter inside tissue. Several 
research groups have exploited this behavior to selectively collect photons from various layers 
(i.e. depths) of epithelial tissues by varying the degree of co-polarization between the 
illumination light and collection optics [48-51]. Since the disparity between probe-based and 
imaging spectra results from imaging collection of more diffuse photons, co-polarizing the 
illumination and collection legs of the system would decrease diffuse photon collection and 
reduce the disparity. It should be noted that since the disparity is optical property dependent, the 
degree of co-polarization would depend on a priori, spatially resolved optical property 
information, which cannot be acquired in vivo with current methods. Further, polarizing the 
illumination and collected light reduces the measured signal intensities, though this is mitigated 
in tunable-filter spectral imaging systems which inherently polarize collected light. 
 Perhaps the most promising imaging solution is the flying-spot scanner [52], in which 
spectral information is acquired a pixel at a time while the pixel of interest is raster scanned 
across the tissue surface. Pixel-by-pixel spectral acquisition prevents crosstalk between pixels 
due to photon diffusion, and careful design of the excitation and collection optics would allow 
close replication of a probe-based illumination-collection geometry depending on the complexity 
of the fiber configuration. The main drawback to a flying-spot scanner is its relatively slow 
frame rate due to the high number of data acquisitions and the need for precise transitions 
between pixels. Further, while most flying-spot scanners are designed with common illumination 
and collection optics to produce perfect overlap while simplifying the optical design, probe 
geometries with non-overlapping illumination-collection areas would require independent 
excitation and collection optical trains, leading to increased complexity for the spectral imaging 
system.  
 The results outlined in this paper provide a guide for intelligent probe design when a 
transition to non-contact spectral imaging is the ultimate goal. However, for research groups 
such as ours, probe-based spectral data has already been acquired from a significant number of 
patients using a fiber-optic probe which is suboptimal in terms of mimicking an imaging 
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geometry. Therefore, an essential step in the transition from probe-based spectroscopy to spectral 
imaging will be to determine whether probe-based and/or imaging spectra can be corrected a 
posteriori for illumination-collection geometry effects to reconcile their lineshapes. While it is 
beyond the scope of this paper, our group plans to undertake such an investigation in the near 
future. It should be noted that the clinical applicability for any such correction method will hinge 
on its independence from a priori sample optical property information, which is impossible to 
acquire for previously measured probe-based spectra and which cannot be determined as a 
function of spatial position during in vivo spectral imaging.  
 In the absence of spectral correction for illumination-collection geometry, the effect of 
lineshape disparity on the inputs to tissue discrimination algorithms and subsequent 
discrimination accuracy must then be investigated. The results outlined here intimate that non-
contact spectral imaging systems collect diffuse photons which have longer path lengths and 
subsequently greater interaction with the tissue of interest before exit, suggesting that the spectral 
differences observed between normal and diseased tissues in probe-based spectroscopy would be 
intensified in spectral imaging. While this would presumably increase discrimination accuracy, 
precedent in the literature indicates that non-layered tissues such as brain and breast render 
photon diffusion level insignificant [20] in terms of discrimination accuracy. However, for 
applications which involve multi-layered tissues when deep-layer tissue information has been 
deemed important to disease diagnosis, collection of diffuse photons, which have been shown to 
probe greater tissue depths [23, 27, 53], should render spectral imaging more diagnostically 
accurate. The effect of lineshape disparity on discrimination accuracy is another issue our 
research group plans to address as we move forward with the transition from fiber-optic probe-
based spectroscopy to clinical spectral imaging for brain tumor resection guidance. 
 
Conclusion 
The transition from fiber-optic probe-based spectroscopy to non-contact spectral imaging 
often involves an inherent shift in illumination-collection geometry. This paper has demonstrated 
that this shift in geometry creates a lineshape disparity between the two systems in fluorescence 
and diffuse reflectance spectra. The behavior of the lineshape disparity with changes in optical 
properties and the fiber-optic probe configuration can be explained in terms of the light diffusion 
within the tissue relative to the distribution of source-detector separation distances for the two 
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measurement system geometries. Imaging spectra consistently show greater absorption effects 
than probe-based spectra due to collection of diffuse photons at large source-detector separation 
distances. Both increased scattering and absorption decrease the diffusion scale of collected 
photons, increase the diffusion level of probe-based photons, and subsequently decrease the 
lineshape disparity between imaging and probe-based spectra; however, the high ratio of 
scattering to absorption magnitude in most soft tissues render the lineshape disparity more 
sensitive to changes in scattering than absorption. Beam-steered fibers, decreasing the fiber 
diameter, and using the illumination fiber for collection increases the lineshape disparity by 
biasing probe-based photon collection towards less diffuse photons. The ideal fiber-optic probe 
configuration uniformly samples all source-detector separation distances; however, photons 
collected by the imaging system travel radial distances up to 20 mm, requiring collection fibers 
to extend beyond limits which may be considered practical. Given further limitations involved 
with adapting the spectral imaging geometry to minimize the lineshape disparity, future research 
will investigate methods to correct lineshape for system-specific illumination-collection 
geometry and the effects of lineshape disparity on tissue discrimination accuracy. 
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CHAPTER VII 
 
INTRA-OPERATIVE BRAIN TUMOR DEMARCATION WITH LIQUID-CRYSTAL TUNABLE 
FILTER SPECTRAL IMAGING 
 
Abstract 
 Brain tumor resection is currently hindered by significant limitations in the intra-
operative localization of tumor margins, which when coupled with conservative resection to 
minimize neurologic deficit often results in incomplete tumor resection and ultimately tumor 
recurrence. Autofluorescence and diffuse reflectance spectroscopy have been repeatedly proven 
capable of discriminating between normal and tumor margin tissues in the brain and other organs 
but are limited in their ability to guide tumor resection with a series of single-point 
measurements. This paper describes a preliminary clinical study to assess the feasibility of using 
autofluorescence and diffuse reflectance spectral imaging for intra-operative brain tumor 
discrimination and image guidance. Fourteen spectral image sets and thirty-one probe-based 
spectroscopy measurements were acquired from nine patients undergoing craniotomy for tumor 
resection or temporal lobectomy. Spectral image acquisition was performed in a clinically viable 
two-minute timeframe and produced excellent spatial resolution for visualization of fine tissue 
structures adequate for surgical guidance. Diagnostic algorithms were independently developed 
for homologous spectral imaging and probe-based spectroscopy data using a non-linear multi-
variate framework, and posterior classification probabilities demonstrated perfect optical 
diagnosis of twenty-eight normal cortex and glioma tissue sites, indicating discrimination 
accuracy for spectral imaging on par with traditional probe-based spectroscopy. Diagnostic 
image maps pseudo-colored from classification probabilities for each pixel within the spectral 
images showed excellent sensitivity and specificity when compared with gross neurosurgical 
diagnosis of the various tissue regions in the image. While the current-generation spectral 
imaging system is limited in its geometry and freedom of movement, hindering image 
acquisition from deep-seated white matter and margin tissues along the walls of the resection 
cavity, future clinical work will focus on the evaluation of discrimination accuracy at the tumor 
margins where current tumor localization techniques fail. 
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Introduction 
 The American Cancer Society estimates that 18,820 new cases of and 12,820 deaths from 
brain tumors were reported in the United States in 2006 [1]. Gliomas comprise 40% of primary 
brain tumors and 78% of malignant tumors, with a five-year survival rate of only 33% and a 12-
18 month average survival time and 5.1% three-year survival rate for infiltrating glioblastomas 
[2]. The current three-prong attack for brain tumor treatment is surgical resection of maximum 
tumor volume followed by radiation and chemotherapy, despite limited efficacy for these adjunct 
therapies. The blood-brain barrier often prevents cancer-targeting drugs from reaching the tumor, 
rendering chemotherapy ineffective; and while surgery and radiation therapy can effectively treat 
the tumor core, the fingerlike protrusions at the margins of infiltrating tumors make treating the 
entire tumor near impossible. The extent of surgical resection at these tumor margins for both 
low-grade and high-grade gliomas has been repeatedly correlated to patient quality of life and 
mortality [3-7]; however, complete tumor resection is achieved in less than 20% of patients 
diagnosed with infiltrating gliomas due to limitation in the surgeon’s ability to discriminate 
between normal tissue and tumor margins during surgery. To this end, tools and techniques are 
constantly being developed to help locate the tumor and identify its margins during a resection 
procedure, to maximize tumor mass resection without sacrificing neurologic function. 
 Current methods for intra-operative tumor localization are limited in their ability to 
differentiate normal brain from tumor margins. Visual inspection can be highly subjective and 
inconclusive, especially when dealing with low-grade tumors or diffuse tumor margins which 
often resemble normal neural tissue. On-site pathology is more histologically reliable but is 
expensive, is far from real-time, and does not spatially demarcate margin extent. Three-
dimensional surgical navigation with x-ray computed tomography (CT) or magnetic resonance 
imaging (MRI) is extremely useful in tumor localization and debulking [8, 9] but limited in its 
margin sensitivity, as tumor cells have been found outside of delineated image margins in many 
documented cases [10]. Furthermore, deformation of brain tissue subsequent to craniotomy, 
retraction, and debulking by as much as a centimeter degrades the accuracy of surgical 
navigation based upon pre-operative images [11, 12]. Real-time intra-operative ultrasound is not 
subject to complications from brain deformation and is capable of detecting tumor margins 
because brain tumors are often hyperechoic relative to normal tissue. But ultrasound imaging is 
frequently unable to differentiate tumor from peritumoral edema, which is also hyperechoic [13, 
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14], and poor image resolution hinders correlation between image features and surgical position. 
Due to the inherent limitations of these adopted tumor visualization techniques, significant 
residual tumor cells frequently remain after resection [3, 5], emphasizing the need to develop an 
objective, on-site, real-time imaging system that is capable of detecting the margins of brain 
tumors with high sensitivity.  
 The first effort to guide glioma resection in the brain with optical techniques employed 
exogenous fluorescence subsequent to systemic administration of 5-aminoluvolinic acid (5-
ALA) [15, 16], one of the precursors to hematoporphyrins along the heme biosynthesis pathway. 
Photosensitizers such as 5-ALA when administered systemically or topically have been shown to 
selectively collect in tumor tissues. While 5-ALA itself is not fluorescent, its porphyrin 
derivatives exhibit strong red fluorescence in response to blue excitation light, making them 
useful for photodynamic therapy and potentially as a means to demarcate tumor borders. As 
mentioned previously, the clinical utility of any technique for glioma resection guidance depends 
on its ability to highlight infiltrating tumor margins from the surrounding normal brain tissue. To 
assess this capability in vivo, Stummer et al administered 5-ALA to patients before tumor 
resection surgery and acquired tissue biopsies from fluorescent and non-fluorescent regions 
along the tumor margins. The presence of fluorescence was correlated to histopathological 
diagnosis, and the presence of residual porphyrin fluorescence after surgery was correlated to 
residual gadolinium contrast enhancement in post-operative MRI as a measure of the extent of 
tumor resection. Over the course of two separate studies which involved 61 patients and 353 
biopsy samples, porphyrin fluorescence possessed a sensitivity of 85%, specificity of 98%, 
positive predictive value (PPV) of 100% and negative predictive value (NPV) of 60% for the 
presence of tumor cells in the biopsy samples. High diagnostic sensitivity and specificity indicate 
sensitive detection without false prediction of the presence of tumor, leading to a high PPV 
which signifies excellent safety to avoid neurologic deficit. However, the low NPV indicates that 
biopsy samples without fluorescence often contained tumor tissue, suggesting limited efficacy 
for positive tumor margin demarcation. While the results demonstrate good correlation between 
residual fluorescence and residual MR contrast enhancement, the correlation simply follows 
from the fact that margin demarcation with porphyrin fluorescence is limited in much the same 
manner as with contrast-enhanced MRI. Since gadolinium and 5-ALA are both polar molecules 
which cannot freely cross the blood-brain barrier [17], contrast enhancement in both modalities 
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is only present in regions where the blood-brain barrier has been breached, such that neither 
modality consistently enhances infiltrating tumor margins or low-grade gliomas.  
 While exogenous contrast methods are spatially correlated to the integrity of the blood-
brain barrier, autofluorescence and diffuse reflectance spectroscopy probe intrinsic tissue 
contrast, giving them the potential to overcome limitations of exogenous contrast by consistently 
demarcating infiltrating tumor margins based upon the inherent changes in tissue structure and 
biochemistry subsequent to tumor invasion. Over the past 20 years, the investigation of optical 
spectroscopy to differentiate between normal and diseased tissues has grown tremendously and 
been applied for disease detection in a host of bodily tissues [18-20]. Intrinsic fluorescence or 
autofluorescence spectra have been shown to differ between normal and neoplastic tissues in 
various organ systems, differences which have been attributed to changes in fluorophore 
concentration or environment with the progression of disease [21]. While fluorescence 
spectroscopy provides information about the chemical and morphological composition of tissue, 
diffuse reflectance spectroscopy yields information about tissue absorption and scattering [22]. 
During the progression from normal to neoplastic, tissue undergoes many structural as well as 
chemical changes at the cellular and subcellular level, altering the optical properties of the tissue 
and thereby enabling tissue discrimination with diffuse reflectance spectroscopy. Thus by 
combining fluorescence with diffuse reflectance spectroscopy, optical techniques have the 
potential to be used for brain tumor margin detection. 
 Optical spectroscopy based on intrinsic tissue changes was first applied for tissue 
discrimination in the brain by Chung et al in vitro [23] and Bottiroli et al in vivo [24]. Using 
fluorescence excitation near 330 nm, both groups observed significant reductions in NADH 
autofluorescence near 460 nm and Bottiroli et al observed a significant red-shift in the peak 
fluorescence wavelength in tumor relative to normal brain tissues. However, given the limited 
number of patients investigated in these studies, true validation of optical spectroscopy as tissue 
discrimination tool in the brain remained unaccomplished, especially where it was most 
important, at the tumor margins. 
 In an effort to determine the clinical utility of optical spectroscopy for tumor resection 
guidance, our research group is in the middle of a multi-center clinical study to determine the 
diagnostic accuracy of combined fluorescence and diffuse reflectance spectroscopy for 
discriminating between normal and tumor margin tissues in vivo [25-27]. During craniotomy 
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procedures for glioma resection or temporal lobectomy, multiple gray matter, white matter, 
tumor core, and tumor margin sites are selected for spectral measurement with a portable 
spectroscopic system [26]. Excitation light from a pulsed nitrogen laser (fluorescence) and 
halogen lamp (diffuse reflectance) are sequentially delivered to a point on the tissue surface by 
two of seven fibers within a handheld, beam-steered, fiber-optic probe. The remaining five fibers 
in the probe are used to collect remitted fluorescence and diffuse reflectance from the tissue 
surface and deliver it to a spectrograph for spectral measurement. Spectra are grouped as normal, 
tumor core, or tumor margin according to gold-standard histopathological diagnosis of tissue 
biopsies acquired at the interrogation site and analyzed to determine spectral differences between 
tissue groups. Despite only subtle spectroscopic differences between normal and tumor tissues, 
initial reports using multivariate analysis of fluorescence and diffuse reflectance spectra 
measured from 184 tissue sites in 35 of more than 125 patients measured to date demonstrate a 
diagnostic accuracy of 100%, 96%, and 94% for normal, tumor core, and tumor margin tissue 
samples, with only 2 out of 35 tumor margin sites misclassified as normal [25]. These results 
indicate not only the promising capability of combined autofluorescence and diffuse reflectance 
spectroscopy to provide contrast between normal and tumor tissues in the brain, but also its 
ability to overcome the limitations of current tumor margin localization techniques by accurately 
differentiating infiltrating tumor margins from surrounding normal brain tissue and potentially 
affecting more complete glioma resection. 
 While fiber-optic probe-based spectroscopy as previously described is useful for 
correlating spectral features to histopathological diagnosis at a specific interrogation site, it is 
limited in clinical applicability since it produces a single-point measurement on the tissue surface 
without providing the spatial extent of tumor margins, information which is necessary to 
efficiently guide tumor resection. For optical biopsy to be clinically useful, single-point 
spectroscopy systems must be extended to spectral imaging in which spectral information is 
acquired at every pixel within a two-dimensional field of view, yielding spatial and spectral 
tissue information for a comprehensive snapshot of tissue pathology during surgery. To extend 
upon the optical spectroscopy results, our research group has developed a clinical, liquid-crystal 
tunable filter spectral imaging system capable of fluorescence and diffuse reflectance imaging 
and coupled to an operating microscope for intra-operative in vivo imaging. As part of a separate 
paper [28], the imaging parameters of the system were quantitatively characterized in terms of 
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linearity, field of view, spatial and spectral resolution, and system sensitivity as a function of 
wavelength. Functional imaging tests also demonstrated the capability of the system to 
differentiate between white and gray matter brain tissue and between brain tissue phantoms with 
disparate levels of exogenous fluorescence. Fluorescence and diffuse reflectance images 
acquired in vivo of a cortical surface glioma revealed excellent visualization of the cortical 
surface vasculature, but also confirmed the subtle spectral differences in measured lineshape 
between normal and neoplastic brain tissues originally observed with probe-based spectroscopy. 
Further, comparisons of fluorescence and diffuse reflectance lineshapes between probe-based 
spectroscopy and spectral imaging have shown significant disparities in fluorescence and diffuse 
reflectance lineshape due to inherent differences in excitation-collection geometry, behavior 
which was thoroughly characterized in a separate paper [29]. These results strongly indicate the 
need for an independent evaluation specific to spectral imaging of its diagnostic accuracy for 
normal and tumor tissues in the brain. 
 This paper describes the results of such a multi-patient clinical study to assess the 
capability of fluorescence and diffuse reflectance spectral imaging to discriminate between 
normal and neoplastic brain tissues in vivo during tumor resection surgery. Due to geometry 
constraints for the first-generation spectral imaging system, this preliminary in vivo study was 
limited to image acquisition from tissue areas near the cortical surface of the brain, preventing 
investigation of deep-seated white matter and tumor margins along the resection cavities. As 
such, discrimination algorithms were developed to differentiate between normal cortex and 
tissues from the tumor core, leaving evaluation of tumor margin demarcation with spectral 
imaging for a future publication. Independent analysis for probe-based spectroscopy and spectral 
imaging was performed for homologous fluorescence and diffuse reflectance measurements at 
twenty-eight tissue sites in nine patients. Diagnostic algorithms and their subsequent accuracy 
are compared between probe-based spectroscopy and spectral imaging to determine the effects of 
the inherent lineshape disparity characterized in [29]. Ultimately, diagnostic image maps are 
created and analyzed by applying imaging-specific algorithms to the entirety of imaging data on 
a pixel-by-pixel basis for a pilot evaluation of the utility of spectral imaging for tumor resection 
guidance in vivo. 
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Materials and Methods 
 Homologous spectral imaging and probe-based spectroscopy measurements were 
acquired from human brain tissue in nine patients undergoing open craniotomy for tumor 
resection or temporal lobectomy. Spectral imaging was performed with a liquid-crystal tunable 
filter spectral imaging system which has been described in detail elsewhere [28], so will only be 
briefly described here. The collection arm of the system was connected to the head of a M690 
Wild-Heerbrugg operating microscope (Figure 1a) and consisted of three main components: a 
liquid-crystal tunable filter (Varispec VIS-20, CRI, Inc.), a variable focal-length camera lens 
(f/3.5, Nikon), and a cooled CCD camera (PhotonMax, Princeton Instruments) [28]. Light from a 
500 W xenon arc lamp, bandpass filtered at 340 nm, was used for fluorescence excitation, while 
light from a 200 W halogen lamp (Luxtec) was used for diffuse reflectance (Figure 1b). A 365 
nm dichroic filter coupled both excitation sources into a single, 10-mm-core liquid light guide 
which delivered the excitation light to the sample. Electronic shutters allowed automated 
switching between the excitation sources and quartz lenses at the distal end of the light guide 
focused the excitation light to a spot roughly 2” in diameter. The system was manually 
positioned for image acquisition with the tissue surface roughly seven inches from the distal face 
of the LCTF, creating a 1” x 1” field of view.  
 The portable, probe-based spectroscopy system (Figure 1c) has been repeatedly used for 
the clinical brain tumor diagnosis study outlined in the introduction and has been described 
numerous times in the literature [26], so again, only the relevant details will be repeated here. A 
fiber-optic probe with seven beam-steered fibers (d = 300 µm, NA = 0.22) in a six-around-one 
configuration (Figure 1d) delivered light from a pulsed nitrogen laser (VSL-337, Spectra-
Physics) for fluorescence excitation (337 nm, 120 µJ per pulse, 20 Hz repetition rate) and from a 
white-light halogen lamp (6.5 W, LS-1, Ocean Optics) for diffuse reflectance illumination. 
Illumination light was delivered by two opposing fibers at the six o’clock and twelve o’clock 
positions along the outer ring, while the remaining five fibers delivered remitted light, collected 
from the sample surface, to a spectrometer (S2000-FL, Ocean Optics) for spectral measurement. 
Electronic shutters allowed automated switching between the excitation sources and the probe 
configuration produced a tissue interrogation area roughly 1 mm in diameter. 
 A standard measurement protocol was designed for the homologous spectral imaging and 
probe-based spectral measurements, approved by the Vanderbilt University Institutional Review 
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Board, and maintained for all nine patients in the study. The measurements were conducted intra-
operatively by the attending neurosurgeon. The spectral imaging system was covered in a sterile 
drape and the fiber-optic probe was sterilized using a low-temperature plasma method (Sterrad) 
prior to each study patient. Due to the angled geometry of the spectral imaging system, 
simultaneous illumination and collection could not be achieved from deep-seated white matter 
and tumor margin areas along the walls of the resection cavity. As such, fluorescence and diffuse 
reflectance spectral image sets were limited to the cortical surface and the tumor core for 
surface-based gliomas and were acquired at various time-points throughout the surgical 
procedure. 
 Fourteen image sets were acquired across nine patients, with each image set comprised of 
fluorescence, fluorescence baseline, diffuse reflectance, and diffuse reflectance baseline images. 
The spectral range for the images extended from 400 to 720 nm, with a 10-nm increment for 
diffuse reflectance and its baseline images and an increment which varied between 10 nm around 
the fluorescence peak to 40 nm in the red region of the spectrum for fluorescence and its baseline 
images. In an effort to obtain uniform signal-to-noise ratio at all wavelengths, integration times 
     
(a)      (b) 
    
(c)      (d) 
Figure 1. System schematics for the combined fluorescence and diffuse reflectance spectral imaging and fiber-optic 
probe-based spectroscopy systems used during the clinical study. (a) collection arm of spectral imaging system 
attached to head of standard operating microscope; (b) excitation optics for spectral imaging system; (c) optical 
spectroscopy system; (d) distal tip of fiber-optic probe for spectroscopy measurement. 
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varied with wavelength according to system sensitivity measured in [28], with total image 
integration times of 15 and 45 seconds for diffuse reflectance and fluorescence, respectively. To 
increase measured signals of tissue autofluorescence, 4 x 4 pixel binning was employed for 
fluorescence and fluorescence baseline imaging. Measured spectra were baseline subtracted and 
corrected for system sensitivity and integration time as a function of wavelength on a pixel-by-
pixel basis. Corrected spectra from 20 x 20 pixel (1 x 1 mm) regions centered about locations 
interrogated by probe-based spectroscopy were extracted and averaged to create imaging 
fluorescence and diffuse reflectance spectra homologous to the probe-based spectroscopy 
measurements described below. 
 For each image set, one to four sites within the imaging field of view were subsequently 
selected for probe-based spectral measurement and their locations within the images were 
recorded. In total, thirty-one image sites were selected across fourteen images for interrogation 
with probe-based spectroscopy. For each site, three spectra (baseline, fluorescence, diffuse 
reflectance) were recorded with the fiber-optic probe placed in gentle contact with the tissue 
surface. A 200-ms integration time was consistently used for all three spectra and all 
interrogation sites. For grossly abnormal tissues, a tissue biopsy was acquired at each 
interrogated site, fixed in formalin, and sent to neuropathology for histopathological diagnosis. 
For grossly normal tissues, opinion of the attending neurosurgeon as to tissue type was recorded. 
Before spectral analysis, all spectra were baseline subtracted, corrected for system sensitivity as 
measured by a standard calibration procedure described in [26], smoothed with a moving-
average filter, and sub-sampled every 5 nm between 400 and 850 nm. 
 Spectral analyses were independently performed on homologous imaging and fiber-
optic-probe spectra from the thirty-one tissue sites to characterize significant spectral differences 
between tissue groups using a multi-step method which has been described in detail elsewhere 
[25]. Briefly, diagnostic features were extracted from the spectra (normalized according to the 
process described in [25]) using the recently formulated theory of nonlinear Maximum 
Representation and Discrimination Feature (MRDF) to perform dimensionality reduction while 
simultaneously maximizing spectral separation between diagnostic groups. Subsequent 
classification of the extracted nonlinear features into respective tissue categories was based on 
the theory of Sparse Multinomial Logistic Regression (SMLR), a Bayesian machine-learning 
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framework of statistical pattern recognition which produces posterior probabilities that a given 
spectral dataset falls into each histology group. 
 The scaffold for diagnostic evaluation was performed in a leave-one-out cross-validation 
scheme to prospectively test its accuracy in an unbiased manner. All spectra from a given patient 
were excluded during algorithm training and then used for algorithm validation to prevent intra-
patient spectra from appearing in both the training and validation datasets. The process was 
repeated for the spectral datasets for each of the nine patients to determine imaging and 
spectroscopy optical diagnoses for all tissue samples in the measured population. Sensitivity, 
specificity, PPV, and NPV metrics were determined for probe-based spectroscopy and spectral 
imaging by comparing optical to gold-standard histopathological or gross neurosurgical 
diagnoses. Finally, all spectral datasets were used to retrain the diagnostic algorithm and 
determine representative algorithms for the spectroscopy and spectral imaging systems. 
 The discrimination algorithm trained upon spectral imaging data was applied individually 
to each pixel within the spectral images acquired from all nine patients to create diagnostic 
image maps. The diagnostic maps were analyzed in terms of “diagnostic noise” in the images 
(i.e. the presence of isolated pixels for a given histology classification), the classification of 
structures (e.g. blood vessels, specular reflectance) falling outside the normal and tumor 
histology groups, the effect of superficial blood contamination, and most importantly, the 
posterior classification probabilities of pixels along boundaries between tissue regions of 
differing histology. 
 
Results 
Histopathological diagnosis of abnormal tissues and neurosurgical diagnosis of grossly 
normal tissues classified the 31 tissue sites interrogated by spectral imaging and fiber-optic-
probe spectroscopy as normal brain cortex (n = 16), primary tumor tissue (n = 12), normal white 
matter (n = 1), a mix of cortex and tumor (n = 1), and a non-diagnostic tissue sample (n = 1) 
which was grossly diagnosed by the surgeon as tumor at the time of measurement. Given the 
paucity of white matter and margin tissue samples within the interrogated population, the latter 
three samples were excluded from the discrimination analysis and diagnostic algorithms were 
subsequently optimized to differentiate between normal brain cortex and primary tumor tissues. 
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Mean fluorescence and diffuse reflectance spectra for normal cortex and primary tumor 
tissues (Figure 2) reveal subtle differences between the tissue groups, especially in the case of 
fiber-optic-probe spectroscopy. Both tissue groups exhibit characteristic hemoglobin absorption 
within diffuse reflectance spectra and peak fluorescence emission near 460 nm, indicative of 
NAD(H) fluorescence. Consistent with results from a previous comparison of fiber-optic-probe 
and imaging spectra [29], imaging fluorescence is slightly red-shifted relative to fiber-optic-
probe spectroscopy and the contrast between the red and blue regions is consistently larger in 
imaging diffuse reflectance spectra. These spectral differences are indicative of longer photon 
path lengths in the tissue for spectral imaging due to a broader distribution of source-detector 
separation distances in the imaging illumination-collection geometry. 
The results from leave-one-out cross-validation demonstrate perfect classification (100% 
sensitivity, specificity, PPV, NPV) of the 28 tissue samples for both spectral imaging and fiber-
optic-probe spectroscopy (Figure 3). The need to run independent spectral analyses for probe-
based spectroscopy and spectral imaging is underscored by the discrimination results when 
probe-based the diagnostic algorithm trained upon probe-based spectroscopy data was 
subsequently applied to spectral imaging data for validation (Figure 3c). The decreased 
sensitivity (75%), specificity (81%), PPV (75%), and NPV (81%) values presumably stem from 
the inherent disparity in lineshape described above between spectral imaging and probe-based 
spectroscopy. 
  
(a)      (b) 
Figure 2. Normalized (a) diffuse reflectance and (b) fluorescence spectra averaged across 16 cortex and 12 tumor 
interrogation sites measured with spectral imaging and fiber-optic-probe spectroscopy. 
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Disparities between spectral imaging and fiber-optic-probe spectroscopy are further 
highlighted when diagnostic algorithms trained upon the spectroscopy and imaging datasets are 
applied to diagnose the three samples (white matter, mix of cortex and tumor, non-diagnostic) 
excluded from the analysis (Table 1). Spectral imaging classifies the white matter sample as 
definitively normal, the tumor/cortex mix as slightly tumor, and the non-diagnostic sample as 
non-diagnostic. Probe-based spectroscopy classifies the white matter and cortex/tumor mix 
samples as definitively tumor and the non-diagnostic sample as definitively normal. 
  
(a) (b) 
 
(c) 
Figure 3. Posterior probabilities for tumor diagnosis using the MRDF-SLMR technique for diagnostic algorithm 
development. Individual probabilities are shown for the 16 cortex (blue) and 12 tumor (red) interrogation sites using 
(a) leave-one-out cross-validation with spectral imaging data, (b) leave-one-out cross-validation with fiber-optic-
probe spectroscopy data, and (c) algorithm training with fiber-optic-probe spectroscopy data and algorithm 
validation with spectral imaging data. 
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Example diffuse reflectance and fluorescence spectral images from a brain tumor patient 
demonstrate the spatial resolution achieved during spectral brain imaging (Figure 4). The images 
were acquired from a region of completely normal cortex and show excellent visualization of the 
pial microcirculation along the cortical surface as well as the underlying major blood vessels. 
Applying the diagnostic algorithm trained upon imaging data produces a diagnostic image map 
(Figure 4c) with good specificity. Misclassifications are limited to tissue areas containing major 
blood vessels, which are not expressly handled by the classification algorithm. 
Figure 5 shows a second example of diffuse reflectance, fluorescence, and diagnostic 
images from a tissue region of mixed normal cortex and tumor tissue. As in Figure 4, tissue 
regions containing major blood vessels as well as image regions with specular reflectance are 
consistently classified as tumor tissue. Outside of these regions, the diagnostic map shows 
excellent sensitivity and specificity with good spatial correlation in the classifications (i.e. 
minimal “diagnostic” noise). The diagnostic algorithm consistently classifies the tumor tissue to 
Table 1. Posterior probabilities for three samples excluded from discrimination analysis using discrimination 
algorithms developed from spectral imaging and fiber-optic-probe spectroscopy data. Posterior probabilities above 
0.5 indicate a diagnosis of tumor while probabilities below 0.5 indicate normal cortex. 
 
 Spectral Imaging Spectroscopy 
white matter 0.0183 0.9713 
cortex + tumor 0.5654 1.000 
non-diagnostic, grossly tumor 0.5096 0.0157 
 
     
(a)    (b)    (c) 
Figure 4. (a) Diffuse reflectance, (b) fluorescence, and (c) discrimination images acquired from the normal cortical 
surface of a brain tumor patient. Color information in (a,b) is derived from a direct integration of measured 
intensities in the spectral imaging data. Pseudo-color in the discrimination image is derived from posterior 
probabilities on a pixel-by-pixel basis with green indicating normal cortex (p = 0.0), yellow indicating a non-
diagnostic transition zone (p = 0.5), and red indicating tumor (p = 1.0). 
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the left of the major blood vessel as tumor, with only small regions of normal. The classification 
algorithm performs even better when applied to the normal cortex to the right of the blood 
vessel, with only minor pockets of tumor classification evident within the image. It is important 
to note that the tissue classifications in the diagnostic maps are being compared to the gross 
tissue diagnosis of the attending neurosurgeon for the various tissue regions in the images, which 
should not be confused with gold-standard histopathological diagnosis of the tissue biopsies. 
 
Discussion 
 Surgical resection of brain tumors and their infiltrating margins is currently limited by 
the surgeon’s ability to differentiate between normal and tumor tissue during surgery. Visual 
similarities between the tissues make such differentiation difficult with direct observation, and 
pre-operative imaging modalities such as CT and MRI provide poor intra-operative guidance due 
to problems with tissue deformation during surgery. Current intra-operative tumor localization 
methods such as ultrasound and contrast-enhanced, intra-operative MRI are limited in their 
specificity or produce tissue contrast from a breach in the blood-brain barrier, which is often 
intact in margin tissue. Given the relatively low success (20%) for complete resection of a brain 
tumor and its associated margins, there exists a distinct need for a real-time, objective imaging 
tool capable of discriminating between normal and tumor tissue to guide tumor resection 
surgery. 
     
(a)    (b)    (c) 
Figure 5. (a) Diffuse reflectance, (b) fluorescence, and (c) discrimination images acquired from an infiltrating 
glioma in a brain tumor patient. The tissue to the left of the major blood vessel bisecting the image was grossly 
classified as tumor by the neurosurgeon. The tissue to the right of the vessel was classified as normal. Color 
information in the images is derived identically to Figure 4. 
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 Preliminary results with optical biopsy methods such as fluorescence and diffuse 
reflectance have shown promise for brain tumor discrimination from normal white and gray 
matter; however, the majority of such methods have employed fiber-optic probes for light 
delivery and collection, limiting the diagnostic throughput to a series of single-point tissue 
measurements. True clinical utility for tumor resection guidance requires spatial resolution of the 
diagnostic spectral information in the form of spectral imaging. This paper reports preliminary 
clinical experience with a dual-mode fluorescence and diffuse reflectance spectral imaging 
system to differentiate between normal cortex and infiltrating glioma tissues in nine human 
patients. The results demonstrate excellent sensitivity and specificity on par with fiber-optic 
probe spectroscopy for this dataset of twenty-eight tissue samples. The spectral images possess 
high spatial resolution capable of visualizing fine structures down to the brain microvasculature, 
vastly superior to intra-operative ultrasound, and more than adequate for guidance of surgery 
with resection tools such as bipolar electro-cautery devices short of direct laser tissue ablation. 
The spectral images intra-operatively interrogate the tissue within a clinically viable two-minute 
image acquisition time which stands to be improved as light sources become more powerful, 
detectors more sensitive, and the diagnostic algorithm more defined to minimize the number of 
spectral bands which must be interrogated for accurate tissue classification. 
 Visual similarities between normal and tumor tissues in the brain derive from subtle 
differences in absorption and scattering across the visible spectrum, in turn producing only subtle 
differences in diffuse reflectance and fluorescence spectra. As such, accurate spectral 
discrimination between these tissues requires a sophisticated feature extraction and classification 
technique. While optical biopsy methods have traditionally employed linear frameworks such as 
principal component analysis for feature extraction and linear discriminant analysis for feature-
set classification, this paper uses a non-linear Maximum Representation and Discrimination 
Feature extraction technique which is more robust in its ability to draw discrimination 
boundaries between spectral clusters from different tissue classifications in multi-dimensional 
spectral space. Further, the Sparse Multinomial Logistic Regression method for spectral 
diagnosis provides posterior probabilities for each tissue classification, which can be exploited to 
create diagnostic maps with pseudo-color which conveys not only the classification at each 
spatial position, but also the confidence in the classification, rather than the simple binary 
(normal vs. tumor) or trinary (normal vs. tumor vs. margin) outputs of traditional thresholding 
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methods. Moreover, probabilistic feedback can be extremely useful in clinical situations to 
judiciously compensate for asymmetric misclassification costs and variable class proportions, 
and to explore fusion of diagnostic outputs with other probabilistic sources of information before 
applying decision criteria. 
 Given that tissue classification in this preliminary study was limited to normal cortex 
versus tumor tissue, further research work is required to take full advantage of the capability of 
MRDF-SLMR to perform simultaneous multi-class tissue classification. The geometry and 
limited freedom of movement for the current generation spectral imaging system restricted image 
acquisition from superficial tissue regions, preventing interrogation of deep-seated white matter 
and margin tissues along the walls of resection cavities. Our research group is currently 
evaluating alternative interfaces which would afford more versatility in terms of image 
acquisition from hard-to-reach tissue areas. In the construction process for the current imaging 
system, direct coupling to the camera port of a neurosurgical microscope was also investigated 
for direct correlation between the neurosurgical field and the imaging system field of view. 
However, light loss through the microscope collection optics reduced collection power for such 
an interface by up to 45-fold over a direct-view imaging system such as the one ultimately 
employed in this clinical study. A more attractive option remains to be coupling the collection 
optics of the imaging system to the distal end of a fused-silica fiber bundle within a flexible 
endoscope. The flexibility of the fiber bundle would permit access to deep-seated tissue regions 
while maintaining spatial resolution of the collected light, which would be collimated through 
the filter at the bundle’s distal end and subsequently focused onto the detector. 
 Future clinical studies on the efficacy of dual-mode spectral imaging for brain tumor 
resection guidance will incorporate image acquisition from white matter and more importantly, 
margin tissues where previous imaging efforts have failed to produce reliable and accurate 
contrast from normal brain tissue. Clinicians often use magnetic resonance imaging with 
gadolinium contrast to determine post-operatively whether any tumor regions survived resection. 
As described in the introduction, a research group from the University of Munich has undertaken 
a prospective clinical study to assess the efficacy of tumor resection guidance using 5-ALA 
fluorescence. Both imaging methods rely on the principle of selective collection of exogenous 
contrast agents within tumor tissue, a phenomenon which only occurs in regions of the brain 
where the blood-brain barrier has been breached, such as in the core of an aggressive tumor. 
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Image contrast correlating to the integrity of the blood-brain barrier affords excellent positive 
predictive values, which are important for surgical guidance in the brain to minimize removal of 
normal brain tissue and disruption of neurologic function. However, the blood-brain barrier is 
often intact at tumor margins and in low-grade gliomas, plaguing exogenous-contrast imaging 
methods with poor negative predictive values in these tissues and resulting in unresected margins 
which ultimately lead to tumor recurrence. Future clinical studies with a next-generation spectral 
imaging system will focus on tissue discrimination at the tumor margins, with the hope that 
probing intrinsic tissue contrast as opposed to collection of exogenous contrast agents will 
overcome limitations with contrast-enhanced MRI and photosensitizer fluorescence methods and 
affect more complete brain tumor margin resection. 
 Future research work is also planned by our research group to ultimately determine the 
biological basis for spectral differences observed between normal and tumor tissues. One 
disadvantage with many sophisticated multi-variate feature extraction techniques such as 
principal component analysis and MRDF is their “black-box” treatment of spectral classification, 
preventing true interpretation of results and correlation of classification outcome to meaningful 
morphologic, cellular, and sub-cellular tissue changes with the progression from normal to 
tumor. Through well-designed experiments, we hope to ultimately shed some light on the 
spectral changes observed during our clinical probe-based spectroscopy and spectral imaging 
studies. 
 
Conclusion 
 The clinical study presented in this paper represents a step toward the development of 
spectral imaging as a tool for intra-operative guidance of brain tumor margin resection. Dual-
mode fluorescence and diffuse reflectance imaging in a clinically viable timeframe was proven 
capable of producing high-resolution spatial images of brain tissue while discriminating between 
glioma and normal cortical tissues with accuracy on par with probe-based spectroscopy. The 
MRDF-SMLR framework for classification algorithm development produced perfect 
classification of twenty-eight tissue biopsy samples from nine patients. Posterior classification 
probabilities were calculated for each pixel within the fourteen image sets to produce diagnostic 
image maps with excellent sensitivity and specificity when compared with gross neurosurgical 
diagnosis. While additional clinical and research work is required to assess the capability of 
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tissue discrimination at the tumor margins and in deep-seated white matter regions and to 
determine the biological basis for spectral differences between normal and tumor tissues, the 
results from this preliminary clinical study indicate promise for optical biopsy to affect more 
complete brain tumor margin resection without sacrificing neurologic function, to ultimately 
improve patient morbidity and mortality from brain cancer. 
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CHAPTER VIII 
 
CONCLUSIONS AND FUTURE DIRECTIONS 
 
Summary 
 This dissertation presents the translation from fiber-optic probe-based spectroscopy to 
non-contact spectral imaging for the clinical application of optical biopsy to intra-operative brain 
tumor and margin demarcation for surgical resection guidance. Specifically, it presents the 
design, construction, and in vitro and in vivo testing of a dual-mode liquid-crystal tunable filter 
spectral imaging system capable of combined fluorescence and diffuse reflectance imaging for 
spectral discrimination between normal, tumor core, and tumor margin tissues during brain 
tumor resection surgery. Parallel to spectral imaging system development, a thorough 
investigation into the effects of the translation from spectroscopy to imaging on measured 
fluorescence and diffuse reflectance lineshapes is presented. The investigation was designed to 
ascertain whether diagnostic algorithms developed for tissue differentiation from probe-based 
spectra should be blindly applied to imaging data or algorithms must be optimized for imaging 
spectra to achieve accurate tissue diagnosis. The results of these investigations demonstrate that 
inherent shifts in excitation-collection geometry between probe-based spectroscopy and spectral 
imaging induce significant changes in measured lineshape. While the effects of these lineshape 
changes on discrimination accuracy are yet to be determined, imaging-specific discrimination 
algorithms are presented and shown to be capable of spectrally discriminating between gray 
matter and tumor core tissues with high sensitivity and specificity. In sum, combined 
fluorescence and diffuse reflectance spectral imaging can achieve intra-operative brain tumor 
and margin demarcation with high accuracy, excellent spatial resolution, and minimal disruption 
to the surgical environment and has the potential to overcome the limitations in current methods 
of brain tumor margin localization. The following sections summarize the important phases of 
this research. 
 
Measurement of Brain Tissue Optical Properties 
 A dearth of optical property coefficient data currently exists within the literature for 
human brain tissues. Previous brain tissue optical property studies are either limited in the 
177 
prediction of true soft tissue behavior (Kubelka-Munk) or in the number of tissue sample 
measurements (inverse Monte Carlo), opening the door for bias in the measurements. The goal of 
this study was to complement the handful of inverse Monte Carlo optical property spectra 
present in the literature and correlate measured optical property measurements to differences 
between normal and tumor tissues within diffuse reflectance spectra acquired in vivo with probe-
based spectroscopy. Reflectance and transmission spectra were measured from 400 to 1300 nm 
for eighty-seven white matter, gray matter, and glioma tissue samples using a single integrating-
sphere spectrophotometer. The measurements were subsequently converted to absorption and 
reduced scattering spectra using an inverse adding-doubling technique. The optical property 
spectra were grouped according to tissue histology and Student’s t-tests were used to determine 
wavelengths at which the optical properties were significantly different between tissue groups.  
 Mean absorption spectra were dominated by hemoglobin absorption bands in the visible 
and water absorption bands in the near-infrared with roughly equivalent levels between white 
matter, gray matter, and glioma tissues. Reduced scattering decreased with wavelength evident 
of Mie scattering with levels which were highest in white matter and lowest in gray matter. 
Ultimately, correlation of optical property measurements to diffuse reflectance spectra revealed 
that while the shape of diffuse reflectance spectra is predominantly dictated by hemoglobin 
absorption, the relative intensity between tissue groups is determined by reduced scattering, 
relationships which are investigated in greater detail in chapter 6. 
 In terms of the utility of these measurements in the two other phases of my research 
project, the mean optical property spectra were used to develop white matter, gray matter, and 
tumor tissue phantoms in chapter 4 for spectral imaging system testing in vitro. The 
concentrations of hemoglobin and polystyrene microspheres for absorption and reduced 
scattering, respectively, were empirically determined by comparing phantom optical property 
measurements to the mean measured optical property spectra from this study. To determine 
whether the translation from probe-based spectroscopy to spectral imaging affects measured 
lineshape, the mean optical property spectra from this study provided bounds on brain tissue 
absorption and reduced scattering coefficients, which were used to investigate the effects of 
optical property changes on observed behaviors via tissue phantoms and Monte Carlo simulation 
of fluorescence and diffuse reflectance. However, more importantly, the agreement observed 
between the diffuse reflectance spectra measured in vivo and the diffuse reflectance spectra 
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predicted by Monte Carlo simulation using optical property spectra measured in vitro provided 
the foundation for many of the aforementioned experiments because it demonstrated that 
spectroscopy and spectral imaging behavior within tissue phantoms or biopsy samples could be 
accurately predicted via Monte Carlo simulation using optical property measurements. 
 
Spectral Lineshape Effects of the Translation from Probe-Based Spectroscopy to Spectral 
Imaging 
 Extending fiber-optic probe-based spectroscopy to non-contact spectral imaging involves 
a drastic shift in excitation-collection geometry for spectral measurement. While probe-based 
spectroscopy exerts a consistent interface between the probe and tissue surface, non-contact 
spectral imaging involves incident excitation and emission collection angles which vary from 
pixel to pixel with surface topography. While probe-based spectroscopy measures spectra across 
sub-millimeter source-detector separation distances dictated by the fiber configuration within the 
probe, macroscopic spectral imaging measures across distances potentially as large as several 
centimeters. The goal of this phase of the research project was to ascertain whether these 
differences in measurement geometry induce changes in diffuse reflectance and fluorescence 
lineshape. The motivation behind such an investigation stems from the desire for spectral 
imaging to produce identical lineshapes as probe-based spectroscopy, because in such an ideal 
case, spectral discrimination algorithms developed from the 125+-patient spectral dataset 
acquired using probe-based spectroscopy could be blindly applied to clinical spectral imaging 
data for accurate tumor demarcation. 
 This phase of the research project was divided into two studies: one which investigated 
the effects of incident excitation and emission collection angles (chapter 5) and one which 
investigated the effects of the distribution of source-detector separation distances (chapter 6). 
The effects of these measurement parameters were determined as functions of optical properties 
within fluorescence and diffuse reflectance spectra.  
 Non-contact spectral imaging of brain tissue during surgery often involves a variable 
sample surface topography which creates spatial variations in incident excitation and emission 
collection angles across the pixels of the image. If angular emission profiles vary with sample 
optical properties and/or incident excitation angle, the unique excitation-collection geometry of 
the imaging system relative to the tissue surface has the potential to induce spectral distortions 
extrinsic to tissue optical properties. The goal of this study was to characterize angular emission 
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profiles of fluorescence and diffuse reflectance as functions of incident excitation angle and 
sample optical properties to determine whether constraints on imaging system geometry are 
necessary to avoid geometry-specific spectral distortion. Fluorescence and diffuse reflectance 
emission intensity were experimentally measured and predicted via Monte Carlo simulation as 
functions of azimuthal and polar emission angles, azimuthal incident excitation angle, sample 
scattering, absorption, and anisotropy coefficient, and combined optical property parameters 
reduced scattering, albedo, and reduced albedo.  
 For a spectral imaging geometry which collects emission from a small pixel region within 
a semi-infinite excitation spot, emission is roughly Lambertian with azimuthal angle for: 1) 
fluorescence independent of excitation-collection geometry, 2) diffuse reflectance when excited 
at an azimuthal angle close to the surface normal, and 3) diffuse reflectance within the plane 
defined by polar angles orthogonal to the polar incident excitation angle. For large oblique 
incident excitation angles, diffuse reflectance emission is skewed away from the excitation 
source within the incident excitation plane due to singly scattered and semi-diffuse photon 
emission. The degree to which emission is skewed from Lambertian behavior is related to the 
degree of correlation between incident and emission photon directions and can be predicted from 
the sample albedo and anisotropy coefficient, with increased skewing for decreased albedo and 
increased anisotropy. Based upon these results, while variations in angular fluorescence emission 
will not affect spectral lineshape due to angular system geometry or a variable surface 
topography of the sample, distortions can be induced in diffuse reflectance spectra at pixels with 
large incident excitation angles if the sample albedo or scattering anisotropy varies significantly 
across the spectral range of interest.  
 The implications of these results for our spectral imaging system design are difficult to 
determine since it involves the interplay of three parameters: incident excitation angle, sample 
albedo, and sample anisotropy. Further, the optical property measurements in chapter 3 combine 
the independent contributions of scattering coefficient and anisotropy to the reduced scattering 
coefficient. Using scattering anisotropy values measured by Yaroslavsky et al [1] to estimate 
scattering from reduced scattering, the albedo and scattering anisotropy of white matter, gray 
matter, and glioma tissue vary over the 400 to 700 nm spectral range as: 
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Tissue Type Albedo Anisotropy 
White Matter 0.961 – 0.998 0.76 – 0.86 
Gray Matter 0.929 – 0.992 0.86 – 0.90 
Glioma 0.954 – 0.998 0.88 – 0.96 
 
From these ranges, it can be argued that gray matter and glioma tissue are susceptible to spectral 
distortion due to the large variation in albedo for gray matter and the large variation in anisotropy 
for glioma tissue. While white matter possesses an equally large change in anisotropy, the 
anisotropy values are more isotropic and the albedo values are higher than those for glioma 
tissue, both of which reduce profile skewing. It should be noted that the effects of variations in 
albedo and anisotropy will partially offset one another since increases in anisotropy, which affect 
increased profile skewing, are universally accompanied by increases in albedo, which have the 
opposite effect.  
 Multiple studies have established that measured fluorescence and diffuse reflectance 
lineshape varies with excitation-collection geometry and with the separation distance within an 
excitation and collection fiber pair, behavior which forms the basis behind optical property 
measurement from bulk tissues in vivo. While several studies in the literature have examined the 
effect of various excitation-collection geometries on measured spectral lineshape, none have 
investigated the effect of the geometry shift from probe-based spectroscopy to non-contact 
spectral imaging. After initial comparisons of imaging and probe-based spectroscopy 
demonstrated significant lineshape disparities in fluorescence and diffuse reflectance spectra, the 
source of the disparities were definitively attributed to the shift in the relative relationship 
between the excitation and collection regions of the two systems. While probe-based 
spectroscopy collects emission from tissue regions adjacent to the excitation spot, spectral 
imaging collects emission from a small region within a large excitation spot. The goal of this 
study was to explore and describe the behavior of the lineshape disparity between probe-based 
and imaging spectra as a function of sample optical properties and changes to the fiber 
configuration in the probe. Probe-based and imaging fluorescence and diffuse reflectance spectra 
were acquired from two series of gelatin-based phantoms with variable absorption and scattering, 
respectively, based on the brain tissue optical properties measured in chapter 3. The effect of 
various fiber configuration parameters such as beam-steering, fiber diameter, and using the 
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excitation fiber for collection were examined through experimental measurement and Monte 
Carlo simulation.  
The behavior of the lineshape disparity between probe-based spectroscopy and spectral 
imaging with changes in optical properties and fiber-optic probe configuration can be explained 
in terms of the light diffusion within the tissue relative to the distribution of source-detector 
separation distances for the two measurement system geometries. Imaging spectra consistently 
show greater absorption effects than probe-based spectra due to collection of diffuse photons at 
large source-detector separation distances. Both increased scattering and absorption decrease the 
diffusion scale of remitted photons, increase the diffusion level of photons collected by probe-
based spectroscopy, and subsequently decrease the lineshape disparity between imaging and 
probe-based spectra; however, the high ratio of scattering to absorption magnitude in most soft 
tissues renders the scale of photon diffusion and subsequently the lineshape disparity more 
sensitive to changes in scattering than absorption. Beam-steered fibers, decreasing the fiber 
diameter, and using the excitation fiber for collection increases the lineshape disparity by biasing 
probe-based photon collection towards less diffuse photons. The ideal fiber-optic probe 
configuration to minimize the lineshape disparity uniformly samples all source-detector 
separation distances; however, photons collected by the imaging system travel radial distances 
up to 20 mm, requiring collection fibers to extend beyond limits which may be considered 
practical.  
 Our research group has completed probe-based fluorescence and diffuse reflectance 
spectral acquisition from over 125 patients, entrenching our probe-based excitation-collection 
geometry to the fiber configuration described in [2]. As such, strategies for the translation to 
spectral imaging are limited to: using a spectral imaging geometry which limits the collection of 
diffuse photons, correcting probe-based or spectral imaging lineshapes for excitation-collection 
geometry a posteriori, or developing imaging-specific discrimination algorithms to differentiate 
between normal and tumor tissue in vivo. As described in chapter 6, the adaptations to non-
contact spectral imaging are either exceedingly complex to implement (spectral imaging fiber 
probe) or require a priori tissue optical property information (co-polarized excitation and 
collection). For these reasons, chapter 4 focuses on the capability of our non-contact spectral 
imaging system design to spectrally discriminate between tissue types independent of probe-
based discrimination algorithms, while chapter 7 concentrates on developing imaging-specific 
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discrimination algorithms and investigating the effects of the lineshape disparity on diagnostic 
accuracy when probe-based discrimination algorithms are applied to imaging data. Since the 
lineshape disparity between probe-based spectroscopy and spectral imaging varies with sample 
absorption and scattering, correction of probe-based and/or spectral imaging lineshapes a 
posteriori requires tissue optical property information and is a point of future research for our 
research group. 
 
Liquid-Crystal Tunable Filter Spectral Imaging for Brain Tumor Demarcation 
 Current brain tumor localization techniques have significant limitations in their clinical 
ability to guide tumor resection, especially at the brain tumor margins where diffuse numbers of 
brain tumor cells and an intact blood-brain barrier make normal and margin tissue visually 
indistinguishable and render exogenous imaging contrast agents ineffective. Past studies have 
demonstrated that optical discrimination methods based upon intrinsic tissue information as 
probed by combined autofluorescence and diffuse reflectance spectroscopy can successfully 
discriminate between normal, tumor core, and tumor margin tissues in the brain. The next step 
for clinical implementation of such technology for tumor resection guidance is the extension of 
fiber-optic probe-based spectroscopy to spectral imaging to spatially demarcate tumor core and 
margin borders. A successful transition from spectroscopy to clinical macroscopic imaging 
depends upon two main factors: 1) reasonable image acquisition time despite significant 
decreases in excitation irradiance due to larger target areas and 2) accurate, sensitive spectral 
discrimination between tissue types, most notably at tumor margins where other tumor 
localization methods fail. The goal of this phase of the research project was to develop a spectral 
imaging system for clinical use and to characterize the system in terms of traditional imaging 
parameters (field of view, resolution, etc), imaging speed, and capability to spectrally 
discriminate between brain tissue types in vivo.  
This phase of the research project was again divided into two studies. The first study 
(chapter 4) describes the design and characterization of a dual-mode liquid-crystal tunable filter 
spectral imaging system capable of intra-operative fluorescence and diffuse reflectance imaging, 
assesses its imaging speed for brain tissues in vitro and in vivo, and qualitatively determines its 
spectral discrimination capability. Given the need to develop tissue discrimination algorithms 
specific to spectral imaging data, the second study (chapter 7) describes a clinical investigation 
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designed to determine the efficacy of tumor demarcation for surgical resection guidance, by 
acquiring fluorescence and diffuse reflectance images in vivo, correlating spectral features to 
histopathological diagnosis of tissue biopsy samples, developing diagnostic algorithms based on 
observed spectral differences between tissue types, and quantitatively assessing diagnostic 
accuracy for brain tissue discrimination in vivo. 
 Subsequent to the quantitative comparison of three benchtop spectral imaging systems 
[3], a liquid-crystal tunable filter spectral imaging system was designed for clinical 
implementation of dual-mode fluorescence and diffuse reflectance imaging. After thoroughly 
describing the design of the clinical imaging system, a battery of tests are employed to 
quantitatively characterize the imaging parameters in terms of linearity of measured intensities to 
emission intensity and integration time, imaging field of view as a function of object distance, 
spatial and spectral resolution, and system sensitivity as a function of wavelength. A series of 
functional tests acquire fluorescence and diffuse reflectance images from gelatin-based phantoms 
designed to optically mimic white matter, gray matter, and glioma tissues, mouse brain tissue in 
vitro, and human cortical tissue in vivo. The images are used to qualitatively assess the ability of 
the spectral imaging system to produce autofluorescence and diffuse reflectance images capable 
of spectral discrimination between brain tissues in a reasonable timeframe for the clinical 
environment.  
 The spectral imaging system is characterized by measured intensities which are linear 
with sample emission intensity and integration time, a one-inch field of view for a seven-inch 
object distance, spectral resolution which is linear with wavelength, spatial resolution which is 
pixel-limited, and sensitivity functions which provide a guide for the distribution of total image 
integration time between wavelengths. Functional testing demonstrated good spatial and spectral 
contrast between brain tissue types, the capability to spectrally discriminate between white and 
gray matter in the brain, the in vivo acquisition of adequate fluorescence and diffuse reflectance 
intensities within a two-minute imaging timeframe, and the importance of hemostasis to acquired 
signal strengths and imaging speed. The simple design of the spectral imaging system around a 
liquid-crystal tunable filter, its linearity of measured intensity with emission intensity and 
integration time, and its pixel-limited spatial resolution make it a very versatile imaging system. 
It can acquire spectral information at specific wavelengths deemed diagnostically significant, 
employ integration times which vary with wavelength to acquire good signal-to-noise across the 
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spectral range of interest, and utilize pixel binning to increase signal levels without sacrificing 
discrimination guidance. These results provided direction as we embarked upon the second part 
of this phase of the research project, a large clinical study to determine the efficacy of combined 
fluorescence and diffuse reflectance spectral imaging to spectrally discriminate between normal 
and glioma tissues in the brain for tumor demarcation and surgical resection guidance. 
 The goal of this study was to quantitatively determine the diagnostic accuracy of the 
clinical spectral imaging system to optically discriminate between normal and tumor core and 
margin tissues in the face of: fewer wavelength samples and lineshape disparities relative to 
probe-based spectra, the loss of absolute intensity information, and crosstalk between pixel 
regions from photon diffusion. Fluorescence and diffuse reflectance spectral images were 
acquired from the cortical surface, tumor core, and margin tissues at various points in the 
surgical resection procedure. Several sites within each image were selected for probe-based 
spectroscopy interrogation and subsequent biopsy acquisition (if neoplastic). Imaging and probe-
based spectra were grouped according to tissue type as determined by gold-standard 
histopathological diagnosis of the biopsy samples and were analyzed using a non-linear multi-
variate framework to determine spectral differences between tissue groups. Discrimination 
algorithms were developed for each system, unbiased diagnostic accuracy was determined using 
the leave-one-out cross-validation method, and accuracies were compared between the systems. 
Imaging-specific algorithms were subsequently applied to all pixels within the fluorescence and 
diffuse reflectance images to create diagnostic image maps. 
 The imaging system proved capable of acquiring high-intensity spectral images within a 
clinically viable two-minute imaging timeframe with spatial resolution more than adequate for 
visualization of fine tissue structures such as the microvasculature and for surgical guidance with 
traditional resection tools. While mean imaging and probe-based spectra for twenty-eight normal 
cortex and tumor samples demonstrated only subtle differences between tissue classes and 
lineshape disparities consistent with results previously described, the diagnostic algorithm 
development achieved perfect classification accuracy for all twenty-eight tissue samples for both 
optical detection methods, indicating discrimination accuracy for spectral imaging on par with 
traditional probe-based spectroscopy. Diagnostic image maps produced from individual 
classification of the totality of pixels within the spectral image sets possessed excellent spatial 
correlation between classification regions, i.e. little to no diagnostic noise, with good sensitivity 
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and specificity compared to gross neurosurgical diagnosis. Tissue regions containing major 
blood vessels and image regions containing specular reflectance were consistently classified as 
tumor tissue. These results indicate excellent promise for dual-mode autofluorescence and 
diffuse reflectance spectral imaging as a clinical tool for intra-operative tumor and margin 
demarcation for surgical resection guidance. 
 
Conclusions 
 In conclusion, the studies described in this dissertation form the basis for the transition 
from probe-based spectroscopy to spectral imaging for clinical applicability of spatial disease 
demarcation and subsequent therapy guidance. While the studies focused on and were optimized 
for brain tissue diagnosis and tumor margin demarcation, many of the results apply to optical 
discrimination in any turbid medium. The following have been shown: 
1. Liquid-crystal tunable filter spectral imaging is capable of intra-operatively acquiring 
autofluorescence and diffuse reflectance spectral images in a clinically viable timeframe 
with sufficient spectral contrast between normal cortex and tumor tissues for 
discrimination accuracy on par with traditional probe-based spectroscopy. 
2. Posterior classification probabilities from the multi-variate MRDF-SMLS framework can 
be exploited to create diagnostic image maps with excellent spatial correlation of 
diagnostic regions as well as sensitivity and specificity for tumor demarcation, indicating 
significant promise as a tool for surgical resection guidance. 
3. The inherent shift in excitation-collection geometry upon the transition from probe-based 
spectroscopy to non-contact spectral imaging induces a significant disparity in 
fluorescence and diffuse reflectance lineshapes between the two systems. While multi-
patient clinical studies with probe-based spectroscopy are still useful to prove the 
principle that optical biopsy is capable of discriminating between normal and diseased 
tissue states or when spatial information is not required for clinical applicability, the 
lineshape disparity necessitates development of tissue discrimination algorithms specific 
to spectral imaging data via independent clinical study. 
4. Large incident excitation angles have the potential to induce spectral distortions extrinsic 
to tissue optical properties when the sample albedo and/or anisotropy vary significantly 
across the spectral range of interest. 
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5. Relative to probe-based spectroscopy, spectral imaging tissue discrimination takes place 
in the face of several confounding factors: decreased signal-to-noise ratio due to 
significantly reduced excitation irradiances, loss of absolute intensity information, 
potential spectral distortion due to angular excitation-collection geometry and variable 
surface topography, crosstalk between pixels due to photon diffusion, and spectral 
information at fewer wavelengths. 
6. Monte Carlo simulation is capable of accurately predicting fluorescence and diffuse 
reflectance spectra for any excitation-collection measurement geometry given a set of 
sample optical property spectra. 
 
Future Directions 
 Given the limited patient population and restriction to cortical surface and surface-based 
tumor tissues in the preliminary clinical study, further research work is required to fully assess 
the capabilities of the imaging system for brain tumor and tumor margin demarcation. 
Alternative imaging interfaces must be investigated for improved positioning and versatility to 
gain better access to deep-seated white matter, margin tissues, and the walls of narrow resection 
cavities. Future clinical studies should focus on tissue discrimination at the tumor margins, with 
the hope that probing intrinsic tissue contrast will overcome limitations with current exogenous-
contrast imaging methods and affect more complete brain tumor margin resection. 
 As mentioned in the introduction, the main limitation to 5-ALA fluorescence guided 
tumor resection was its lack of sensitivity at tumor margins due to an intact blood-brain barrier 
[4]. Since extent of margin resection has been repeatedly cited as the main prognostic factor for 
patient quality of life and mortality, the ultimate assessment for clinical utility of the LCTF 
spectral imaging system will be its sensitivity to the presence of diffuse tumor cells within the 
tumor margins. Because spectral imaging contrast with autofluorescence and diffuse reflectance 
derives from intrinsic changes in tissue structure and biochemistry with tumor invasion, it is not 
limited by the blood-brain barrier and has the potential to detect the presence of very low levels 
of infiltrating tumor cells. To determine the sensitivity of tumor demarcation to tumor invasion, 
spectral imaging diagnosis must be correlated to histological quantification of coalescent tumor 
cells in biopsy samples. A tumor invasion model which produces a gradient of tumor cell 
concentration between normal and tumor core tissue would be useful to quantify system 
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sensitivity. Understanding the basis behind the system sensitivity to tumor invasion and 
development of a tissue model to quantify that sensitivity would aide from a thorough 
understanding of the biological bases behind the spectral signature differences observed between 
normal and tumor tissues in the brain, a topic of imminent experimental investigation in this 
research project. 
 Once the accuracy and sensitivity of tumor margin demarcation is established 
retrospectively, the next logical step is to conduct a prospective study of the efficacy of brain 
tumor margin demarcation for surgical resection guidance. Unlike in a retrospective study, a 
prospective study asks neurosurgeons to make surgical decisions based upon spectral imaging 
diagnoses and tumor margin demarcation. Using the 5-ALA fluorescence guided resection study 
as a model, the study would correlate spectral image diagnosis to histopathological diagnosis of 
sample biopsies at tumor margins to determine the baseline diagnostic accuracy of spectral 
imaging during the study. Since tumor margins located near eloquent cortical areas cannot be 
resected for reasons of safety, the patient population can be stratified based upon the presence of 
residual margin tissue as predicted by spectral imaging. Extent of margin resection as predicted 
by spectral imaging could then be correlated to two endpoints, gadolinium contrast enhancement 
of tumor margins in post-operative MR images and patient survival time, to determine the 
benefit of spectral imaging guidance of tumor margin resection.  
 This study in this dissertation on the effects of incident excitation angle, emission 
collection angles, and sample optical properties focused solely on angular emission profile 
shape. However, results in that study from a Monte Carlo simulation of diffuse reflectance 
spectral imaging indicate that variations in angular emission profile amplitude with optical 
properties and incident excitation angle may induce distortions in spectral lineshape extrinsic to 
sample optical properties. Despite consistently Lambertian emission profiles independent of 
optical properties, incident excitation normal to the tissue surface and large-angle incident 
excitation with emission collected along the plane orthogonal to the polar angle of excitation 
produced disparate diffuse reflectance spectra. The underlying cause of this behavior obviously 
influences diffuse reflectance lineshape, could affect fluorescence lineshape as well, and should 
be examined in order to fully investigate the effects of spectral imaging excitation-collection 
geometry on measured lineshapes. Fortunately, Monte Carlo simulation data already exists from 
the previous study, from which absolute angular emission profiles can be constructed for 
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fluorescence and diffuse reflectance. Unfortunately, experimental data to validate these 
simulation results will prove to be difficult to obtain since careful attention must be paid to 
excitation irradiances, detection solid angles, and other details which can affect absolute 
measured intensities. 
 A significant future direction for any engineering system is improvement over time as the 
technology of different system components moves forward. One of the main areas of 
improvement for the liquid-crystal tunable filter spectral imaging system is imaging speed, 
which is dictated by collection sensitivity, excitation irradiances, and the number of wavelength 
interrogations necessary for diagnosis. Collection sensitivity of the imaging system can be 
improved as CCD technology advances with higher quantum yield chips and by incorporating 
the newest generation of liquid-crystal tunable filters with increased transmission capability. 
Excitation irradiances can be improved by using higher power excitation sources and liquid light 
guides with higher throughput. Most importantly, one of the reasons LCTF spectral imaging was 
chosen for clinical implementation was its random access filter tuning capability. As the 
diagnostic algorithm for accurate brain tumor margin demarcation is finalized, this capability 
will allow image acquisition at only those wavelengths which are deemed diagnostically 
significant and thus improve the imaging speed. 
 A second main area of improvement for the spectral imaging system is in its clinical 
interface, not only in terms of clinical convenience but also in terms of clinical versatility. The 
current system is attached to the side assembly of an operating microscope designed from 
ophthalmologic applications, requiring the neurosurgeon to stop the surgery, remove the 
neurosurgical microscope from the surgical field, and position the spectral imaging scope for 
image acquisition. A better interface for the spectral imaging system would be through direct 
incorporation into the neurosurgical microscope. Such an alternative was originally investigated 
by our research group with the imaging system coupled to the camera port of neurosurgical 
scope. However, a comparison between an interface at the camera port and the current interface 
with a direct view of the tissue surface realized a 30- to 40-fold increase in signal intensity with 
the direct view system due to greater solid angle of emission collection and a beamsplitter used 
to split the sample image between the neurosurgical microscope oculars and the camera port 
(Appendix B). Given the weak nature of tissue autofluorescence for macroscopic imaging, it was 
not feasible to acquire autofluorescence images within a reasonable timeframe with the 
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neurosurgical microscope interface. As the technology improves to allow better collection 
sensitivity and higher excitation irradiances, direct incorporation of LCTF spectral imaging into 
operating microscopes may become a possibility. In terms of clinical versatility, experience 
during the clinical tumor demarcation study revealed that excitation and collection at oblique 
angles from the optical axis of the operating microscope prevents illumination and visualization 
of tissue regions at the bottom or along the walls of deep resection cavities. While simply 
incorporating the spectral imaging system into the neurosurgical microscope which possesses 
greater freedom of movement than the ophthalmologic scope would ameliorate the problem, 
adding a contact-based fiber-optic probe or flexible endoscope for spectral acquisition (with or 
without spatial resolution) from these tissue regions would greatly improve the clinical versatility 
of the spectral imaging system.  
 The ultimate goal for spectral imaging development has always been to incorporate 
diagnostic spectral images into a surgical navigation system to allow tracking of resection 
instruments within diagnostic image space. Surgical navigation systems allow surgeons to 
dynamically correlate the position of anatomic structures within their visual field to features 
within images loaded into the surgical navigation platform. The most recent generation of 
neurosurgical microscopes have begun interfacing with surgical navigation systems to track the 
location of the microscope head in physical space, retrieve the relative position of the 
microscope focal plane, and extrapolate and display the position of the focal plane within the 
brain. Once direct incorporation of the spectral imaging system into the microscope is achieved, 
importing spectral images into the surgical navigation platform would be easily realized. 
However, while importing spectral images into the surgical navigation system would be useful to 
correlate features between spectral images and images from other modalities, the utility of 
surgical navigation with spectral images to may be diminished. Surgical navigation with MR and 
CT images is useful because features in CT/MR images do not visually resemble their physical 
counterparts. For spectral imaging, diffuse reflectance information can be easily used to 
construct images which resemble the visual appearance of tissue, as demonstrated in chapters 4 
and 7. Therefore, assuming enough feature contrast in the diffuse reflectance image to localize 
and orient the spectral imaging field of view, correlating features in the diagnostic image to 
physical position along the brain tissue surface should be relatively straight-forward without the 
help of a surgical navigation system. 
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APPENDIX A 
 
INSTRUMENTATION CONSIDERATIONS IN SPECTRAL IMAGING FOR TUMOR 
DEMARCTION: COMPARING THREE METHODS OF SPECTRAL RESOLUTION 
 
Abstract 
 Multiple methodologies exist to implement spectral imaging for tissue demarcation and 
disease diagnosis. In this paper, benchtop acousto-optic tunable filter (AOTF), liquid-crystal 
tunable filter (LCTF) and Fourier interferometric spectral imaging systems were quantitatively 
compared in terms of imaging speed of soft tissue autofluorescence. Optical throughput, image 
signal-to-noise ratio (SNR), and collagen autofluorescence imaging in chicken breast were 
assessed. Within this comparison, the Fourier system possessed the largest optical throughput 
(~50%) relative to the tunable-filter imaging systems; however, its throughput advantage failed 
to correlate to improved image SNR over the LCTF system. Further, while the autofluorescence 
imaging capability of the Fourier system exceeded that of the LCTF system for comparable total 
image integration times, the LCTF is capable of producing equivalent autofluorescence SNR 
with superior SNR when interrogations at only a few wavelengths are required and the random 
access filter tuning of the LCTF can be exploited. Therefore, the simple, rugged design and 
random-access filter-tuning capability of LCTF-based spectral imaging makes it best-suited for 
clinical development of soft tissue autofluorescence imaging. 
 
Introduction 
 Optical spectroscopy, specifically combined fluorescence and diffuse reflectance 
spectroscopy, has been shown to discriminate between normal, neoplastic, and margin tissue in 
the brain and other organs [1-4]. Substantial work has been published expanding optical 
spectroscopy methods for spectral imaging development [5-19], but none have quantitatively 
addressed which spectral imaging modality is best-suited for tissue autofluorescence imaging in 
the operating room. We believe a spectral imaging system that acquires fluorescence and diffuse 
reflectance information can bolster brain tumor margin resection. However, given the multiple 
methodologies that exist to implement spectral imaging (e.g. tunable-filter, Fourier 
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interferometric, line-scanning, Hadamard transform), we sought to answer the outstanding 
question of “which modality?” before beginning clinical development. 
 The clinical utility of spectral imaging systems should be judged on two major criteria. 
First, to apply a diagnostic algorithm developed during a large clinical trial using a fiber-based, 
single-pixel spectroscopy system, spectral imaging must be capable of faithfully reproducing the 
fluorescence and diffuse reflectance spectra from the single-pixel system. Second, given the 
large cost associated with image acquisition time in the operating room, a premium is placed on 
the speed with which the system can image weak emission signals such as tissue 
autofluorescence while providing accurate spectral information for tissue diagnosis. While the 
factors that affect spectral line-shapes measured by non-contact imaging systems are currently 
under investigation by our research group, this paper seeks to quantitatively assess the imaging 
speed of a variety of spectral imaging systems.  
 The quantitative comparison in this paper is limited to imaging systems that resolve the 
wavelength dimension of the spectral image across acquisition of multiple CCD frames. These 
imaging systems can be grouped into two major categories – tunable-filter and Fourier 
interferometric systems – based upon how they resolve the spectral dimension. Tunable-filter 
based spectral imaging systems [11, 19, 20] directly parse the wavelength dimension of the 
spectral image between the CCD frames. They employ an electronically tunable bandpass filter, 
such as an acousto-optic tunable filter (AOTF) or a liquid-crystal tunable filter (LCTF), to 
diffract or pass, respectively, one band of the emission spectrum to the CCD camera at a time. 
Therefore, to build the spectral image, a frame of CCD data is acquired for each tuning 
wavelength of interest within the spectral image. The major drawback to tunable-filter systems is 
the inherent tradeoff between spectral resolution and system optical throughput. Since only one 
band of the collected emission is passed to the CCD camera at a time, the majority of collected 
emission is lost. 
 Liquid-crystal tunable filters are constructed from a stack of linear polarizers with 
interspersed layers of liquid crystals sandwiched between birefringent crystals. The retardance 
(R) of each stage, defined as the product of its thickness (d) and the difference between its 
ordinary (no) and extraordinary (ne) indices of refraction – ( )eo nndR −=  – can be modulated by 
applying a voltage to the liquid crystal and changing its extraordinary index of refraction. 
Altering the stage’s retardance affects the phase delay between the ordinary and extraordinary 
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light rays emerging from the stage, thereby changing its transmission (T) as a function of 
wavelength (λ) –  ( )xT 2cos5.0=  where λdRx = . The stage thicknesses (d) in the filter stack are 
often selected to produce a binary series of retardances such that all of the stages transmit the 
selected passband while destructive interference at the other wavelengths “trims” the stopband 
light. The number of stages employed in the filter (10 in current LCTFs) dictates the width of the 
passband and the degree of stopband attenuation.  
 Acousto-optic tunable filters apply radio-frequency (RF) acoustic waves to modulate the 
index of refraction of the filter crystal. If the incident wavelength satisfies a momentum-
matching condition based upon the frequency of the RF wave, the linear polarization states of the 
incoming light are diffracted to the opposite state and the light is deflected upon its exit from the 
crystal, with two symmetrically diffracted passband beams and a transmitted zero-order stopband 
beam exiting the filter. Since the diffracted and zero-order beams must be separated in any type 
of imaging setup, the optical design of AOTF systems require either: 
1) a long distance between the filter and CCD camera to allow physical separation of 
the diffracted and zero-order beams; or,  
2) orthogonally oriented polarizers on either side of the filter to pre-polarize the 
input light and allow only the orthogonally oriented passband to reach the camera.  
Although AOTF diffraction efficiency is on the order of 90-95% for pre-polarized input light 
(and 70% for unpolarized light), both beam separation solutions result in a loss of at least 50% of 
the light collected from the sample. 
 Fourier interferometric spectral imaging [13] indirectly resolves the spectral dimension 
of a spectral image by multiplexing the emission wavelengths. Rather than isolating and 
measuring individual spectral bands of a signal as tunable-filter systems do, multiplexing 
methods weigh the spectral components in groups using orthogonal basis functions and measure 
the total intensity of each weighted group. Measuring multiple spectral components 
simultaneously and back-calculating their intensities from the weighted measurements provides 
greater optical throughput than filter-based systems, ideally leading to a subsequent increase in 
SNR for equivalent integration times.  
 Fourier-based imaging systems use Michelson or Sagnac interferometers where the 
optical path difference (OPD) between two beams created and subsequently recombined by a 
50/50 beamsplitter is varied between successive CCD frames. Varying the OPD modulates the 
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interference pattern seen by the CCD camera, building interferograms at each pixel as the OPD is 
shifted and the CCD frames are acquired. After complete image acquisition, each pixel 
interferogram represents the Fourier transform of the pixel spectrum and can be individually 
converted to such via the inverse Fourier transform. Employing a beamsplitter-based 
interferometer for multiplexing provides a theoretical system optical throughput of 50% over the 
entire spectrum.  
 The comparison in this paper was limited to three spectral imaging systems (Fourier, 
AOTF, and LCTF) which resolve the spectral dimension of the image across multiple CCD 
frames since all three require excitation of the entire sample surface during image acquisition. 
The three systems employed equivalent optics for sample excitation and emission collection and 
the same CCD camera for image acquisition. Experiments were designed to assess imaging 
speed in terms of optical throughput, image signal-to-noise ratio (SNR), and collagen 
autofluorescence imaging to determine which imaging system is most amenable to therapy 
guidance in the operating room. 
 
Materials and Methods 
 In an effort to assess the spectral imaging modality most suitable for intraoperative brain 
tissue imaging, three benchtop spectral imaging systems were assembled and compared. The first 
system was based on a Fourier interferometry camera from Applied Spectral Imaging (Carlsbad, 
CA). The other two were tunable-filter based systems using a LCTF from CRI (Woburn, MA) 
and a Brimrose AOTF (Baltimore, MD), respectively. Given the ultimate goal of developing a 
clinical imaging system capable of rapidly imaging weak emission signals, the imaging system 
characteristics of most interest were: (1) optical throughput of the imaging system, where optical 
throughput refers to the fraction of light collected by the imaging system which is ultimately 
detected by the camera; (2) signal-to-noise ratio, defined as the ratio of the image intensity mean 
(signal) to its standard deviation (noise) at each wavelength; and (3) soft-tissue autofluorescence 
imaging capability. Experiments were first conducted at Oak Ridge National Laboratory to 
compare equivalent AOTF and LCTF imaging systems. Similar experiments were then 
performed at Vanderbilt University to compare Fourier and LCTF systems.  
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Figure 1. Schematic of excitation optics for comparison of benchtop spectral imaging system comparison. 
Excitation Optics 
 To facilitate a direct and fair system comparison, the three imaging systems employed 
identical excitation optics (Figure 1) for fluorescence and diffuse reflectance excitation over the 
visible range of the spectrum (400 to 720 nm). The system consisted of separate legs for white 
light (diffuse reflectance) and ultraviolet illumination (fluorescence). For diffuse reflectance 
imaging, the broadband visible output from a 150 W halogen lamp was coupled into a 6 mm 
diameter liquid light guide (LLG). For fluorescence imaging, the broadband ultraviolet output 
from a Thermo-Oriel (Stratford, CT) 500 W Xe arc lamp reflected off a 280 nm dichroic mirror, 
passed through a 330-345 nm band-pass filter, and was coupled into another LLG. The large-
diameter LLGs were chosen over fiber-optic light delivery to provide better coupling efficiency 
from the characteristically large lamp filaments of the illumination sources. Both illumination 
legs contained distal collimating and focusing lenses for practical adjustment of the illumination 
spot sizes on the sample. Illuminating the sample from roughly a 45º angle prevented specular 
reflectance of the white light and UV sources from entering the imaging systems. 
 
Imaging Systems 
AOTF vs. LCTF 
 Above the collection optics, an acousto-optic tunable filter (TEAF 10-0.45-0.70-S) was 
sandwiched between two orthogonally oriented polarizers and followed by an iris diaphragm 
(Figure 2a) for maximum rejection of the zero-order (stopband) image. The filter possessed a 
peak diffraction efficiency of 90-95% of pre-polarized light and an operating spectral range 
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between 450 and 700 nm. The optics distal to the AOTF were oriented at a 6º angle relative to 
the central axis of the AOTF to direct the diffracted beam to an intensified CCD camera 
(Princeton Instruments, PI-Max 512 T/GII, Trenton, NJ). The beam was collected by a 105 mm, 
f/2.8 camera lens (Nikon) and focused onto a 512 x 512 array of 19 µm square pixels. The 
camera was thermoelectrically cooled to -20ºC during all measurements. With this configuration, 
the sample stage was located roughly 610 mm (24 in.) from the camera lens. 
 For the LCTF setup (Figure 2b), the camera and lens were aligned with the aperture of 
the liquid-crystal tunable filter (VariSpec VIS). The filter possessed a maximum passband 
transmission of pre-polarized light equal to 60% with a spectral range of 400 to 720 nm. For 
comparison sake, the collection lens was maintained at an object distance of 610 mm from the 
sample. 
 
Fourier vs. LCTF 
 An 80 mm, f/3.5 camera lens (Sigma) was attached to a commercially available Fourier 
Sagnac-interferometric imaging system (SpectraCube) and aligned with the center of the 
excitation optics (Figure 3a). The imaging system had an operating spectral range between 350 
  
(a)        (b) 
Figure 2. Schematics of benchtop (a) acousto-optic and (b) liquid-crystal tunable-filter spectral imaging systems 
constructed at Oak Ridge National Laboratory. 
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and 1100 nm and a 656 x 494 array of 9.9 µm square pixels (Hamamatsu, C4880-85). The 
system possessed an object distance between sample and lens of roughly 380 mm (15 in.).  
 To acquire a direct comparison of the LCTF and Fourier imaging systems using the same 
collection optics, CCD camera, and object distance, the direct-image mode of the SpectraCube 
system was exploited for LCTF imaging. The tunable filter was placed in front of the 80-mm 
collection lens (Figure 3b) and the SpectraCube controller program was used to acquire a 16-bit 
TIFF image at each tuning wavelength to build the LCTF spectral image.  
 
Comparison Experiments 
AOTF vs. LCTF 
 Relative optical throughput measurements were performed between the imaging systems 
by acquiring spectral images of a 99% reflectance standard under white-light excitation and 
comparing the mean image intensities over consistent 25 x 25 pixel regions.  Images were 
acquired for each system with a 1-second integration time at each tuning wavelength across the 
spectral range of each filter. Signal-to-noise ratios (SNR) were calculated across the same 25 x 
25 pixel regions, where the SNR was defined as the ratio of the mean image region intensity to 
its standard deviation (i.e. 1/COV) at each tuning wavelength. While small regions were utilized 
to minimize the effect of non-uniform illumination on the intensity standard deviation, it should 
be noted that any illumination variations were consistent between the two systems.  
 
(a)      (b) 
Figure 3. Schematics of benchtop (a) Fourier and (b) liquid-crystal tunable-filter spectral imaging systems 
constructed at Vanderbilt University. 
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 To assess the autofluorescence imaging capability of the systems, and to correlate this 
capability to their relative optical throughput and image SNR, fluorescence images of chicken 
breast and adipose tissue were acquired. Chicken tissue was chosen as the soft-tissue phantom 
for two reasons: 1) its collagen autofluorescence peaks around 510 nm, which falls within the 
tuning range of the Brimrose AOTF, and 2) strict guidelines at Oak Ridge National Laboratory 
prohibited the use of ex vivo animal or human tissues in laboratory experiments without an 
arduous approval process.  
 Ten images at 2-second integration per image were acquired at each tuning wavelength 
to give a total integration time of 20 s per wavelength. The wavelength was varied across the 
individual spectral ranges of the filters in 10 nm increments, except around the expected collagen 
fluorescence peak (λ = 510 nm) where a sampling of 2 nm was used. Baseline corrections were 
applied to the images and the mean spectral intensity at each pixel was calculated for grayscale 
image display. Representative fluorescence spectra were then calculated from three 15 x 15 pixel 
image regions corresponding to chicken muscle tissue, chicken adipose tissue, and background 
emission outside the illumination area. Signal-to-noise ratios were calculated for the three 
regions at the wavelengths of peak fluorescence emission. 
 
Fourier vs. LCTF 
 Optical throughput measurements were performed between imaging systems by 
acquiring spectral images of a 99% reflectance standard under combined halogen- and xenon-
lamp (with the bandpass filter removed) excitation. To obtain a true optical throughput 
measurement of the LCTF as a function of wavelength, a 200 x 200 pixel Fourier spectral image 
of the reflectance standard was acquired without the LCTF in place using a 20-ms integration 
time per frame, acquiring 2330 frames with 3 interferometer steps between frames. With the 
LCTF replaced along the collection leg, similar Fourier images were acquired with the same 
interferometer and integration settings for tuning wavelengths from 400 to 720 nm in 10 nm 
increments. The optical throughput (T) for each tuning wavelength of the LCTF was computed at 
each pixel in the image using 
( )
( ) ( )( )∑∑ =
=
∆
∆
= N
i i
ifilter
iN
i
i
I
I
T
1 %100
1
1 λ
λ
,     (1) 
199 
where N is the number of wavelengths in the Fourier spectral image, (∆λ)i is the mean 
wavelength spacing between λi-1, λi, and λi+1, (Ifilter)i is the spectral intensity at the ith wavelength 
in the Fourier image with the LCTF in place, and (I100%)i is the spectral intensity at the ith 
wavelength in the Fourier image with the LCTF removed. The optical throughput was calculated 
for and averaged over every pixel within the 200 x 200 image and the mean-throughput 
calculation process was repeated for every LCTF tuning wavelength. 
 To measure the optical throughput of the Fourier system as a function of wavelength, 200 
x 200 pixel, 16-bit TIFF images of the 99% reflectance standard were acquired using direct-
imaging mode (i.e. no fringes) with the LCTF in place and tuned to 400 to 720 nm in 20 nm 
increments. The integration times varied between 75 and 1000 ms depending upon the 
transmission of the LCTF to acquire adequate signal for the 100% throughput measurements. At 
each LCTF tuning wavelength, the fringe position was manually adjusted to the positions used 
during Fourier spectral imaging to build the interferogram. With the SpectraCube controller 
program set to fringe mode, sixty-four fringe frames were manually exported to 16-bit TIFF 
images with 40 interferometer steps between frames. The optical throughput (T) of the Fourier 
interferometer for each LCTF tuning wavelength was computed at each pixel in the image using 
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where N = 64 is the number of fringe images acquired at each LCTF tuning wavelength, (Ifringe)i 
is the spectral intensity at the pixel of interest in the ith fringe image, and (I100%)i is the spectral 
intensity at the pixel of interest in the 100% direct-mode image. For each tuning wavelength, the 
optical throughput was calculated for and averaged over every pixel within the 200 x 200 image. 
 To calculate the image SNR of the LCTF and Fourier imaging systems for the same 
emission input, spectral images were acquired of the 99% reflectance standard using equivalent 
total image acquisition times. LCTF frames were acquired as 16-bit TIFF images with 21-ms 
integration per frame using the direct-imaging mode of the SpectraCube controller software at 
tuning wavelengths of 400 to 720 nm in 10 nm increments. To achieve equivalent spectral 
sampling, spectral resolution, and total image integration time, a Fourier spectral image was 
acquired using 231 frames, 30 interferometer steps between frames, and 3 ms integration per 
frame. SNR metrics were calculated for both imaging systems across 25 x 25 pixel regions in the 
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middle of the images. Similar to the AOTF/LCTF comparison, the SNR was defined as the ratio 
of the mean image region intensity to its standard deviation (i.e. 1/COV). 
 To assess the autofluorescence imaging capability of the systems, and to correlate this 
capability to their optical throughput and image SNR, fluorescence images of chicken breast and 
adipose tissue were acquired. The spectral sampling and interferometer settings for the two 
systems were maintained from the SNR measurements and the total spectral image integration 
time for was held constant at 330 s (1430 ms per frame for Fourier, 10 s per tuning wavelength 
for the LCTF) for comparison purposes. A major advantage of LCTF imaging is the random-
access tuning capability of the LCTF allows the system to only interrogate the wavelengths 
necessary for tissue diagnosis. To compare Fourier and LCTF imaging when only 3 wavelengths 
are required for tissue diagnosis, an additional Fourier image with a 30 s total integration time 
was acquired. Baseline corrections were applied to the three images and the mean spectral 
intensity at each pixel was calculated for grayscale image display. Representative fluorescence 
spectra were then calculated from three 25 x 25 pixel image regions corresponding to chicken 
muscle tissue, chicken adipose tissue, and background emission outside the illumination area. 
Signal-to-noise ratios were calculated for the three regions at the wavelengths of peak 
fluorescence emission. 
 
Results 
 
AOTF vs. LCTF 
 The relative optical throughput measurements from the benchtop AOTF and LCTF 
spectral imaging systems (Figure 4) demonstrate that the mean image intensity of the LCTF was 
consistently higher than the AOTF.  While the throughput of both filter systems peaked in the 
red and bottomed out in the blue regions of the visible spectrum, the AOTF throughput possessed 
a dynamic range of 100 while the LCTF throughput possessed a larger dynamic range of 250. 
The ratio of the LCTF throughput to the AOTF throughput was lowest at 504 nm, due to a 
resonance-type transmission for the AOTF at that wavelength, and highest at 470 nm due to a 
sharp drop in AOTF throughput below 500 nm. It should be noted that the dynamic range in 
optical throughput for the systems incorporates the spectral variation in excitation intensity and 
CCD quantum efficiency. 
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 The signal-to-noise ratio measurements from the tunable-filter imaging systems (Figure 
5) demonstrate that the larger throughput of the LCTF results in larger signal-to-noise ratio than 
the AOTF. While the shape of the AOTF SNR and the LCTF-advantage spectra correlate 
reasonably well with their respective throughput spectra, the LCTF SNR is fairly constant over 
the 470 to 700 nm spectral range, regardless of 14-fold increase in throughput, and the maximum 
LCTF SNR occurs at the wavelength with the lowest throughput. These and several other 
behaviors within the SNR results suggest a curious relationship between system throughput and 
image signal-to-noise ratio which will be discussed in the next section. 
 Within the collagen autofluorescence images (Figure 6), both tunable-filter systems show 
fluorescence peaks between 500 and 520 nm where expected. However, the AOTF mean spectra 
are dominated by the throughput resonance of the filter at 504 nm while the fluorescence peaks 
of the LCTF spectra are significantly wider and red-shifted by ~15 nm. As expected from the 
SNR and throughput advantages of the LCTF over the AOTF (63.7-fold throughput and 10.6-
fold SNR at 518 nm), the autofluorescence image from the LCTF system possesses higher image 
 
(a)    (b)    (c) 
Figure 5. Signal-to-noise ratio (SNR) measurements for the benchtop (a) AOTF and (b) LCTF spectral imaging 
systems constructed at Oak Ridge National Laboratory. (c) SNR advantage for LCTF imaging over the AOTF. 
 
(a)    (b)    (c) 
Figure 4. Relative optical throughput measurements for the benchtop (a) AOTF and (b) LCTF spectral imaging 
systems constructed at Oak Ridge National Laboratory. (c) Throughput advantage for LCTF imaging over the 
AOTF. 
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(a) 
 
(b) 
Figure 6. Autofluorescence images of chicken breast from the (a) AOTF and (b) LCTF imaging systems with mean 
spectra from regions corresponding to background, muscle (black), and adipose tissue. 
 
Table 1. Signal-to-noise ratios for tunable-filter autofluorescence images of chicken muscle, adipose tissue, and 
background. 
Signal Noise SNR Signal Noise SNR
Muscle 2788 413.2 6.75 15456 1109.4 13.9
Fat 4937 596.5 8.28 23427 1978.1 11.8
Background 797.9 287.0 2.78 1805.6 693.52 2.60
AOTF LCTF
 
intensities than the AOTF with equivalent background noise between the two. The signal-to-
noise ratios at the fluorescence peaks (Table 1) further underscore the superior autofluorescence 
imaging capability of the LCTF system.  
 
Fourier vs. LCTF 
 The optical throughput measurements from the benchtop Fourier and LCTF spectral 
imaging systems (Figure 7) demonstrate that the Fourier system enjoys a considerable 
throughput advantage over the LCTF. As expected from a beamsplitter-based interferometer, the 
Fourier throughput was consistently near 50% with slightly lower values in the blue region of the 
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spectrum. The LCTF throughput possessed a dynamic range of roughly 150-fold that was lowest 
at 400 nm and peaked at 2.65% at 710 nm. As such, the throughput advantage for the Fourier 
system was greatest at 400 nm (3100-fold) and lowest in the red region (21-fold). 
 The signal-to-noise ratio measurements from the two imaging systems (Figure 8) 
demonstrate that while the Fourier system possesses a considerable throughput advantage over 
the LCTF, it does not correlate to an advantage in SNR. The SNR for both systems were 
relatively consistent with wavelength, varying less than two-fold between their maximum and 
minimum values. However, the SNR of the LCTF system averaged twice as large as the Fourier 
SNR. Consistent with the AOTF-LCTF comparison the large dynamic range of the LCTF 
throughput failed to correlate to a large dynamic range in SNR. Contrary to the AOTF-LCTF 
results, the SNR for the LCTF below 450 nm was consistent with the other tuning wavelengths. 
 The three autofluorescence spectral images (Figure 9) of chicken breast show 
fluorescence peaks around 520 nm. Due to the equivalent spectral resolutions of the two systems, 
the fluorescence peaks have roughly the same width for all three images, but the LCTF peaks are 
slightly red-shifted. As expected from the throughput advantage of the Fourier interferometer, 
the grayscale Fourier autofluorescence image after 330 s integration (Figure 9a) possesses 
 
(a)    (b)    (c) 
Figure 7. Optical throughput measurements for the benchtop (a) Fourier and (b) LCTF spectral imaging systems 
constructed at Vanderbilt University. (c) Throughput advantage for Fourier imaging over the LCTF. 
 
(a)    (b)    (c) 
Figure 8. Signal-to-noise ratio (SNR) measurements for the benchtop (a) Fourier and (b) LCTF spectral imaging 
systems constructed at Vanderbilt University. (c) SNR advantage for Fourier imaging over the LCTF. 
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(a) 
 
(b) 
 
(c) 
Figure 9. Autofluorescence images of chicken breast from the (a,b) Fourier and (c) LCTF imaging systems with 
mean spectra from regions corresponding to background, muscle (black), and adipose tissue. Images (a) and (c) were 
acquired with 330 s total integration times while image (b) was acquired with a 30 s integration time. 
 
Table 2. Signal-to-noise ratios for Fourier and LCTF autofluorescence images of chicken muscle, adipose tissue, and 
background. 
Signal Noise SNR Signal Noise SNR Signal Noise SNR
Muscle 391 34.1 11.5 74.5 34.1 2.18 222 32.6 6.82
Fat 1039 96.5 10.8 155 39.3 3.95 480 42.7 11.2
Background 81.6 24.8 3.29 41.8 26.3 1.59 82.6 30.3 2.73
Fourier (330 s integration) LCTFFourier (30 s integration)
 
superior clarity and higher image intensities than the LCTF image (Figure 9c) for equivalent 
levels of background noise. However, there appears to be no considerable difference in spectral 
quality, consistent with the SNR results. Further, reducing the integration time for the Fourier 
system to 30 s, equal to the LCTF integration for three wavelengths, creates an image with lower 
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quality than the LCTF image and reduces the spectral intensities below the LCTF spectra. The 
signal-to-noise ratios at the fluorescence peaks (Table 2) for the three images further underscore 
these results.  
 
Discussion 
 The optical throughput, image signal-to-noise ratio, and collagen autofluorescence 
imaging experiments were designed to assess the relative speed with which three different 
spectral imaging systems were capable of capturing high-quality soft-tissue autofluorescence 
images. The relative optical throughput comparison between the tunable-filter imaging systems 
was designed to measure the relative amounts of light that reach the CCD camera under 
consistent imaging conditions (e.g. excitation irradiance, sample emission, integration time). 
This throughput is affected by three aspects of the system: 1) the peak transmission of the filter 
at the tuning wavelength, 2) the passband width (i.e. full width at half maximum – FWHM) of 
the filter, and 3) light lost via the other optical components. Therefore, while the AOTF is known 
to possess a higher peak transmission than the LCTF for similarly polarized light, the throughput 
advantage of the LCTF seen in this comparison must be due to the other two sources of 
throughput loss. 
 There is an inherent tradeoff between the spectral resolution of the individual filters and 
the light throughput of the filter that skews the throughput results toward a filter with a broader 
passband. The FWHM of the LCTF passband is nominally 20 nm at 550 nm and monotonically 
increases quadratically with wavelength across the spectral range of the filter. Combining this 
with a peak transmission that is higher in the red region than in the blue explains the 150-fold 
dynamic range measured for the LCTF throughput. The passband width of the AOTF varies from 
1.7 to 6.2 nm across its spectral range while its peak transmission varies between 70% and 90% 
for polarized light. The increased spectral resolution of the LCTF increases the spectral range 
and amount of light admitted to the camera relative to the AOTF, giving it an unfair advantage in 
such a comparison.  
 Modeling the normalized passband transmission (i.e. without the effect of peak 
transmission) as a Gaussian function and integrating it over wavelength, the ratio of light passed 
by the LCTF to that diffracted by the AOTF is equal to the ratio of their passband FWHM values 
(derivation not shown). While the multiplicative nature of a correction for this effect would not 
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change the signal-to-noise ratio metrics (i.e. the mean and standard deviation of the intensities 
would be equally modulated and would therefore cancel in the COV calculation), the mean 
intensity data of the images should be normalized for the higher spectral resolution of the LCTF. 
To correct the relative throughput for spectral resolution, the advantage values (Figure 4c) should 
be divided by FWHMLCTF / FWHMAOTF at each wavelength. However, the maximum dispersion 
ratio is only 20.2 (FWHMAOTF = 1.7, FWHMLCTF = 34.3 at 720 nm) while the minimum 
throughput advantage is 28.5. Given the intensity ratio of 31.4 at 500 nm and that FWHMLCTF = 
16.5 mm at that wavelength, the LCTF throughput advantage is at least 9.7 near the collagen 
autofluorescence peak. Similarly, after spectral resolution correction at 700 nm, the LCTF 
throughput advantage is reduced (at most) from 150 to 7.9. Therefore, while the respective 
spectral resolution values for the two filters explains part of the LCTF throughput advantage, the 
remainder must be due to light lost at the polarizers and iris diaphragm of the AOTF imaging 
system when blocking the stopband image. 
 Spectral resolution correction is not necessary for the LCTF vs. Fourier comparison since 
the Fourier system accepts all wavelengths of light simultaneously with a beamsplitter which 
sends half of the collected light to the CCD camera and the other half back toward the sample. 
Therefore, no tradeoff exists between its spectral resolution and the amount of light detected by 
the camera. However, the Fourier throughput was consistently less than the expected 50% in the 
blue region of the spectrum. While the exact reason for this behavior is unknown, it may relate to 
the number of interferometer steps (30) between frames used during the throughput 
measurement. The separation between interferogram fringes for light in the blue region is 
roughly 100 interferometer steps while the separation in the red region is 180 steps. Therefore, 
using 30 steps between frames provides fewer than 4 samples per fringe in the blue region, as 
opposed to the six samples per fringe in the red region, and could result in throughput 
underestimation. 
 While an advantage in optical throughput for a given imaging system was expected to 
produce a corresponding advantage in image signal-to-noise ratio and thus superior 
autofluorescence images, the relationships between the three gauges of imaging speed were not 
so straightforward. However, a Fourier throughput advantage over the LCTF that averages 300 
over the spectral range of the filter produces a two-fold disadvantage in image signal-to-noise 
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ratio. Further, the SNR of the LCTF imaging system peaks for a tuning wavelength of 400 nm 
where the imaging system possesses the smallest throughput. 
 A possible explanation for the disadvantage in Fourier SNR relative to the LCTF is 
disparate interferogram sampling between pixels within the Fourier image. The interferometry 
fringes run vertically along the columns of the spectral image such that each column within a 
fringe image corresponds to a unique position within the interferogram. This disparity in starting 
position within the interferogram produces unique interferogram sampling and multiplexing 
schemes for each column as the interferograms are built. This in turn creates small changes in the 
pixel spectra, thereby reducing the Fourier signal-to-noise ratio. Oversampling the interferogram 
with a large number of frames and small number of steps between frames could help minimize 
the disparity in sampling with spatial position; however, to maintain a consistent total image 
integration time, the integration time per frame must be proportionally decreased and could 
exacerbate the effects of readout noise from the CCD camera on the image spectra. Since 30 
interferometer steps between frames were used for the Fourier SNR and autofluorescence 
imaging measurements, this same effect could be responsible for the qualitatively similar image 
spectra and spectral SNR between the LCTF and Fourier systems. 
 For the SNR measurements, 1000 LCTF acquisitions with 1 ms integration times were 
acquired to accrue the 1 second total integration time per wavelength. Given the 250-fold 
reduction in optical throughput of the LCTF from the red to the blue regions of the spectrum, the 
mean intensity for each acquisition decreases from 36,000 to 140 across the same range. If the 
readout noise is directly and asymptotically related to the pixel intensity, one can imaging that 
the low intensities at 400 nm would create less readout noise with correspondingly increased 
signal-to-noise ratios, producing a curve similar in shape to the one in Figure 5b. Whatever the 
cause for this anomalous increase in SNR at the wavelength of minimum throughput, the 
robustness of the SNR and throughput measurements would be improved by acquiring and 
subtracting a baseline measurement from the spectral images. While no ambient light was 
present during image measurement, such a correction would remove the effects of camera dark 
current which could be substantial at wavelengths with lower throughput. 
 A major drawback to any filter-based imaging system is the inherent trade-off between 
the system’s optical throughput and its spectral resolution. The transmission of liquid-crystal 
devices ranges from 5% (at 400 nm) to 60% (at 700 nm) of pre-polarized light across the visible 
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spectrum. Throughput can be improved by increasing the spatial resolution (commercially 
available at different resolution settings), but could result in “spectral distortion” in the form of 
low-pass filtering if trying to resolve narrow emission peaks. While the AOTF has increased 
transmission rates of pre-polarized light, an AOTF spectral imaging system must separate the 
stopband and passband beams. Using orthogonally oriented polarizers to create a single passband 
diffraction beam and block the stopband beam automatically decreases the beam signal by 50% 
and may require an additional iris diaphragm to complete the job since the stopband beam 
intensity dwarfs the passband. Using increased path length for physical beam separation only 
collects one of the passband beams (loss of 50%) and decreases the solid angle of the detector 
with respect to the emission source. Given these constraints, the throughput of an LCTF spectral 
imaging system is superior to AOTF imaging given the less than two-fold differences in peak 
transmission, the larger LCTF passbands available, and the lack of constraints on object distance 
and separation between the filter and CCD camera. 
 The advantage to LCTF spectral imaging system over Fourier imaging is the simplicity 
in optical design and system control. The system requires only a camera lens to focus the 
transmitted light onto the CCD focal plane with no worry about moving parts or the vibration 
artifacts they may cause. While the system comparison in this paper maintained a constant image 
integration time, considerable overhead is expended in Fourier spectral image acquisition time 
for spectral extraction using the inverse fast Fourier transform at every spatial pixel within the 
image. This process requires N2 additions or multiplications at each pixel for N interferogram 
frames, a process that can become computationally intensive for a highly resolved image. While 
the LCTF system possessed no post-processing computational cost, the Fourier system required 
approximately 3 seconds to extract the pixel spectra from a 512 x 512 image zero-padded to 128 
samples, further offsetting its throughput advantage. Also, the relationship between 
interferogram and spectral sampling is not intuitive, to the point where we found that certain 
combinations of interferogram sampling parameters lead to incomplete spectra or images which 
contain spatial harmonics running vertically across the final spectral image. Foremost, as seen in 
these experiments, variations in interferogram sampling between columns in the image create 
small changes in the image spectra, and Fourier imaging must acquire full spectral image 
information rather than interrogating only the wavelengths required for tissue diagnosis. 
Assuming that only 2 to 3 wavelengths are needed across a fluorescence spectrum, the 
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interrogation time for LCTF imaging can be increased 10 to 15 times per interrogation to 
partially offset the Fourier throughput advantage and produce higher signal-to-noise ratios. 
 
Conclusion 
 One of the main challenges facing any autofluorescence spectral imaging system will be 
to achieve adequate signal-to-noise ratio with sufficient imaging speed. Addressing this 
challenge, the results outlined in this paper highlight advantages of the LCTF spectral imaging 
system over equivalent AOTF and Fourier systems. The LCTF enjoys increased relative optical 
throughput and SNR over the AOTF with a significant edge in the blue region of the visible 
spectrum. These advantages yield superior autofluorescence imaging capability and LCTF 
spectra with higher image SNR at the collagen autofluorescence peak. Conversely, while the 
Fourier system possessed a throughput advantage of roughly 100-fold over the LCTF system in 
the 500 nm region, the average LCTF SNR from 400 to 720 nm was twice that of the Fourier 
system, and tissue images with equivalent integration times produced qualitatively similar 
results. Moreover, random access filter tuning by the LCTF system allows interrogation to be 
limited to the wavelengths required for tissue diagnosis, thereby increasing the allowable 
integration time per interrogation. Dividing the total LCTF image integration time between three 
wavelengths overcomes the throughput advantage of the Fourier system, producing 
autofluorescence images with higher spectral intensities and SNR values at the autofluorescence 
peak. Based on these results, our research group believes that of the three imaging systems 
compared in this paper, LCTF spectral imaging is best-suited for autofluorescence imaging.  
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APPENDIX B 
 
COMPARISON OF MEASURED INTENSITIES BETWEEN MICROSCOPE-COUPLED 
AND DIRECT-VIEW SPECTRAL IMAGING SYSTEMS 
 
Motivation 
 The original proposal for this dissertation outlined a clinical interface in which the liquid-
crystal tunable filter spectral imaging system is directly coupled to the camera port on the Zeiss 
operating microscope that neurosurgeons at Vanderbilt University Medical Center employ during 
tumor resection surgery. Direct coupling to the microscope aligns the imaging and microscope 
fields of view for streamlined diagnostic imaging and minimal disruption to the surgical 
procedure. While the spectral imaging system described in this dissertation is coupled to a Wild-
Heerbrugg operating microscope, the Wild operating microscope is designed for ophthalmologic 
applications and is not employed during brain tumor resection surgery. This creates a more 
cumbersome spectral imaging implementation since the neurosurgical microscope must be 
removed from the surgical field, the Wild microscope wheeled into its place, and the tissue target 
of interest re-localized with the oculars before spectral image acquisition is possible. This 
unwieldy protocol for spectral image acquisition reduces its efficiency, making neurosurgeons 
less likely to exploit the capabilities of spectral imaging diagnosis.  
 
Methods 
 A direct-view system coupled to the side assembly of a separate microscope was 
ultimately chosen for clinical implementation based upon a quantitative comparison of imaging 
speeds between such a system and one coupled to the camera port of a Zeiss operating 
microscope. The direct-view system (Figure 1a) consisted of the VIS-20 liquid-crystal tunable 
filter connected to the variable focal-length camera lens and PhotonMax CCD camera. The 
system was supported by an aluminum arm connected to the top of a standard optical table, 
creating a 90° angle between the optical axis of the imaging system and the table surface. The 
microscope-coupled system (Figure 1b) was connected to the camera port of a Zeiss OPMI 
Vario/NC2 operating microscope outfitted with f170 oculars. The VIS-20 tunable filter was 
mounted between the microscope camera port and an 85-mm focal length camera adapter. The 
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distal end of the camera adapter connected to the PhotonMax CCD camera. System focusing was 
dually controlled by the focusing optics of the microscope and the camera adapter.  
 To compare effective imaging speed between the two systems, image intensities were 
measured given equivalent samples and integration times. For the sample, a 99% Spectralon 
diffuse reflectance standard was illuminated by the halogen lamp used for diffuse reflectance 
excitation in the imaging system. A 10 mm x 10 mm square aperture was used to cover the 
reflectance standard to form a clearly defined sample for both imaging systems. Baseline and 
diffuse reflectance spectral images were acquired with both systems from 400 to 720 nm in 10 
nm increments and a 10 ms integration time per wavelength for the direct-view system and 100 
ms integration times for the microscope-based system. Measured spectra were baseline 
subtracted and corrected for the lamp spectrum and system sensitivity on a pixel-by-pixel basis. 
The spectra were corrected in a way so as to maintain the mean measured intensity across the 
spectrum for each pixel. The corrected spectra were then summed, rather than averaged, over the 
sample aperture such that differences in field of view and the subsequent number of pixels 
involved would not play a role in the measured intensities. A ratio of the summed spectra was 
calculated, taking into account the 10-fold difference in integration time between systems. The 
comparison was repeated for object distances of 8”, 10”, and 12” between the reflectance 
standard and the front face of the LCTF or the collection lens of the operating microscope. 
              
(a)                                                              (b)                                                              (c) 
Figure 1. (a) Direct-view and (b) microscope-coupled LCTF spectral imaging systems. (c) Experimental setup for 
quantitative comparison between interfaces. 
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Results 
 The corrected, summed spectra for each of the systems as well the ratio between them for 
each of the object distances are outlined in Figure 2. The corrected spectra for both systems are 
consistently uniform with wavelength, with coefficients of variation across the summed spectra 
that vary between 3% and 7.5%. The direct-view imaging system measures summed intensities 
which are consistently higher than the microscope-coupled system. The direct-view spectra 
decrease with object distance while the microscope-coupled spectra increases slightly, resulting 
in a decreased ratio between the two as object distance increases. The mean ratios across the 
spectral range of interest for the 8”, 10”, and 12” object distances are 43.2, 39.8, and 27.0, 
respectively.  
 
Discussion 
 The spectral uniformity for both systems indicates that the spectral correction procedure 
properly normalizes for the excitation spectrum of the halogen lamp and the detection sensitivity 
of the spectral imaging system. 
 The direct-view spectra decrease in intensity with object distance because the solid angle 
of the collection lens decreases with object distance. Given a constant aperture size and object 
distance for the collection lens, the solid angle should vary non-linearly with object distance (d) 
as 1/d2. However, the mean spectral intensities for the three object distances actually vary 
linearly with d (results not shown).  
              
(a)                                                            (b)                                                            (c) 
Figure 2. Comparison spectra for the direct-view and microscope-coupled LCTF spectral imaging systems for object 
distances of (a) 8”, (b) 10”, and (c) 12”. 
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 While the intensity ratios decrease with increased object distance, the mean intensities for 
the microscope-coupled system show no trend with d. While the collection solid angle for the 
microscope-coupled system also decreases with object distance, the optical throughput of the 
imaging system is more complex than a simple relationship to the collection solid angle. The 
field of view of the microscope-coupled system is consistently limited by one of the apertures 
along the light path from the collection lens to the camera. While the square aperture for the 
sample was inside the field of view of the microscope-coupled imaging system for all three 
object distances, the effective numerical aperture of the system may be a complex function of the 
focusing optics on the microscope and camera adapter. 
 Most importantly, the measured intensities for the direct-view spectral imaging system 
were consistently 25-45 times greater than equivalent measurements with the microscope-
coupled system. Given the fact that the microscope uses a 50/50 beamsplitter to split the 
collected light between the oculars and the camera port, a two- to three-fold difference between 
the systems was expected. While that kind of marginal difference in imaging speed could be 
overcome by the convenience of direct imaging with a microscope-coupled system, requiring in 
vivo autofluorescence image acquisition times to increase 35-fold from 45 seconds to 25 minutes 
is excessive. For these reasons, a microscope-coupled spectral imaging system is not a 
reasonable option at this time. However, as mentioned in the future directions, as LCTF, CCD, 
and excitation source technology improves and depending upon a more efficient interface for 
microscope coupling, incorporation LCTF spectral imaging directly into the operating 
microscope design may become feasible in the future.  
 Some of the reasons for the greater-than-expected intensity ratios between the imaging 
systems are 1) while the microscope uses a wide collection lens, it uses separate, significantly 
smaller apertures for each ocular with a beamsplitter along each path, and 2) while we cannot be 
sure where along the light path the field of view is aperture-limited (rather than array-limited), 
the bottleneck may occur at one of the apertures along the large distance between the camera port 
and the camera adapter, resulting in significant loss of light due to spectral imaging system 
design. Various focal length collection lenses were inserted between the microscope head and 
LCTF to determine if an extra focusing stage would improve the field of view, but every lens 
tested resulted in an inability to focus the system on the sample. 
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Conclusion 
 Given the current state of LCTF, CCD, and excitation source technology, direct-view 
LCTF spectral imaging is a more attractive option for clinical implementation, despite the burden 
of an imaging field of view which is decoupled from the surgical field as viewed through the 
operating microscope. Hopefully, future advances in spectral imaging technology and/or 
operating microscope design will allow for direct incorporation of the benefits of spectral 
imaging diagnosis into neurosurgical operating microscopes without significant loss of imaging 
speed and quality. 
 
